Research Sample bioBank
Can’t find what you’re looking for? Contact us.
Or, need help ordering? 805.528.4341
Get Weekly Research Sample Updates in your Inbox:
Tuberculosis (TB) Clinical Research Samples
Discovery Life Sciences provides the highest quality Tuberculosis (TB) Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank.
- All Tuberculosis (TB) Sample Orders are Packaged for Delivery within 24 Hours.
- All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
- Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
- Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations.
Advanced Data View:
Showing 689 of 689 total samples
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test Data 1 | Sample Detail 1 | Test 2 | Test Data 2 | Sample Detail 2 | Test 3 | Test Data 3 | Sample Detail 3 | Product Details | Price | Buy | Additional Information 1 | Additional Data 1 | Additional Detail 1 | Additional Information 2 | Additional Data 2 | Additional Detail 2 | Additional Information 3 | Additional Data 3 | Additional Detail 3 | Additional Information 4 | Additional Data 4 | Additional Detail 4 | Additional Information 5 | Additional Data 5 | Additional Detail 5 | Additional Information 6 | Additional Data 6 | Additional Detail 6 | Additional Information 7 | Additional Data 7 | ICD10 codes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DLS12-1255 | Tuberculosis (TB) | Russia | Sputum | 0.50 | 1.00 | $95.00 | 56 Y | M | White | <-70°C | 27-Mar-14 | Smear | Negative | Liquid Culture | Positive | Solid Culture | Positive | $95.00 | Symptoms | Cough/Sputum; Fever; Weight loss/Anorexia; Wheezing/SoB; Night sweats | Oraquick Advance HIV Rapid Test | Negative | Recent Contact with a Person Known to have TB | Yes | Previously Diagnosed with TB: | No | Previously Treated for TB: | No | Previously Vaccinated with BCG: | Yes | |||||||||||||||
| DLS12-1421 | Tuberculosis (TB) | Russia | Sputum | 0.50 | 1.00 | $95.00 | 52 Y | M | White | <-70°C | 04-Apr-14 | Smear | Negative | Liquid Culture | Positive | Solid Culture | Positive | $95.00 | Symptoms | Cough/Sputum; Weight loss/Anorexia; Wheezing/SoB; Night sweats; Fatigue | Oraquick Advance HIV Rapid Test | Negative | Recent Contact with a Person Known to have TB | Yes | Previously Diagnosed with TB: | No | Previously Treated for TB: | No | Previously Vaccinated with BCG: | Yes | |||||||||||||||
| DLS12-1424 | Tuberculosis (TB) | Russia | Sputum | 0.75 | 1.00 | $95.00 | 25 Y | M | White | <-70°C | 02-Apr-14 | Smear | Negative | Liquid Culture | Positive | Solid Culture | Positive | $95.00 | Symptoms | Cough/Sputum; Fever; Weight loss/Anorexia; Wheezing/SoB; Night sweats; Fatigue | Oraquick Advance HIV Rapid Test | Negative | Recent Contact with a Person Known to have TB | Yes | Previously Diagnosed with TB: | No | Previously Treated for TB: | No | Previously Vaccinated with BCG: | Yes | |||||||||||||||
| DLS12-1425 | Tuberculosis (TB) | Russia | Sputum | 0.50 | 1.00 | $95.00 | 35 Y | F | White | <-70°C | 24-Mar-14 | Smear | 3 | Liquid Culture | Positive | Solid Culture | Positive | $95.00 | Symptoms | Cough/Sputum; Fever; Weight loss/Anorexia; Wheezing/SoB; Night sweats; Fatigue: Lymphadenopathy | Oraquick Advance HIV Rapid Test | Negative | Recent Contact with a Person Known to have TB | Yes | Previously Diagnosed with TB: | No | Previously Treated for TB: | No | Previously Vaccinated with BCG: | Yes | |||||||||||||||
| DLS12-1428 | Tuberculosis (TB) | Russia | Sputum | 0.75 | 1.00 | $95.00 | 62 Y | M | White | <-70°C | 04-Apr-14 | Smear | 1 | Liquid Culture | Positive | Solid Culture | Positive | $95.00 | Symptoms | Cough/Sputum; Weight loss/Anorexia; Wheezing/SoB; Night sweats; Fatigue | Oraquick Advance HIV Rapid Test | Negative | Recent Contact with a Person Known to have TB | Unknown | Previously Diagnosed with TB: | No | Previously Treated for TB: | No | Previously Vaccinated with BCG: | Yes | |||||||||||||||
| DLS12-1429 | Tuberculosis (TB) | Russia | Sputum | 0.75 | 1.00 | $95.00 | 33 Y | M | White | <-70°C | 04-Apr-14 | Smear | 1 | Liquid Culture | Positive | Solid Culture | Positive | $95.00 | Symptoms | Cough/Sputum; Weight loss/Anorexia; Wheezing/SoB; Night sweats; Fatigue | Oraquick Advance HIV Rapid Test | Negative | Recent Contact with a Person Known to have TB | Yes | Previously Diagnosed with TB: | No | Previously Treated for TB: | No | Previously Vaccinated with BCG: | Yes | |||||||||||||||
| DLS12-1433 | Tuberculosis (TB) | Russia | Sputum | 0.50 | 1.00 | $350.00 | 35 Y | F | White | <-70°C | 24-Mar-14 | Smear | 2 | Liquid Culture | Positive | Solid Culture | Positive | $350.00 | Symptoms | Cough/Sputum; Fever; Weight loss/Anorexia; Wheezing/SoB; Night sweats; Fatigue | Oraquick Advance HIV Rapid Test | Negative | Recent Contact with a Person Known to have TB | Unknown | Previously Diagnosed with TB: | No | Previously Treated for TB: | No | Previously Vaccinated with BCG: | Yes | |||||||||||||||
| DLS12-1442 | Tuberculosis (TB) | Russia | Sputum | 0.75 | 1.00 | $95.00 | 47 Y | M | White | <-70°C | 24-Mar-14 | Smear | Negative | Liquid Culture | Negative | Solid Culture | Positive | $95.00 | Symptoms | Cough/Sputum; Fever; Weight loss/Anorexia; Wheezing/SoB; Night sweats | Oraquick Advance HIV Rapid Test | Negative | Recent Contact with a Person Known to have TB | Unknown | Previously Diagnosed with TB: | No | Previously Treated for TB: | No | Previously Vaccinated with BCG: | Yes | |||||||||||||||
| DLS12-1449 | Tuberculosis (TB) | Russia | Sputum | 0.25 | 1.00 | $95.00 | 42 Y | M | White | <-70°C | 27-Mar-14 | Smear | 1 | Liquid Culture | Positive | Solid Culture | Positive | $95.00 | Symptoms | Cough/Sputum; Fever; Weight loss/Anorexia; Wheezing/SoB; Night sweats; Fatigue | Oraquick Advance HIV Rapid Test | Negative | Recent Contact with a Person Known to have TB | Yes | Previously Diagnosed with TB: | No | Previously Treated for TB: | No | Previously Vaccinated with BCG: | Yes | |||||||||||||||
| DLS12-1452 | Tuberculosis (TB) | Russia | Sputum | 0.50 | 1.00 | $95.00 | 37 Y | M | White | <-70°C | 04-Apr-14 | Smear | 2 | Liquid Culture | Positive | Solid Culture | Positive | $95.00 | Symptoms | Cough/Sputum; Weight loss/Anorexia; Wheezing/SoB; Night sweats; Fatigue | Oraquick Advance HIV Rapid Test | Negative | Recent Contact with a Person Known to have TB | Unknown | Previously Diagnosed with TB: | No | Previously Treated for TB: | No | Previously Vaccinated with BCG: | Yes | |||||||||||||||
| DLS12-1453 | Tuberculosis (TB) | Russia | Sputum | 0.50 | 1.00 | $95.00 | 46 Y | M | White | <-70°C | 27-Mar-14 | Smear | 3 | Liquid Culture | Positive | Solid Culture | Positive | $95.00 | Symptoms | Cough/Sputum; Fever; Weight loss/Anorexia; Night sweats; Fatigue | Oraquick Advance HIV Rapid Test | Negative | Recent Contact with a Person Known to have TB | Yes | Previously Diagnosed with TB: | No | Previously Treated for TB: | No | Previously Vaccinated with BCG: | Yes | |||||||||||||||
| DLS14-01662 | Tuberculosis (TB) | Vietnam | Sputum | 0.75 | 1.00 | $350.00 | 26 Y | M | Asian | < -70C | 12-Mar-14 | Smear | 1 | Liquid Culture | Positive (17-Apr-14) | $350.00 | Symptoms | Cough/Sputum; Fever; Weight loss/Anorexia; Fatigue; Lymphadenopathy | Has Subject Had a Positive HIV Test in the Past 6 Months? | No | HIV Test Result and Manufacturer of Rapid Test | Negative; Roche | 12-Mar-14 | Recent Contact with a Person Known to have TB? | No | Been Diagnosed with TB in the Past? | No | Been Treated for TB in the Past? | No | Been Vaccinated with BCG in the Past? | Yes | ||||||||||||||
| DLS14-01703 | Tuberculosis (TB) | Vietnam | Sputum | 1.00 | 1.00 | $350.00 | 36 Y | M | Asian | < -70C | 15-Mar-14 | Smear | Negative | Liquid Culture | Positive (8-Apr-14) | $350.00 | Symptoms | Cough/Sputum; Fever; Weight loss/Anorexia; Fatigue; Lymphadenopathy | Has Subject Had a Positive HIV Test in the Past 6 Months? | No | HIV Test Result and Manufacturer of Rapid Test | Negative; Roche | 15-Mar-14 | Recent Contact with a Person Known to have TB? | No | Been Diagnosed with TB in the Past? | No | Been Treated for TB in the Past? | No | Been Vaccinated with BCG in the Past? | Yes | ||||||||||||||
| DLS14-01753 | Tuberculosis (TB) | South Africa | Sputum | 0.50 | 1.00 | $350.00 | 31 Y | M | Black | < -70C | 04-Feb-14 | Cepheid Gene X-Pert | Negative 4-Feb-2014 | $350.00 | Symptoms | Cough/Sputum; Fever; Weight loss/Anorexia; Night sweats; Fatigue; Chest pain | Has Subject Had a Positive HIV Test in the Past 6 Months? | No | HIV Test Result and Manufacturer of Rapid Test | Negative; Uni-gold Recombigen: Trinity Biotech | 4-Feb-14 | Recent Contact with a Person Known to have TB? | No | Been Diagnosed with TB in the Past? | No | Been Treated for TB in the Past? | No | Been Vaccinated with BCG in the Past? | Unknown | ||||||||||||||||
| DLS14-01755 | Tuberculosis (TB) | South Africa | Sputum | 0.50 | 1.00 | $350.00 | 42 Y | F | Black | < -70C | 05-Feb-14 | Liquid Culture | Negative | Cepheid Gene X-Pert | Negative | 5-Feb-2014 | $350.00 | Symptoms | Cough/Sputum; Fever; Wheezing/SoB; Fatigue; Chest pain; Loss of appetite; Headache | Has Subject Had a Positive HIV Test in the Past 6 Months? | No | HIV Test Result and Manufacturer of Rapid Test | Positive; Uni-gold Recombigen: Trinity Biotech | 5-Feb-14 | Recent Contact with a Person Known to have TB? | No | Been Diagnosed with TB in the Past? | Yes | 15-Dec-10 | Been Treated for TB in the Past? | Yes Rifafour and Rifinah for 9 months | Been Vaccinated with BCG in the Past? | Yes | ||||||||||||
| DLS14-01756 | Tuberculosis (TB) | South Africa | Sputum | 0.50 | 1.00 | $350.00 | 40 Y | M | Black | < -70C | 05-Feb-14 | Solid Culture | Positive (19-Feb-14) | Cepheid Gene X-Pert | Negative | 5-Feb-2014 | $350.00 | Symptoms | Cough/Sputum; Wheezing/SoB; Night sweats; Fatigue; Loss of appetite | Has Subject Had a Positive HIV Test in the Past 6 Months? | No | HIV Test Result and Manufacturer of Rapid Test | Positive; Uni-gold Recombigen: Trinity Biotech | 5-Feb-14 | Recent Contact with a Person Known to have TB? | No | Been Diagnosed with TB in the Past? | Yes | 15-Mar-08 | Been Treated for TB in the Past? | Yes Rifafour and Rifinah for 7 months | Been Vaccinated with BCG in the Past? | Yes | ||||||||||||
| DLS14-01891 | Tuberculosis (TB) | Uganda | Sputum | 1.00 | 1.00 | $350.00 | 21 Y | M | Black | < -70C | 27-Feb-14 | Smear | 2 | Solid Culture | Positive (28-Mar-14) | $350.00 | Symptoms | Cough/Sputum; Fever; Weight loss/Anorexia; Night sweats; Fatigue; Lymphadenopathy | Has Subject Had a Positive HIV Test? | Yes | 5-Feb-13 | Recent Contact with a Person Known to have TB? | No | Been Diagnosed with TB in the Past? | No | Been Treated for TB in the Past? | No | Been Vaccinated with BCG in the Past? | Yes | ||||||||||||||||
| DLS14-01917 | Tuberculosis (TB) | Uganda | Sputum | 0.75 | 1.00 | $350.00 | 54 Y | M | Black | < -70C | 26-Feb-14 | Smear | 1 | Solid Culture | Positive (1-Apr-14) | $350.00 | Symptoms | Cough/Sputum; Fever; Chest pain | Has Subject Had a Positive HIV Test? | No | Alere Determine HIV-1/2 | Negative | 26-Feb-14 | Recent Contact with a Person Known to have TB? | Unknown | Been Diagnosed with TB in the Past? | No | Been Treated for TB in the Past? | No | Been Vaccinated with BCG in the Past? | Unknown | ||||||||||||||
| DLS14-01920 | Tuberculosis (TB) | Uganda | Sputum | 0.50 | 1.00 | $350.00 | 34 Y | F | Black | < -70C | 21-Feb-14 | Smear | 3 | Solid Culture | Positive (28-Mar-14) | $350.00 | Symptoms | Cough/Sputum; Fever; Weight loss/Anorexia; Wheezing/SoB; Night sweats; Fatigue; Lymphadenopathy | Has Subject Had a Positive HIV Test? | No | Alere Determine HIV-1/2 | Negative | 21-Feb-14 | Recent Contact with a Person Known to have TB? | No | Been Diagnosed with TB in the Past? | No | Been Treated for TB in the Past? | No | Been Vaccinated with BCG in the Past? | Yes | ||||||||||||||
| DLS14-01940 | Tuberculosis (TB) | Uganda | Sputum | 0.75 | 1.00 | $350.00 | 31 Y | M | U/A | < -70C | 10-Mar-14 | Smear | 1 | Solid Culture | Positive (15-Apr-14) | $350.00 | Symptoms | Cough/Sputum; Fever; Chest pain | Has Subject Had a Positive HIV Test? | No | Alere Determine HIV-1/2 | Positive | 10-Mar-14 | Recent Contact with a Person Known to have TB? | Unknown | Been Diagnosed with TB in the Past? | No | Been Treated for TB in the Past? | No | Been Vaccinated with BCG in the Past? | Unknown | ||||||||||||||
| DLS14-01948 | Tuberculosis (TB) | Uganda | Sputum | 0.75 | 1.00 | $350.00 | 25 Y | M | Black | < -70C | 19-Feb-14 | Smear | 3 | Solid Culture | Positive (31-Mar-14) | $350.00 | Symptoms | Cough/Sputum; Fever; Weight loss/Anorexia; Night sweats; Fatigue; Lymphadenopathy | Has Subject Had a Positive HIV Test? | Yes | 14-May-13 | Recent Contact with a Person Known to have TB? | No | Been Diagnosed with TB in the Past? | No | Been Treated for TB in the Past? | No | Been Vaccinated with BCG in the Past? | Yes | ||||||||||||||||
| DLS14-01967 | Tuberculosis (TB) | Uganda | Sputum | 0.50 | 1.00 | $350.00 | 21 Y | F | Black | < -70C | 25-Mar-14 | Smear | 2 | Solid Culture | Positive (30-Apr-14) | $350.00 | Symptoms | Cough/Sputum; Fever; Weight loss/Anorexia; Night sweats | Has Subject Had a Positive HIV Test? | No | Alere Determine HIV-1/2 | Negative | 25-Mar-14 | Recent Contact with a Person Known to have TB? | No | Been Diagnosed with TB in the Past? | No | Been Treated for TB in the Past? | No | Been Vaccinated with BCG in the Past? | Yes | ||||||||||||||
| DLS14-02006 | Tuberculosis (TB) | Uganda | Sputum | 0.75 | 1.00 | $350.00 | 18 Y | M | Black | < -70C | 18-Mar-14 | Smear | 2 | Solid Culture | Positive (2-May-14) | $350.00 | Symptoms | Cough/Sputum; Fever; Weight loss/Anorexia; Night sweats | Has Subject Had a Positive HIV Test? | No | Alere Determine HIV-1/2 | Positive | 18-Mar-14 | Recent Contact with a Person Known to have TB? | No | Been Diagnosed with TB in the Past? | No | Been Treated for TB in the Past? | No | Been Vaccinated with BCG in the Past? | Yes | ||||||||||||||
| DLS14-02029 | Tuberculosis (TB) | Uganda | Sputum | 0.75 | 1.00 | $350.00 | 30 Y | M | Black | < -70C | 05-Mar-14 | Smear | 2 | Solid Culture | Positive (30-Apr-14) | $350.00 | Symptoms | Cough/Sputum; Fever | Has Subject Had a Positive HIV Test? | No | Alere Determine HIV-1/2 | Negative | 5-Mar-14 | Recent Contact with a Person Known to have TB? | No | Been Diagnosed with TB in the Past? | No | Been Treated for TB in the Past? | No | Been Vaccinated with BCG in the Past? | Yes | ||||||||||||||
| DLS14-02038 | Tuberculosis (TB) | Uganda | Sputum | 0.75 | 1.00 | $350.00 | 34 Y | M | Black | < -70C | 31-Mar-14 | Smear | 1 | Solid Culture | Positive (8-May-14) | $350.00 | Symptoms | Cough/Sputum; Fever | Has Subject Had a Positive HIV Test? | No | Alere Determine HIV-1/2 | Negative | 31-Mar-14 | Recent Contact with a Person Known to have TB? | No | Been Diagnosed with TB in the Past? | No | Been Treated for TB in the Past? | No | Been Vaccinated with BCG in the Past? | Yes | ||||||||||||||
| DLS14-20781 | Tuberculosis (TB) | Uganda | Sputum | 0.75 | 1.00 | $350.00 | 26 Y | F | Black | < -70C | 12-Sep-14 | Smear | 1 | Solid Culture | Positive (Confluent growth); 24-Nov-14 | $350.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Night sweats; Fatigue; Lymphadenopathy | Has Subject Had Positive HIV Test | Yes; 11-Jun-2014 | If no, Result, Date & Test Type of Rapid HIV Test | N/A; | Recent Contact with a Person Known to have TB? | No | Been Diagnosed with TB in the Past? | No | Been Treated for TB in the Past? | No | |||||||||||||||||
| DLS14-20790 | Tuberculosis (TB) | Uganda | Sputum | 0.50 | 1.00 | $350.00 | 29 Y | M | Black | < -70C | 11-Sep-14 | Smear | 2 | Solid Culture | Positive (Confluent growth); 24-Nov-14 | $350.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Night sweats; Fatigue | Has Subject Had Positive HIV Test | No | If no, Result, Date & Test Type of Rapid HIV Test | Negative; Alere Determine HIV 1/2 | 11-Sep-14 | Recent Contact with a Person Known to have TB? | No | Been Diagnosed with TB in the Past? | No | Been Treated for TB in the Past? | No | ||||||||||||||||
| DLS14-20811 | Tuberculosis (TB) | Uganda | Sputum | 0.25 | 1.00 | $350.00 | 42 Y | M | Black | < -70C | 10-Sep-14 | Smear | 3 | Solid Culture | Positive (Innumerable colonies); 15-Oct-14 | $350.00 | Symptoms | Cough; Fever; Wheezing / Shortness of breath; Night sweats; Fatigue | Has Subject Had Positive HIV Test | No | If no, Result, Date & Test Type of Rapid HIV Test | Negative; Alere Determine HIV 1/2 | 10-Sep-14 | Recent Contact with a Person Known to have TB? | No | Been Diagnosed with TB in the Past? | No | Been Treated for TB in the Past? | No | ||||||||||||||||
| DLS14-20769-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 5.00 | $450.00 | 25 Y | M | Black | <-70C | 02-Feb-15 | Smear | 1 | 2-Feb-2015 | Culture | Negative | 2-Feb-2015 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 2-Feb-2015 | ||||||||||||||||||||||
| DLS14-20801-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 2.00 | $450.00 | 34 Y | M | Black | <-70C | 09-Feb-15 | Smear | 1 | 9-Feb-2015 | Culture | Positive (9-Mar-2015) | 9-Feb-2015 | $450.00 | Symptoms | Cough; Fever; Fatigue | Alere Determine HIV 1/2 | Positive | 9-Feb-2015 | ||||||||||||||||||||||
| DLS14-31334-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 5.00 | $450.00 | 21 Y | F | Black | <-70C | 04-Feb-15 | Smear | 2 | 4-Feb-2015 | Culture | Positive (20-Mar-2015) | 4-Feb-2015 | $450.00 | Symptoms | Cough; Fever; Night sweats | Previous HIV Test | Positive | 12-Oct-2014 | ||||||||||||||||||||||
| DLS14-31335-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 6.00 | $450.00 | 24 Y | M | Black | <-70C | 09-Feb-15 | Smear | 1 | 9-Feb-2015 | Culture | Positive (9-Mar-2015) | 9-Feb-2015 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 9-Feb-2015 | ||||||||||||||||||||||
| DLS14-31341-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 1.00 | $450.00 | 37 Y | M | Black | <-70C | 03-Feb-15 | Smear | 1 | 3-Feb-2015 | Culture | Positive (6-Mar-2015) | 3-Feb-2015 | $450.00 | Symptoms | Cough; Fever; Fatigue | Alere Determine HIV 1/2 | Positive | 3-Feb-2015 | ||||||||||||||||||||||
| DLS14-31343-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 6.00 | $450.00 | 37 Y | M | Black | <-70C | 21-Jan-15 | Smear | 2 | 21-Jan-2015 | Culture | Positive (5-Mar-2015) | 21-Jan-2015 | $450.00 | Symptoms | Cough; Fever; Night sweats | Alere Determine HIV 1/2 | Positive | 21-Jan-2015 | ||||||||||||||||||||||
| DLS14-31344-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 7.00 | $450.00 | 33 Y | F | Black | <-70C | 30-Jan-15 | Smear | 2 | 30-Jan-2015 | Culture | Positive | 30-Jan-2015 | $450.00 | Symptoms | Cough; Fever; Wheezing / shortness of breath | Alere Determine HIV 1/2 | Positive | 30-Jan-2015 | ||||||||||||||||||||||
| DLS14-31346-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 1.00 | $450.00 | 21 Y | F | Black | <-70C | 02-Feb-15 | Smear | 1 | 2-Feb-2015 | Culture | Positive (3-Mar-2015) | 2-Feb-2015 | $450.00 | Symptoms | Cough; Fever; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 2-Feb-2015 | ||||||||||||||||||||||
| DLS14-31347-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 4.00 | $450.00 | 35 Y | F | Black | <-70C | 14-Jan-15 | Smear | 1 | 14-Jan-2015 | Culture | Negative | 14-Jan-2015 | $450.00 | Symptoms | Cough; Fever; Fatigue | Alere Determine HIV 1/2 | Negative | 14-Jan-2015 | ||||||||||||||||||||||
| DLS14-31348-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 1.00 | $450.00 | 24 Y | M | Black | <-70C | 30-Jan-15 | Smear | 2 | 30-Jan-2015 | Culture | Positive | 30-Jan-2015 | $450.00 | Symptoms | Cough; Fever; Night sweats | Alere Determine HIV 1/2 | Positive | 30-Jan-2015 | ||||||||||||||||||||||
| DLS14-31350-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 6.00 | $450.00 | 34 Y | F | Black | <-70C | 14-Jan-15 | Smear | 2 | 14-Jan-2015 | Culture | Positive (27-Feb-2015) | 14-Jan-2015 | $450.00 | Symptoms | Cough; Fever; Wheezing / shortness of breath | Previous HIV Test | Positive | 20-Dec-2014 | ||||||||||||||||||||||
| DLS14-31351-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 6.00 | $450.00 | 33 Y | F | Black | <-70C | 09-Feb-15 | Smear | 3 | 9-Feb-2015 | Culture | Positive (9-Mar-2015) | 9-Feb-2015 | $450.00 | Symptoms | Cough; Fever; Wheezing / shortness of breath | Alere Determine HIV 1/2 | Positive | 9-Feb-2015 | ||||||||||||||||||||||
| DLS14-31352-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 1.00 | $450.00 | 22 Y | M | Black | <-70C | 03-Feb-15 | Smear | 3 | 3-Feb-2015 | Culture | Positive (6-Mar-2015) | 3-Feb-2015 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 3-Feb-2015 | ||||||||||||||||||||||
| DLS14-31353-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 2.00 | $450.00 | 33 Y | F | Black | <-70C | 04-Feb-15 | Smear | 1 | 4-Feb-2015 | Culture | Positive (20-Mar-2015) | 4-Feb-2015 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Negative | 4-Feb-2015 | Exposure History | Unknown if recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. | ||||||||||||||||||||
| DLS14-31354-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 1.00 | $450.00 | 25 Y | F | Black | <-70C | 06-Feb-15 | Smear | 2 | 6-Feb-2015 | Culture | Positive (20-Mar-2015) | 6-Feb-2015 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Negative | 6-Feb-2015 | Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. | ||||||||||||||||||||
| DLS14-31355-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 7.00 | $450.00 | 31 Y | F | Black | <-70C | 01-Jan-15 | Smear | 3 | 1-Jan-2015 | Culture | Positive | 1-Jan-2015 | $450.00 | Symptoms | Cough; Fever; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 1-Jan-2015 | ||||||||||||||||||||||
| DLS14-31357-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 3.00 | $450.00 | 47 Y | M | Black | <-70C | 04-Feb-15 | Smear | 2 | 4-Feb-2015 | Culture | Positive (23-Mar-2015) | 4-Feb-2015 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Negative | 4-Feb-2015 | Exposure History | Unknown if recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. | ||||||||||||||||||||
| DLS14-31359-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 4.00 | $450.00 | 21 Y | F | Black | <-70C | 21-Jan-15 | Smear | 3 | 21-Jan-2015 | Culture | Positive (5-Mar-2015) | 21-Jan-2015 | $450.00 | Symptoms | Cough; Fever; Fatigue | Alere Determine HIV 1/2 | Positive | 21-Jan-2015 | ||||||||||||||||||||||
| DLS14-31361-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 7.00 | $450.00 | 25 Y | F | Black | <-70C | 30-Jan-15 | Smear | 2 | 30-Jan-2015 | Culture | Positive | 30-Jan-2015 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 30-Jan-2015 | ||||||||||||||||||||||
| DLS14-31362-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 6.00 | $450.00 | 37 Y | F | Black | <-70C | 02-Feb-15 | Smear | 2 | 2-Feb-2015 | Culture | Positive (27-Feb-2015) | 2-Feb-2015 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 2-Jan-2015 | ||||||||||||||||||||||
| DLS14-31363-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 7.00 | $450.00 | 27 Y | F | Black | <-70C | 14-Jan-15 | Smear | 2 | 14-Jan-2015 | Culture | Positive | 14-Jan-2015 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 14-Jan-2015 | ||||||||||||||||||||||
| DLS14-31364-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 6.00 | $450.00 | 42 Y | M | Black | <-70C | 01-Jan-15 | Smear | 2 | 1-Jan-2015 | Culture | Positive | 1-Jan-2015 | $450.00 | Symptoms | Cough; Fever; Night sweats | Alere Determine HIV 1/2 | Positive | 1-Jan-2015 | ||||||||||||||||||||||
| DLS14-31366-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 6.00 | $450.00 | 22 Y | M | Black | <-70C | 04-Feb-15 | Smear | 1 | 4-Feb-2015 | Culture | Positive | 4-Feb-2015 | $450.00 | Symptoms | Cough; Fever | Previous HIV Test | Positive | 13-Nov-2014 | ||||||||||||||||||||||
| DLS14-31367-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 1.00 | $450.00 | 36 Y | M | Black | <-70C | 02-Jan-15 | Smear | 2 | 2-Jan-2015 | Culture | Positive (27-Feb-2015) | 2-Jan-2015 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 2-Jan-2015 | ||||||||||||||||||||||
| DLS14-31369-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 7.00 | $450.00 | 25 Y | M | Black | <-70C | 05-Jan-15 | Smear | 2 | 5-Jan-2015 | Culture | Positive (27-Feb-2015) | 5-Jan-2015 | $450.00 | Symptoms | Cough; Fever; Fatigue | Alere Determine HIV 1/2 | Positive | 5-Jan-2015 | ||||||||||||||||||||||
| DLS14-31370-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 5.00 | $450.00 | 27 Y | F | Black | <-70C | 07-Jan-15 | Smear | 2 | 7-Jan-2015 | Culture | Positive | 7-Jan-2015 | $450.00 | Symptoms | Cough; Fever; Fatigue | Alere Determine HIV 1/2 | Positive | 7-Jan-2015 | ||||||||||||||||||||||
| DLS14-31371-S | Tuberculosis (TB) | Uganda | Serum | 1.00 | 3.00 | $450.00 | 22 Y | M | Black | <-70C | 21-Jan-15 | Smear | 2 | 21-Jan-2015 | Culture | Positive (5-Mar-2015) | 21-Jan-2015 | $450.00 | Symptoms | Cough; Fever; Wheezing / shortness of breath | Alere Determine HIV 1/2 | Negative | 21-Jan-2015 | Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. | ||||||||||||||||||||
| DLS14-31120 | Tuberculosis (TB) | Vietnam | Sputum | 2.00 | 1.00 | $350.00 | 63 Y | F | Asian | <-70C | 26-Mar-15 | Smear | 1 | Liquid Culture | NTM Nontuberculous mycobacteria (7-Apr-2015) | Rapid HIV Test | Negative | 26-Mar-15 | $350.00 | Symptoms | Cough/Sputum; Fever; Weight loss; Night sweats | Recent Contact with a Person Known to have TB | No | Been Diagnosed with TB in the Past | No | Been Treated for TB in the Past | No | Been Vaccinated with BCG in the Past | Unknown | ||||||||||||||||
| DLS14-20479 | Tuberculosis (TB) | Uganda | Sputum | 0.50 | 1.00 | $350.00 | 47 Y | M | Black | <-70C | 25-Jun-14 | Smear | 3 | Solid Culture | Positive (31-Jul-2014) | $350.00 | Symptoms | Cough; Fever; Weight loss; Night sweats; Fatigue | Has subject had a Positive HIV Test | N/A | 25-Jun-14 | Recent Contact with a person known to have TB? | No | Been Diagnosed with TB in the past? | No | Been Vaccinated with BCG in the past? | Yes | ||||||||||||||||||
| DLS14-20488 | Tuberculosis (TB) | Uganda | Sputum | 0.50 | 1.00 | $350.00 | 50 Y | M | Black | <-70C | 02-Jun-14 | Smear | 2 | Solid Culture | Positive (31-Jul-2014) | $350.00 | Symptoms | Cough; Fever; Weight loss; Night sweats; Lymphadenopathy | Has subject had a Positive HIV Test | HIV + | 6-Mar-14 | Recent Contact with a person known to have TB? | No | Been Diagnosed with TB in the past? | No | Been Vaccinated with BCG in the past? | Yes | ||||||||||||||||||
| DLS14-20489 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $350.00 | 37 Y | F | Black | <-70C | 23-Jun-14 | Smear | 3 | Solid Culture | Positive (29-Aug-2014) | 27-Jun-2014 | $350.00 | Symptoms | Cough; Fever; Weight loss; Night sweats; Fatigue | Has subject had a Positive HIV Test | N/A | 23-Jun-14 | Recent Contact with a person known to have TB? | No | Been Diagnosed with TB in the past? | No | Been Vaccinated with BCG in the past? | Yes | |||||||||||||||||
| DLS14-20490 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $350.00 | 47 Y | M | Black | <-70C | 05-Jun-14 | Smear | 2 | Solid Culture | Positive (25-Aug-2014) | 18-Jul-2014 | $350.00 | Symptoms | Cough; Fever; Night sweats; Fatigue | Has subject had a Positive HIV Test | N/A | 5-Jun-14 | Recent Contact with a person known to have TB? | No | Been Diagnosed with TB in the past? | No | Been Vaccinated with BCG in the past? | Yes | |||||||||||||||||
| DLS14-20491 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $350.00 | 37 Y | M | Black | <-70C | 10-Jun-14 | Smear | 2 | Solid Culture | Positive (31-Jul-2014) | 10-Jun-2014 | $350.00 | Symptoms | Cough; Fever; Weight loss; Night sweats; Fatigue; Lymphadenopathy | Has subject had a Positive HIV Test | HIV + | 4-Mar-14 | Recent Contact with a person known to have TB? | No | Been Diagnosed with TB in the past? | No | Been Vaccinated with BCG in the past? | Yes | |||||||||||||||||
| DLS14-20494 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $350.00 | 36 Y | M | Black | <-70C | 07-Aug-14 | Smear | Negative | Solid Culture | Negative (N/A) | $350.00 | Symptoms | Cough; Fever; Weight loss; Wheezing / SoB; Night sweats; Fatigue; Lymphadenopathy | Has subject had a Positive HIV Test | HIV + | 14-Jun-14 | Recent Contact with a person known to have TB? | No | Been Diagnosed with TB in the past? | No | Been Vaccinated with BCG in the past? | Yes | ||||||||||||||||||
| DLS14-20505 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $350.00 | 32 Y | M | Black | <-70C | 26-Jun-14 | Smear | 2 | Solid Culture | Positive (11-Aug-2014) | 30-Jun-2014 | $350.00 | Symptoms | Cough; Fever; Wheezing / SoB; Night sweats; Lymphadenopathy | Has subject had a Positive HIV Test | HIV + | 6-Apr-14 | Recent Contact with a person known to have TB? | No | Been Diagnosed with TB in the past? | No | Been Vaccinated with BCG in the past? | Yes | |||||||||||||||||
| DLS14-20506 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $350.00 | 30 Y | M | Black | <-70C | 14-Aug-14 | Smear | Negative | Solid Culture | Negative (N/A) | $350.00 | Symptoms | Cough; Weight loss; Wheezing / SoB; Night sweats; Fatigue | Has subject had a Positive HIV Test | N/A | 14-Aug-14 | Recent Contact with a person known to have TB? | No | Been Diagnosed with TB in the past? | No | Been Vaccinated with BCG in the past? | Yes | ||||||||||||||||||
| DLS14-20509 | Tuberculosis (TB) | Uganda | Sputum | 1.00 | 1.00 | $350.00 | 35 Y | M | Black | <-70C | 12-Aug-14 | Smear | Negative | Solid Culture | Negative (N/A) | $350.00 | Symptoms | Cough; Weight loss; Wheezing / SoB; Fatigue | Has subject had a Positive HIV Test | HIV + | 2-Mar-14 | Recent Contact with a person known to have TB? | No | Been Diagnosed with TB in the past? | No | Been Vaccinated with BCG in the past? | Yes | ||||||||||||||||||
| DLS14-20511 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $350.00 | 34 Y | F | Black | <-70C | 22-Jul-14 | Smear | 3 | Solid Culture | Positive (25-Aug-2014) | $350.00 | Symptoms | Cough; Fever; Weight loss; Night sweats; Fatigue | Has subject had a Positive HIV Test | N/A | 22-Jul-14 | Recent Contact with a person known to have TB? | No | Been Diagnosed with TB in the past? | No | Been Vaccinated with BCG in the past? | Yes | ||||||||||||||||||
| DLS14-20512 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $350.00 | 26 Y | M | Black | <-70C | 12-Jun-14 | Smear | 3 | Solid Culture | Positive (31-Jul-2014) | 27-Jun-2014 | $350.00 | Symptoms | Cough; Fever; Weight loss; Wheezing / SoB; Night sweats; Fatigue; Lymphadenopathy | Has subject had a Positive HIV Test | N/A | 12-Jun-14 | Recent Contact with a person known to have TB? | No | Been Diagnosed with TB in the past? | No | Been Vaccinated with BCG in the past? | Yes | |||||||||||||||||
| DLS14-20520 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $350.00 | 40 Y | F | Black | <-70C | 11-Jun-14 | Smear | 3 | Solid Culture | Positive (31-Jul-2014) | 22-Jun-2014 | $350.00 | Symptoms | Cough; Fever; Weight loss; Wheezing / SoB; Night sweats; Fatigue | Has subject had a Positive HIV Test | N/A | 11-Jun-14 | Recent Contact with a person known to have TB? | No | Been Diagnosed with TB in the past? | No | Been Vaccinated with BCG in the past? | No | |||||||||||||||||
| DLS14-20525 | Tuberculosis (TB) | Uganda | Sputum | 1.00 | 1.00 | $350.00 | 45 Y | M | Black | <-70C | 07-Jun-14 | Smear | 3 | Solid Culture | Positive (31-Jul-2014) | $350.00 | Symptoms | Cough; Fever; Night sweats; Fatigue | Has subject had a Positive HIV Test | N/A | 7-Jun-14 | Recent Contact with a person known to have TB? | No | Been Diagnosed with TB in the past? | No | Been Vaccinated with BCG in the past? | Yes | ||||||||||||||||||
| DLS14-20526 | Tuberculosis (TB) | Uganda | Sputum | 0.25 | 1.00 | $350.00 | 35 Y | F | Black | <-70C | 21-Aug-14 | Smear | 1 | Solid Culture | Positive (30-Sep-2014) | $350.00 | Symptoms | Cough; Weight loss; Wheezing / SoB; Night sweats; Fatigue; Lymphadenopathy | Has subject had a Positive HIV Test | HIV + | 16-Feb-14 | Recent Contact with a person known to have TB? | No | Been Diagnosed with TB in the past? | No | Been Vaccinated with BCG in the past? | Yes | ||||||||||||||||||
| DLS14-20528 | Tuberculosis (TB) | Uganda | Sputum | 0.25 | 1.00 | $350.00 | 27 Y | F | Black | <-70C | 03-Jul-14 | Smear | Negative | Solid Culture | Negative (N/A) | $350.00 | Symptoms | Cough; Weight loss; Night sweats; Fatigue; Lymphadenopathy | Has subject had a Positive HIV Test | N/A | 3-Jul-14 | Recent Contact with a person known to have TB? | No | Been Diagnosed with TB in the past? | No | Been Vaccinated with BCG in the past? | Yes | ||||||||||||||||||
| DLS14-20535 | Tuberculosis (TB) | Uganda | Sputum | 0.25 | 1.00 | $350.00 | 34 Y | M | Black | <-70C | 14-Jul-14 | Smear | Negative | Solid Culture | Negative (N/A) | $350.00 | Symptoms | Cough; Fever; Weight loss; Fatigue | Has subject had a Positive HIV Test | N/A | 14-Jul-14 | Recent Contact with a person known to have TB? | No | Been Diagnosed with TB in the past? | No | Been Vaccinated with BCG in the past? | Yes | ||||||||||||||||||
| DLS14-20541 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $350.00 | 34 Y | M | Black | <-70C | 16-Jul-14 | Smear | 3 | Solid Culture | Positive (25-Aug-2014) | $350.00 | Symptoms | Cough; Fever; Weight loss; Wheezing / SoB; Night sweats; Fatigue | Has subject had a Positive HIV Test | N/A | 16-Jul-14 | Recent Contact with a person known to have TB? | No | Been Diagnosed with TB in the past? | No | Been Vaccinated with BCG in the past? | Yes | ||||||||||||||||||
| DLS15-11064 | Tuberculosis (TB) | Russia | Sputum | 2.00 | 1.00 | $350.00 | 54 Y | M | White | <-70C | 26-Feb-16 | TB Acid Fast Bacili Smear | 1+ | TB Culture Method & Date | Method: LJ | 25-Feb-16 | TB Culture Results and Date of Positive Result | Positive | 20-Apr-2016 | $350.00 | Clinical Diagnosis Following Clincial Assessment / Test Results | M.Tb positive and X-ray positive | Symptoms | Cough; Fever; Weight loss / Anorexia; Night Sweats; Fatigue | Acquisition Method | Expectorated | Morning | Previous Exposure History | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | ||||||||||||||||
| DLS15-11077 | Tuberculosis (TB) | Russia | Sputum | 3.00 | 2.00 | $350.00 | 34 Y | M | White | <-70C | 18-Feb-16 | TB Acid Fast Bacili Smear | Negative | TB Culture Method & Date | Method: LJ | 15-Feb-16 | TB Culture Results and Date of Positive Result | Positive | 19-Apr-2016 | $350.00 | Clinical Diagnosis Following Clincial Assessment / Test Results | M.Tb positive and X-ray positive | Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / SoB; Night Sweats; Fatigue | Acquisition Method | Expectorated | Morning | Previous Exposure History | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | ||||||||||||||||
| DLS15-11108 | Tuberculosis (TB) | Russia | Sputum | 3.00 | 1.00 | $350.00 | 43 Y | M | White | <-70C | 18-Feb-16 | TB Acid Fast Bacili Smear | 1+ | TB Culture Method & Date | Method: LJ | 17-Feb-16 | TB Culture Results and Date of Positive Result | Positive | 14-Apr-2016 | $350.00 | Clinical Diagnosis Following Clincial Assessment / Test Results | M.Tb positive and X-ray positive | Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / SoB; Night Sweats; Fatigue; Lymphadenopathy | Acquisition Method | Expectorated | Morning | Previous Exposure History | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | ||||||||||||||||
| DLS16-36007-RAW | Tuberculosis (TB) | Uganda | Sputum | 3.00 | 1.00 | $450.00 | 27 Y | F | Black | <-70C | 18-Nov-16 | Smear | 1+ | 18-Nov-16 | Culture | Negative | 20-Jun-2017 | $450.00 | Symptoms | Cough; Fever; Weight loss | Alere Determine HIV 1/2 | Positive | 20-Dec-12 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | ||||||||||||||||||
| DLS16-36015-RAW | Tuberculosis (TB) | Uganda | Sputum | 2.75 | 1.00 | $450.00 | 30 Y | F | Black | <-70C | 21-Nov-16 | Smear | 1+ | 21-Nov-16 | Culture | Positive | 21-Nov-16 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Weight loss; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 10-Feb-14 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | Sensitive For | RIF, INH | |||||||||||||
| DLS16-36017-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 27 Y | F | Black | <-70C | 22-Nov-16 | Smear | 1+ | 22-Nov-16 | Culture | Positive | 12-May-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats | Alere Determine HIV 1/2 | Positive | 20-Jan-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | ||||||||||||||||||
| DLS16-36018-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 32 Y | M | Black | <-70C | 18-Nov-16 | Smear | 1+ | 18-Nov-16 | Culture | Negative | 18-Nov-16 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 11-Jun-00 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | ||||||||||||||||||
| DLS16-36022-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 31 Y | M | Black | <-70C | 24-Dec-16 | Smear | 1+ | 24-Dec-16 | Culture | Negative | 24-Dec-16 | $450.00 | Symptoms | Cough | Alere Determine HIV 1/2 | Positive | 10-Sep-13 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | ||||||||||||||||||
| DLS16-36026-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.75 | 1.00 | $450.00 | 50 Y | M | Black | <-70C | 28-Dec-16 | Smear | 2+ | 28-Dec-16 | Culture | Positive | 20-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 10-Feb-00 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | ||||||||||||||||||
| DLS16-36028-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 61 Y | M | Black | <-70C | 30-Nov-16 | Smear | 2+ | 30-Nov-16 | Culture | Negative | 13-Apr-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Negative | 10-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | U/A | ||||||||||||||||||
| DLS16-36029-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 35 Y | M | Black | <-70C | 13-Feb-17 | Smear | 1+ | 13-Feb-17 | Culture | Positive | 5-Jul-17 | $450.00 | Symptoms | Cough; Fever; Night sweats | Alere Determine HIV 1/2 | Positive | 30-Jan-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | ||||||||||||||||||
| DLS16-36035-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 35 Y | M | Black | <-70C | 01-Mar-17 | Smear | 1+ | 29-Feb-17 | Culture | Positive | 16-May-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 20-Sep-15 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | U/A | ||||||||||||||||||
| DLS16-36036-RAW | Tuberculosis (TB) | Uganda | Sputum | 3.00 | 1.00 | $450.00 | 32 Y | M | Black | <-70C | 18-Dec-16 | Smear | 1+ | 18-Dec-16 | Culture | Positive | 14-Apr-17 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough | Alere Determine HIV 1/2 | Positive | 10-Feb-2011 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | Sensitive for | RIF , INH | |||||||||||||
| DLS16-36037-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 32 Y | M | Black | <-70C | 18-Nov-16 | Smear | 2+ | 18-Nov-16 | Culture | Positive | 5-May-17 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 10-Jul-12 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | |||||||||||||||
| DLS16-36039-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 22 Y | M | Black | <-70C | 08-Dec-16 | Smear | 1+ | 8-Dec-16 | Culture | Negative | 20-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 10-Nov-2016 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | ||||||||||||||||||
| DLS16-36046-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 25 Y | M | Black | <-70C | 10-Feb-17 | Smear | 1+ | 10-Feb-17 | Culture | Positive | 10-Feb-17 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 15-Sep-14 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | Sensitive for | RIF, INH | |||||||||||||
| DLS16-36047-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 47 Y | M | Black | <-70C | 12-Jan-17 | Smear | 1+ | 12-Jan-17 | Culture | Negative | 20-Jun-17 | $450.00 | Symptoms | Cough; Fever; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 10-Jan-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | U/A | ||||||||||||||||||
| DLS16-36048-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 30 Y | F | Black | <-70C | 05-Jan-17 | Smear | 2+ | 5-Jan-17 | Culture | Negative | 20-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats | Alere Determine HIV 1/2 | Positive | 4-Jan-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | U/A | ||||||||||||||||||
| DLS16-36052-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 24 Y | F | Black | <-70C | 14-Jan-17 | Smear | 1+ | 14-Jan-17 | Culture | Negative | 20-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 6-Feb-2015 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | ||||||||||||||||||
| DLS16-36061-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 54 Y | M | Black | <-70C | 02-Jan-17 | Smear | 2+ | 2-Jan-17 | Culture | Negative | 20-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Negative | 1-Jan-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | ||||||||||||||||||
| DLS16-36063-RAW | Tuberculosis (TB) | Uganda | Sputum | 3.00 | 1.00 | $450.00 | 64 Y | M | Black | <-70C | 30-Dec-16 | Smear | 2+ | 30-Dec-16 | Culture | Positive | 5-May-17 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 20-Jan-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | U/A | |||||||||||||||
| DLS16-36065-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 44 Y | M | Black | <-70C | 12-Nov-16 | Smear | 1+ | 12-Nov-16 | Culture | Negative | 12-Nov-16 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Fatigue | Alere Determine HIV 1/2 | Positive | 16-Jun-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | ||||||||||||||||||
| DLS16-36066-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 26 Y | M | Black | <-70C | 24-Jan-17 | Smear | 2+ | 24-Jan-17 | Culture | Negative | 20-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 17-Jan-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | ||||||||||||||||||
| DLS16-36069-RAW | Tuberculosis (TB) | Uganda | Sputum | 3.00 | 1.00 | $450.00 | 35 Y | M | Black | <-70C | 30-Nov-16 | Smear | 2+ | 30-Nov-16 | Culture | Negative | 20-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats | Alere Determine HIV 1/2 | Negative | 10-Apr-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | ||||||||||||||||||
| DLS16-36073-RAW | Tuberculosis (TB) | Uganda | Sputum | 3.50 | 1.00 | $450.00 | 52 Y | F | Black | <-70C | 21-Dec-16 | Smear | 1+ | 21-Dec-16 | Culture | Positive | 16-May-17 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 11-Aug-99 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | U/A | |||||||||||||||
| DLS16-36074-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.75 | 1.00 | $450.00 | 24 Y | M | Black | <-70C | 23-Nov-16 | Smear | 1+ | 23-Nov-16 | Culture | Negative | 20-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia | Alere Determine HIV 1/2 | Negative | 22-Jul-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | U/A | ||||||||||||||||||
| DLS16-36075-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.25 | 1.00 | $450.00 | 24 Y | M | Black | <-70C | 23-Dec-16 | Smear | 2+ | 23-Dec-16 | Culture | Negative | 20-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 20-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | U/A | ||||||||||||||||||
| DLS16-36087-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 32 Y | M | Black | <-70C | 12-Jan-17 | Smear | 2+ | 12-Jan-17 | Culture | Negative | 20-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Negative | 16-Jan-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | ||||||||||||||||||
| DLS16-36089-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 24 Y | F | Black | <-70C | 12-Jan-17 | Smear | 2+ | 12-Jan-17 | Culture | Positive | 02-May-17 | Hain | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 12-Jan-2017 | Previous Exposure History | Unknown if has had recent contact with person with TB | Previously Vaccinated with BCG: | U/A | |||||||||||||||
| DLS16-36090-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 60 Y | M | Black | <-70C | 03-Jan-17 | Smear | 1+ | 3-Jan-17 | Culture | Positive | 3-May-17 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 16-Jan-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | U/A | |||||||||||||||
| DLS16-36093-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 25 Y | M | Black | <-70C | 25-Dec-16 | Smear | 1+ | 25-Dec-16 | Culture | Negative | 25-Dec-16 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Negative | 29-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | ||||||||||||||||||
| DLS16-36094-RAW | Tuberculosis (TB) | Uganda | Sputum | 3.00 | 1.00 | $450.00 | 45 Y | M | Black | <-70C | 28-Dec-16 | Smear | 1+ | 28-Dec-16 | Culture | Negative | 20-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 10-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | ||||||||||||||||||
| DLS16-36097-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 30 Y | F | Black | <-70C | 24-Jan-17 | Smear | 1+ | 24-Jan-17 | Culture | Positive | 5-May-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Negative | 20-Jan-2017 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | ||||||||||||||||||
| DLS16-36099-RAW | Tuberculosis (TB) | Uganda | Sputum | 3.00 | 1.00 | $450.00 | 43 Y | M | Black | <-70C | 17-Jan-17 | Smear | 1+ | 17-Jan-17 | Culture | Negative | 20-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 20-Sep-14 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | ||||||||||||||||||
| DLS16-36100-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 31 Y | M | Black | <-70C | 12-Jan-17 | Smear | 1+ | 12-Jan-17 | Culture | Positive | 3-May-17 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Negative | 9-Feb-2017 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | |||||||||||||||
| DLS16-36115-RAW | Tuberculosis (TB) | Uganda | Sputum | 3.00 | 1.00 | $450.00 | 38 Y | M | Black | <-70C | 03-Feb-17 | Smear | 1+ | 3-Feb-17 | Culture | Positive | 4-May-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 19-Apr-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | ||||||||||||||||||
| DLS16-36122-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.75 | 1.00 | $450.00 | 64 Y | M | Black | <-70C | 21-Nov-16 | Smear | 1+ | 21-Nov-16 | Culture | Negative | 20-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Negative | N/A | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | U/A | ||||||||||||||||||
| DLS16-36123-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 56 Y | M | Black | <-70C | 03-Feb-17 | Smear | 1+ | 3-Feb-17 | Culture | Negative | 20-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 20-Aug-14 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | ||||||||||||||||||
| DLS16-36128-RAW | Tuberculosis (TB) | Uganda | Sputum | 7.00 | 1.00 | $450.00 | 37 Y | F | Black | <-70C | 13-Feb-17 | Smear | 1+ | 13-Feb-17 | Culture | Positive | 5-May-17 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 19-Mar-2015 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | Yes | |||||||||||||||
| DLS16-36142-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 37 Y | M | Black | <-70C | 23-Nov-16 | Smear | 1+ | 23-Nov-16 | Culture | Positive | 19-May-17 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia | Alere Determine HIV 1/2 | Positive | 10-Jun-2015 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously | Previously Vaccinated with BCG: | U/A | |||||||||||||||
| DLS12-2575 | Tuberculosis (TB) | Mexico | Sputum | 4.50 | 1.00 | $350.00 | 24 Y | F | Hispanic | <-70C | 12-Apr-16 | Clinical Diagnosis | Suspect TB | Smear | Negative | 12-Apr-16 | Liquid Culture | Positive | 12-Apr-16 | $350.00 | Solid Culture | Positive | 12-Apr-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure History | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Acquisition Method | Induced | ||||||||||||||||
| DLS12-1890 | Tuberculosis (TB) | Mexico | Sputum | 4.00 | 1.00 | $350.00 | 23 Y | F | Hispanic | <-70C | 13-Apr-16 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 13-Apr-16 | Liquid Culture | Positive | 13-Apr-16 | $350.00 | Solid Culture | Positive | 13-Apr-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats | Previous TB Exposure History | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Acquisition Method | Expectorated | ||||||||||||||||
| DLS12-1814 | Tuberculosis (TB) | Mexico | Sputum | 7.50 | 1.00 | $350.00 | 50 Y | M | Hispanic | <-70C | 21-Apr-16 | Clinical Diagnosis | Suspect TB | Smear | Negative | 21-Apr-16 | Liquid Culture | Negative | 21-Apr-16 | $350.00 | Solid Culture | Negative | 21-Apr-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure History | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Acquisition Method | Expectorated | ||||||||||||||||
| DLS12-1902 | Tuberculosis (TB) | Mexico | Sputum | 4.50 | 1.00 | $350.00 | 63 Y | F | Hispanic | <-70C | 22-Apr-16 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 22-Apr-16 | Liquid Culture | Positive | 22-Apr-16 | $350.00 | Solid Culture | Positive | 22-Apr-16 | Signs and Symptoms | Cough; Weight loss / Anorexia; Night sweats; Fatigue | Previous TB Exposure History | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Acquisition Method | Expectorated | ||||||||||||||||
| DLS12-1913 | Tuberculosis (TB) | Mexico | Sputum | 3.00 | 1.00 | $350.00 | 36 Y | M | Hispanic | <-70C | 25-Apr-16 | Clinical Diagnosis | Suspect TB | Smear | Negative | 25-Apr-16 | Liquid Culture | Negative | 25-Apr-16 | $350.00 | Solid Culture | Negative | 25-Apr-16 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure History | Recent contact with person with TB. Previous TB diagnosis in Oct-2009. Previous treatment with HZRE from Oct-2009 to Apr-2010. Previous BCG vaccine. | Acquisition Method | Expectorated | ||||||||||||||||
| DLS12-1905 | Tuberculosis (TB) | Mexico | Sputum | 4.50 | 1.00 | $350.00 | 48 Y | M | Hispanic | <-70C | 25-Apr-16 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 25-Apr-16 | Liquid Culture | Positive | 25-Apr-16 | $350.00 | Solid Culture | Positive | 25-Apr-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure History | No recent contact with person with TB. Previous TB diagnosis in Mar-2004. Previous treatment with DOTBAL from Mar-2004 to Sep-2004. Previous BCG vaccine. | Acquisition Method | Expectorated | ||||||||||||||||
| DLS12-1911 | Tuberculosis (TB) | Mexico | Sputum | 4.00 | 1.00 | $350.00 | 49 Y | M | Hispanic | <-70C | 04-May-16 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 4-May-16 | Liquid Culture | Positive | 4-May-16 | $350.00 | Solid Culture | Positive | 4-May-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure History | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Acquisition Method | Expectorated | ||||||||||||||||
| DLS12-1897 | Tuberculosis (TB) | Mexico | Sputum | 4.00 | 1.00 | $350.00 | 45 Y | M | Hispanic | <-70C | 09-May-16 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 9-May-16 | Liquid Culture | Positive | 9-May-16 | $350.00 | Solid Culture | Positive | 9-May-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Previous TB Exposure History | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Acquisition Method | Expectorated | ||||||||||||||||
| DLS12-1872 | Tuberculosis (TB) | Mexico | Sputum | 2.00 | 1.00 | $350.00 | 48 Y | M | Hispanic | <-70C | 09-May-16 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 9-May-16 | Liquid Culture | Positive | 9-May-16 | $350.00 | Solid Culture | Positive | 9-May-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure History | Recent contact with person with TB. Previous TB diagnosis in Feb-2006. Previous treatment with HRZE from Feb-2006 to Jul-2006. Previous BCG vaccine. | Acquisition Method | Expectorated | ||||||||||||||||
| DLS12-1893 | Tuberculosis (TB) | Mexico | Sputum | 4.75 | 1.00 | $350.00 | 48 Y | M | Hispanic | <-70C | 09-May-16 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 9-May-16 | Liquid Culture | Positive | 9-May-16 | $350.00 | Solid Culture | Positive | 9-May-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Previous TB Exposure History | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Acquisition Method | Expectorated | ||||||||||||||||
| DLS12-1889 | Tuberculosis (TB) | Mexico | Sputum | 4.75 | 1.00 | $350.00 | 40 Y | M | Hispanic | <-70C | 16-May-16 | Clinical Diagnosis | Suspect TB | Smear | Negative | 16-May-16 | Liquid Culture | Contaminated | 16-May-16 | $350.00 | Solid Culture | Negative | 16-May-16 | Signs and Symptoms | Cough; Wheezing / Shortness of breath; Night sweats | Previous TB Exposure History | No recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Acquisition Method | Expectorated | ||||||||||||||||
| DLS12-1914 | Tuberculosis (TB) | Mexico | Sputum | 4.50 | 1.00 | $350.00 | 48 Y | M | Hispanic | <-70C | 16-May-16 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 16-May-16 | Liquid Culture | Positive | 16-May-16 | $350.00 | Solid Culture | Positive | 16-May-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Previous TB Exposure History | No contact with person with TB. No previous TB diagnosis. Previous BCG vaccine. | Acquisition Method | Induced | ||||||||||||||||
| DLS12-1908 | Tuberculosis (TB) | Mexico | Sputum | 5.00 | 1.00 | $350.00 | 77 Y | F | Hispanic | <-70C | 17-May-16 | Clinical Diagnosis | Suspect TB | Smear | Negative | 17-May-16 | Liquid Culture | Contaminated | 17-May-16 | $350.00 | Solid Culture | Negative | 17-May-16 | Signs and Symptoms | Cough; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure History | Recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Acquisition Method | Expectorated | ||||||||||||||||
| DLS12-1894 | Tuberculosis (TB) | Mexico | Sputum | 4.50 | 1.00 | $350.00 | 51 Y | F | Hispanic | <-70C | 19-May-16 | Clinical Diagnosis | Suspect TB | Smear | Negative | 19-May-16 | Liquid Culture | Negative | 19-May-16 | $350.00 | Solid Culture | Negative | 19-May-16 | Signs and Symptoms | Cough; Wheezing / Shortness of breath; Fatigue; Lymphadenopathy | Previous TB Exposure History | Unknown if recent contact with person with TB. Previous TB diagnosis in Feb-2009. Previous treatment with HRZE from Feb-2009 to Aug-2009. No previous BCG vaccine. | Acquisition Method | Expectorated | ||||||||||||||||
| DLS12-1904 | Tuberculosis (TB) | Mexico | Sputum | 6.00 | 1.00 | $350.00 | 60 Y | F | Hispanic | <-70C | 24-May-16 | Clinical Diagnosis | Suspect TB | Smear | Negative | 24-May-16 | Liquid Culture | Positive | 24-May-16 | $350.00 | Solid Culture | Positive | 24-May-16 | Signs and Symptoms | Cough; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure History | Recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Acquisition Method | Expectorated | ||||||||||||||||
| DLS12-1912 | Tuberculosis (TB) | Mexico | Sputum | 5.00 | 1.00 | $350.00 | 34 Y | M | Hispanic | <-70C | 25-May-16 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 25-May-16 | Liquid Culture | Positive | 25-May-16 | $350.00 | Solid Culture | Positive | 25-May-16 | Signs and Symptoms | Cough; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure History | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Acquisition Method | Expectorated | ||||||||||||||||
| DLS12-1909 | Tuberculosis (TB) | Mexico | Sputum | 4.00 | 1.00 | $350.00 | 48 Y | M | Hispanic | <-70C | 26-May-16 | Clinical Diagnosis | Suspect TB | Smear | Negative | 26-May-16 | Liquid Culture | Negative | 26-May-16 | $350.00 | Solid Culture | Negative | 26-May-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure History | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Acquisition Method | Expectorated | ||||||||||||||||
| DLS12-1915 | Tuberculosis (TB) | Mexico | Sputum | 5.00 | 1.00 | $350.00 | 40 Y | M | Hispanic | <-70C | 31-May-16 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 31-May-16 | Liquid Culture | Positive | 1-Jun-16 | $350.00 | Solid Culture | Positive | 1-Jun-16 | Signs and Symptoms | Cough; Fever; Fatigue | Previous TB Exposure History | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Acquisition Method | Expectorated | ||||||||||||||||
| DLS12-1910 | Tuberculosis (TB) | Mexico | Sputum | 3.25 | 1.00 | $350.00 | 57 Y | F | Hispanic | <-70C | 01-Jun-16 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 1-Jun-16 | Liquid Culture | Positive | 1-Jun-16 | $350.00 | Solid Culture | Positive | 1-Jun-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure History | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Acquisition Method | Expectorated | ||||||||||||||||
| DLS12-1899 | Tuberculosis (TB) | Mexico | Sputum | 3.50 | 1.00 | $350.00 | 69 Y | M | Hispanic | <-70C | 01-Jun-16 | Clinical Diagnosis | Suspect TB | Smear | Negative | 1-Jun-16 | Liquid Culture | Negative | 1-Jun-16 | $350.00 | Solid Culture | Negative | 1-Jun-16 | Signs and Symptoms | Cough; Night sweats | Previous TB Exposure History | Unknown contact with person with TB. Previous TB diagnosis in 2011. Previous treatment from May-2011 to Nov-2011. Unknown if previous BCG vaccine. | Acquisition Method | Expectorated | ||||||||||||||||
| DLS12-1892 | Tuberculosis (TB) | Mexico | Sputum | 17.00 | 1.00 | $350.00 | 22 Y | F | Hispanic | <-70C | 03-Jun-16 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 3-Jun-16 | Liquid Culture | Positive | 3-Jun-16 | $350.00 | Solid Culture | Positive | 3-Jun-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Previous TB Exposure History | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Acquisition Method | Induced | ||||||||||||||||
| DLS12-1952 | Tuberculosis (TB) | Mexico | Sputum | 5.00 | 1.00 | $350.00 | 30 Y | F | Hispanic | <-70C | 03-Jun-16 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 3-Jun-16 | Liquid Culture | Positive | 3-Jun-16 | $350.00 | Solid Culture | Positive | 3-Jun-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats | Previous TB Exposure History | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Acquisition Method | Induced | ||||||||||||||||
| DLS12-1917 | Tuberculosis (TB) | Mexico | Sputum | 4.75 | 1.00 | $350.00 | 45 Y | M | Hispanic | <-70C | 03-Jun-16 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 3-Jun-16 | Liquid Culture | Positive | 3-Jun-16 | $350.00 | Solid Culture | Positive | 3-Jun-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Previous TB Exposure History | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Acquisition Method | Induced | ||||||||||||||||
| DLS12-1803 | Tuberculosis (TB) | Mexico | Sputum | 4.25 | 1.00 | $350.00 | 43 Y | M | Hispanic | <-70C | 06-Jun-16 | Clinical Diagnosis | Suspect TB | Smear | Negative | 6-Jun-16 | Liquid Culture | Contaminated | 6-Jun-16 | $350.00 | Solid Culture | Negative | 6-Jun-16 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure History | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Acquisition Method | Induced | ||||||||||||||||
| DLS12-1967 | Tuberculosis (TB) | Mexico | Sputum | 4.25 | 1.00 | $350.00 | 27 Y | F | Hispanic | <-70C | 07-Jun-16 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 7-Jun-16 | Liquid Culture | Positive | 7-Jun-16 | $350.00 | Solid Culture | Positive | 7-Jun-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure History | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Acquisition Method | Induced | ||||||||||||||||
| DLS12-1937 | Tuberculosis (TB) | Mexico | Sputum | 2.00 | 1.00 | $95.00 | 36 Y | M | U/A | <-70C | 13-Oct-15 | Clinical Diagnosis | Suspect TB | Smear | 3 | 13-Oct-15 | Liquid Culture | Positive | 17-Oct-15 | $95.00 | Solid Culture | Positive | 27-Oct-15 | Signs and Symptoms | Cough; Weight loss; Wheezing / SoB; Night sweats; Fatigue | Previous TB Exposure History | Has not had recent contact with person with TB. Has not been diagnosed or treated with TB previously. Has received BCG vaccine previously. | ||||||||||||||||||
| DLS12-1944 | Tuberculosis (TB) | Mexico | Sputum | 1.00 | 1.00 | $95.00 | 52 Y | M | U/A | <-70C | 10-Nov-15 | Clinical Diagnosis | Suspect TB | Smear | 1 | 10-Nov-15 | Liquid Culture | Positive | 24-Nov-15 | $95.00 | Solid Culture | Positive | 30-Nov-15 | Signs and Symptoms | Cough; Fever; Wheezing / SoB; Night sweats | Previous TB Exposure History | Recent contact with person with TB. Has not been previously diagnosed with TB . Has not received BCG vaccine previously. | ||||||||||||||||||
| DLS12-1964 | Tuberculosis (TB) | Mexico | Sputum | 3.00 | 1.00 | $95.00 | 17 Y | F | U/A | <-70C | 18-Nov-15 | Clinical Diagnosis | Suspect TB | Smear | 3 | 18-Nov-15 | Liquid Culture | Positive | 25-Nov-15 | $95.00 | Solid Culture | Positive | 18-Nov-15 | Signs and Symptoms | Cough; Weight loss; Wheezing / SoB; Fatigue | Previous TB Exposure History | Has not had recent contact with person with TB. Previously diagnosed with TB on 4-Jul-2014. Previously treated for TB with HRZE. Has received BCG vaccine previously. | ||||||||||||||||||
| DLS14-20484 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 41 Y | F | Black | <-70C | 20-Aug-14 | Clinical Diagnosis | Suspect TB | Smear | 1 | 20-Aug-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Positive (30-Sep-14) | 20-Aug-2014 | Signs and Symptoms | Cough; Fever; Weight loss; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Positive | 12-Aug-14 | ||||||||||||||||
| DLS14-20492 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 39 Y | F | Black | <-70C | 14-Aug-14 | Clinical Diagnosis | Suspect TB | Smear | Negative | 14-Aug-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Negative | 14-Aug-2014 | Signs and Symptoms | Cough; Fever; Weight loss; Night sweats | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Positive | 10-Feb-14 | ||||||||||||||||
| DLS14-20500 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 24 Y | F | Black | <-70C | 18-Aug-14 | Clinical Diagnosis | Suspect TB | Smear | 3 | 18-Aug-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Positive (30-Sep-14) | 18-Aug-2014 | Signs and Symptoms | Cough; Fever; Weight loss; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Positive | 3-May-14 | ||||||||||||||||
| DLS14-20501 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 35 Y | M | Black | <-70C | 22-Aug-14 | Clinical Diagnosis | Suspect TB | Smear | 1 | 22-Aug-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Positive (30-Sep-14) | 25-Aug-2014 | Signs and Symptoms | Cough; Weight loss; Wheezing / SoB; Night sweats; Fatigue | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Negative | 22-Aug-14 | ||||||||||||||||
| DLS14-20503 | Tuberculosis (TB) | Uganda | Sputum | 1.25 | 1.00 | $95.00 | 52 Y | F | Black | <-70C | 11-Jul-14 | Clinical Diagnosis | Suspect TB | Smear | Negative | 11-Jul-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Negative | 22-Jul-2014 | Signs and Symptoms | Cough; Wheezing / SoB; Night sweats; Fatigue | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Negative | 11-Jul-14 | ||||||||||||||||
| DLS14-20533 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 28 Y | M | Black | <-70C | 04-Jul-14 | Clinical Diagnosis | Suspect TB | Smear | Negative | 4-Jul-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Negative | 22-Jul-2014 | Signs and Symptoms | Cough; Fever; Night sweats; Fatigue | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Negative | 4-Jul-14 | ||||||||||||||||
| DLS14-20536 | Tuberculosis (TB) | Uganda | Sputum | 1.00 | 1.00 | $95.00 | 37 Y | F | Black | <-70C | 26-Jun-14 | Clinical Diagnosis | Suspect TB | Smear | Negative | 26-Jun-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Negative | 30-Jun-2014 | Signs and Symptoms | Cough; Fever; Weight loss; Wheezing / SoB; Night sweats | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Negative | 26-Jun-14 | ||||||||||||||||
| DLS14-20539 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 34 Y | M | Black | <-70C | 19-Jun-14 | Clinical Diagnosis | Suspect TB | Smear | Negative | 19-Jun-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Negative | 30-Jun-2014 | Signs and Symptoms | Cough; Weight loss; Wheezing / SoB; Night sweats; Fatigue | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Negative | 19-Jun-14 | ||||||||||||||||
| DLS14-20542 | Tuberculosis (TB) | Uganda | Sputum | 0.50 | 1.00 | $95.00 | 33 Y | F | Black | <-70C | 01-Jul-14 | Clinical Diagnosis | Suspect TB | Smear | 1 | 1-Jul-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Positive (15-Aug-14) | 22-Jul-2014 | Signs and Symptoms | Cough; Fever; Weight loss; Wheezing / SoB; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Positive | 10-Jun-14 | ||||||||||||||||
| DLS14-20544 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 25 Y | M | Black | <-70C | 21-Jul-14 | Clinical Diagnosis | Suspect TB | Smear | 3 | 21-Jul-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Positive (30-Sep-14) | 22-Jul-2014 | Signs and Symptoms | Cough; Weight loss; Wheezing / SoB; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Positive | 2-Mar-14 | ||||||||||||||||
| DLS14-20545 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 30 Y | M | Black | <-70C | 02-Jul-14 | Clinical Diagnosis | Suspect TB | Smear | Negative | 2-Jul-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Negative | 2-Jul-2014 | Signs and Symptoms | Cough; Weight loss; Wheezing / SoB; Night sweats; Lymphadenopathy | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Positive | 1-May-14 | ||||||||||||||||
| DLS14-20546 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 33 Y | M | Black | <-70C | 27-Jun-14 | Clinical Diagnosis | Suspect TB | Smear | Negative | 27-Jun-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Negative | 30-Jun-2014 | Signs and Symptoms | Cough; Fever; Weight loss; Night sweats; Fatigue | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Negative | 27-Jun-14 | ||||||||||||||||
| DLS14-20547 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 22 Y | F | Black | <-70C | 15-Jul-14 | Clinical Diagnosis | Suspect TB | Smear | Negative | 15-Jul-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Negative | 22-Jul-2014 | Signs and Symptoms | Cough; Weight loss; Night sweats; Fatigue | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Negative | 15-Jul-14 | ||||||||||||||||
| DLS14-20550 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 33 Y | M | Black | <-70C | 19-Jun-14 | Clinical Diagnosis | Suspect TB | Smear | Negative | 19-Jun-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Negative | 30-Jun-2014 | Signs and Symptoms | Cough; Fever; Weight loss; Wheezing / SoB; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Positive | 12-May-14 | ||||||||||||||||
| DLS14-20551 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 38 Y | M | Black | <-70C | 30-Jun-14 | Clinical Diagnosis | Suspect TB | Smear | Negative | 30-Jun-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Negative | 30-Jun-2014 | Signs and Symptoms | Cough; Weight loss; Night sweats; Fatigue | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Negative | 30-Jun-14 | ||||||||||||||||
| DLS14-20552 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 28 Y | M | Black | <-70C | 13-Jun-14 | Clinical Diagnosis | Suspect TB | Smear | Negative | 13-Jun-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Negative | 30-Jun-2014 | Signs and Symptoms | Cough; Fever; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Positive | 4-Feb-14 | ||||||||||||||||
| DLS14-20554 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 25 Y | F | Black | <-70C | 27-Jun-14 | Clinical Diagnosis | Suspect TB | Smear | Negative | 27-Jun-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Negative | 30-Jun-2014 | Signs and Symptoms | Cough; Fever; Weight loss; Night sweats | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Negative | 27-Jun-14 | ||||||||||||||||
| DLS14-20558 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 35 Y | F | Black | <-70C | 18-Jul-14 | Clinical Diagnosis | Suspect TB | Smear | Negative | 18-Jul-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Negative | 22-Jul-2014 | Signs and Symptoms | Cough; Fever; Weight loss; Night sweats; Fatigue | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Negative | 18-Jul-14 | ||||||||||||||||
| DLS14-20559 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 35 Y | F | Black | <-70C | 30-Jun-14 | Clinical Diagnosis | Suspect TB | Smear | Negative | 30-Jun-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Negative | 22-Jul-2014 | Signs and Symptoms | Cough; Fever; Wheezing / SoB; Night sweats | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Negative | 30-Jun-14 | ||||||||||||||||
| DLS14-20562 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 25 Y | M | Black | <-70C | 25-Jun-14 | Clinical Diagnosis | Suspect TB | Smear | Negative | 25-Jun-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Negative | 30-Jun-2014 | Signs and Symptoms | Cough; Fever; Weight loss; Night sweats | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Negative | 25-Jun-14 | ||||||||||||||||
| DLS14-20563 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 36 Y | F | Black | <-70C | 09-Jul-14 | Clinical Diagnosis | Suspect TB | Smear | Negative | 9-Jul-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Negative | 9-Jul-2014 | Signs and Symptoms | Cough; Fever; Wheezing / SoB; Night sweats; Fatigue | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Negative | 9-Jul-14 | ||||||||||||||||
| DLS14-20564 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 29 Y | M | Black | <-70C | 25-Jun-14 | Clinical Diagnosis | Suspect TB | Smear | Negative | 25-Jun-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Negative | 30-Jun-2014 | Signs and Symptoms | Cough; Fever; Weight loss; Wheezing / SoB; Night sweats; Fatigue | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Negative | 25-Jun-14 | ||||||||||||||||
| DLS14-20565 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 35 Y | M | Black | <-70C | 01-Aug-14 | Clinical Diagnosis | Suspect TB | Smear | 3 | 1-Aug-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Positive (18-Sep-14) | 1-Aug-2014 | Signs and Symptoms | Cough; Fever; Weight loss; Night sweats; Fatigue | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Negative | 1-Aug-14 | ||||||||||||||||
| DLS14-20567 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 30 Y | F | Black | <-70C | 03-Jul-14 | Clinical Diagnosis | Suspect TB | Smear | 1 | 3-Jul-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Negative | 3-Jul-2014 | Signs and Symptoms | Cough; Fever; Weight loss; Night sweats; Fatigue | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Negative | 3-Jul-14 | ||||||||||||||||
| DLS14-20569 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 41 Y | F | Black | <-70C | 20-Jun-14 | Clinical Diagnosis | Suspect TB | Smear | Negative | 20-Jun-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Negative | 30-Jun-2014 | Signs and Symptoms | Cough; Fever; Weight loss; Wheezing / SoB; Night sweats; Fatigue | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Positive | 8-May-14 | ||||||||||||||||
| DLS14-20570 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 31 Y | F | Black | <-70C | 26-Jun-14 | Clinical Diagnosis | Suspect TB | Smear | Negative | 26-Jun-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Negative | 30-Jun-2014 | Signs and Symptoms | Cough; Fever; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Positive | 2-May-14 | ||||||||||||||||
| DLS14-20571 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 31 Y | M | Black | <-70C | 04-Jul-14 | Clinical Diagnosis | Suspect TB | Smear | Negative | 4-Jul-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Negative | 4-Jul-2014 | Signs and Symptoms | Cough; Fever; Weight loss; Wheezing / SoB; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Positive | 14-Mar-14 | ||||||||||||||||
| DLS14-20572 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 30 Y | F | Black | <-70C | 21-Jul-14 | Clinical Diagnosis | Suspect TB | Smear | 1 | 21-Jul-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Positive (30-Sep-14) | 22-Jul-2014 | Signs and Symptoms | Cough; Fever; Weight loss; Wheezing / SoB; Night sweats; Fatigue | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Negative | 21-Jul-14 | ||||||||||||||||
| DLS14-20574 | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $95.00 | 35 Y | M | Black | <-70C | 19-Jun-14 | Clinical Diagnosis | Suspect TB | Smear | Negative | 19-Jun-14 | Liquid Culture | N/A | $95.00 | Solid Culture | Negative | 30-Jun-2014 | Signs and Symptoms | Cough; Fever; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | HIV Testing Result (Alere Determine HIV-1/2) | Negative | 19-Jun-14 | ||||||||||||||||
| DLS16-35660-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 27 Y | F | Hispanic | <-70C | 04-Jul-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 4-Jul-17 | Liquid Culture | Positive | 4-Jul-17 | $350.00 | Solid Culture | Positive | 8-Jul-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in Jan-2015. Previous treatment with HZRE from Jan-2015 to May-2015. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Mono-resistant TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35660-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 27 Y | F | Hispanic | <-70C | 04-Jul-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 4-Jul-17 | Liquid Culture | Positive | 4-Jul-17 | $350.00 | Solid Culture | Positive | 8-Jul-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in Jan-2015. Previous treatment with HZRE from Jan-2015 to May-2015. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Mono-resistant TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35660-RAW | Tuberculosis (TB) | Mexico | Sputum | 0.50 | 2.00 | $350.00 | 27 Y | F | Hispanic | <-70C | 04-Jul-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 4-Jul-17 | Liquid Culture | Positive | 4-Jul-17 | $350.00 | Solid Culture | Positive | 8-Jul-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in Jan-2015. Previous treatment with HZRE from Jan-2015 to May-2015. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Mono-resistant TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35661-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 39 Y | M | Hispanic | <-70C | 01-Dec-16 | Clinical Diagnosis | Suspect TB | Smear | Negative | 1-Dec-16 | Liquid Culture | Negative | 1-Dec-16 | $350.00 | Solid Culture | Negative | N/A | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in Jul-2004. Previous treatment with HZRE from Jul-2004 to Jan-2005. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : TB Detected | ||||||||||
| DLS16-35661-RAW | Tuberculosis (TB) | Mexico | Sputum | 1.00 | 2.00 | $350.00 | 39 Y | M | Hispanic | <-70C | 01-Dec-16 | Clinical Diagnosis | Suspect TB | Smear | Negative | 1-Dec-16 | Liquid Culture | Negative | 1-Dec-16 | $350.00 | Solid Culture | Negative | N/A | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in Jul-2004. Previous treatment with HZRE from Jul-2004 to Jan-2005. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : TB deteced | ||||||||||
| DLS16-35664-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 48 Y | M | Hispanic | <-70C | 08-Jun-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 8-Jun-17 | Liquid Culture | Positive | 8-Jun-17 | $350.00 | Solid Culture | Positive | 14-Jun-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35664-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 48 Y | M | Hispanic | <-70C | 08-Jun-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 8-Jun-17 | Liquid Culture | Positive | 8-Jun-17 | $350.00 | Solid Culture | Positive | 14-Jun-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35667-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 47 Y | M | Hispanic | <-70C | 18-Apr-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 18-Apr-17 | Liquid Culture | Positive | 18-Apr-17 | $350.00 | Solid Culture | Positive | 23-Apr-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Unknown if recent contact with person with TB. Previous TB diagnosis in 2012. Previous treatment with HZRE in 2012. Unknown if previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Mono-resistant TB | Diagnostic Status | Mode of transmission | HIV Seropositive | Sexual transmission | Date of Last HIV Positive Test and Test Manufacturer | Positive in 2008. Seropositive for 9 years. | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35667-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 47 Y | M | Hispanic | <-70C | 18-Apr-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 18-Apr-17 | Liquid Culture | Positive | 18-Apr-17 | $350.00 | Solid Culture | Positive | 23-Apr-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Unknown if recent contact with person with TB. Previous TB diagnosis in 2012. Previous treatment with HZRE in 2012. Unknown if previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Mono-resistant TB | Diagnostic Status | Mode of transmission | HIV Seropositive | Sexual transmission | Date of Last HIV Positive Test and Test Manufacturer | Positive in 2008. Seropositive for 9 years. | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35667-RAW | Tuberculosis (TB) | Mexico | Sputum | 1.00 | 2.00 | $350.00 | 47 Y | M | Hispanic | <-70C | 18-Apr-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 18-Apr-17 | Liquid Culture | Positive | 18-Apr-17 | $350.00 | Solid Culture | Positive | 23-Apr-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Unknown if recent contact with person with TB. Previous TB diagnosis in 2012. Previous treatment with HZRE in 2012. Unknown if previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Mono-resistant TB | Diagnostic Status | Mode of transmission | HIV Seropositive | Sexual transmission | Date of Last HIV Positive Test and Test Manufacturer | Positive in 2008. Seropositive for 9 years. | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35668-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.00 | 1.00 | $350.00 | 44 Y | F | Hispanic | <-70C | 30-Nov-16 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 30-Nov-16 | Liquid Culture | Positive | 30-Nov-16 | $350.00 | Solid Culture | Positive | 8-Dec-16 | Signs and Symptoms | Cough | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in May-2008. Previous treatment with HZRE from May-2008 to Sep-2008. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35668-NALC | Tuberculosis (TB) | Mexico | Sputum | 0.50 | 1.00 | $350.00 | 44 Y | F | Hispanic | <-70C | 30-Nov-16 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 30-Nov-16 | Liquid Culture | Positive | 30-Nov-16 | $350.00 | Solid Culture | Positive | 8-Dec-16 | Signs and Symptoms | Cough | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in May-2008. Previous treatment with HZRE from May-2008 to Sep-2008. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35668-RAW | Tuberculosis (TB) | Mexico | Sputum | 1.00 | 2.00 | $350.00 | 44 Y | F | Hispanic | <-70C | 30-Nov-16 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 30-Nov-16 | Liquid Culture | Positive | 30-Nov-16 | $350.00 | Solid Culture | Positive | 8-Dec-16 | Signs and Symptoms | Cough | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in May-2008. Previous treatment with HZRE from May-2008 to Sep-2008. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35679-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.00 | 1.00 | $350.00 | 53 Y | M | Hispanic | <-70C | 14-Sep-16 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 14-Sep-16 | Liquid Culture | Positive | 14-Sep-16 | $350.00 | Solid Culture | Positive | 20-Sep-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35679-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 53 Y | M | Hispanic | <-70C | 14-Sep-16 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 14-Sep-16 | Liquid Culture | Positive | 14-Sep-16 | $350.00 | Solid Culture | Positive | 20-Sep-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35679-RAW | Tuberculosis (TB) | Mexico | Sputum | 1.00 | 2.00 | $350.00 | 53 Y | M | Hispanic | <-70C | 14-Sep-16 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 14-Sep-16 | Liquid Culture | Positive | 14-Sep-16 | $350.00 | Solid Culture | Positive | 20-Sep-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35681-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 49 Y | M | Hispanic | <-70C | 28-Sep-16 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 28-Sep-16 | Liquid Culture | Positive | 28-Sep-16 | $350.00 | Solid Culture | Positive | 6-Oct-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Fatigue | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35681-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.00 | 1.00 | $350.00 | 49 Y | M | Hispanic | <-70C | 28-Sep-16 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 28-Sep-16 | Liquid Culture | Positive | 28-Sep-16 | $350.00 | Solid Culture | Positive | 6-Oct-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Fatigue | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35687-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 74 Y | M | Hispanic | <-70C | 18-Apr-17 | Clinical Diagnosis | Suspect TB | Smear | Negative | 18-Apr-17 | Liquid Culture | Negative | 18-Apr-17 | $350.00 | Solid Culture | Negative | N/A | Signs and Symptoms | Cough; Fever; Wheezing / Shortness of breath; Fatigue | Previous TB Exposure | Unknown if recent contact with person with TB. Previous TB diagnosis on 25-Apr-2013. Previous treatment with HZRE from 25-Apr-2013 to 19-Dec-2013. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | No TB detected | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35687-RAW | Tuberculosis (TB) | Mexico | Sputum | 2.00 | 1.00 | $350.00 | 74 Y | M | Hispanic | <-70C | 18-Apr-17 | Clinical Diagnosis | Suspect TB | Smear | Negative | 18-Apr-17 | Liquid Culture | Negative | 18-Apr-17 | $350.00 | Solid Culture | Negative | N/A | Signs and Symptoms | Cough; Fever; Wheezing / Shortness of breath; Fatigue | Previous TB Exposure | Unknown if recent contact with person with TB. Previous TB diagnosis on 25-Apr-2013. Previous treatment with HZRE from 25-Apr-2013 to 19-Dec-2013. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | No TB detected | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35689-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 32 Y | F | Hispanic | <-70C | 26-Apr-17 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 26-Apr-17 | Liquid Culture | Positive | 26-Apr-17 | $350.00 | Solid Culture | Positive | 8-May-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Mono-resistant TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35689-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 32 Y | F | Hispanic | <-70C | 26-Apr-17 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 26-Apr-17 | Liquid Culture | Positive | 26-Apr-17 | $350.00 | Solid Culture | Positive | 8-May-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Mono-resistant TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35689-RAW | Tuberculosis (TB) | Mexico | Sputum | 3.00 | 1.00 | $350.00 | 32 Y | F | Hispanic | <-70C | 26-Apr-17 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 26-Apr-17 | Liquid Culture | Positive | 26-Apr-17 | $350.00 | Solid Culture | Positive | 8-May-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Mono-resistant TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35690-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.00 | 1.00 | $350.00 | 21 Y | M | Hispanic | <-70C | 06-Dec-16 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 6-Dec-16 | Liquid Culture | Positive | 6-Dec-16 | $350.00 | Solid Culture | Positive | 9-Dec-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35690-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 21 Y | M | Hispanic | <-70C | 06-Dec-16 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 6-Dec-16 | Liquid Culture | Positive | 6-Dec-16 | $350.00 | Solid Culture | Positive | 9-Dec-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35690-RAW | Tuberculosis (TB) | Mexico | Sputum | 1.00 | 2.00 | $350.00 | 21 Y | M | Hispanic | <-70C | 06-Dec-16 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 6-Dec-16 | Liquid Culture | Positive | 6-Dec-16 | $350.00 | Solid Culture | Positive | 9-Dec-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35691-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.00 | 1.00 | $350.00 | 51 Y | F | Hispanic | <-70C | 26-Sep-16 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 26-Sep-16 | Liquid Culture | Positive | 26-Sep-16 | $350.00 | Solid Culture | Positive | 30-Sep-16 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35691-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.00 | 1.00 | $350.00 | 51 Y | F | Hispanic | <-70C | 26-Sep-16 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 26-Sep-16 | Liquid Culture | Positive | 26-Sep-16 | $350.00 | Solid Culture | Positive | 30-Sep-16 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35691-RAW | Tuberculosis (TB) | Mexico | Sputum | 1.00 | 1.00 | $350.00 | 51 Y | F | Hispanic | <-70C | 26-Sep-16 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 26-Sep-16 | Liquid Culture | Positive | 26-Sep-16 | $350.00 | Solid Culture | Positive | 30-Sep-16 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35698-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 25 Y | M | Hispanic | <-70C | 23-Nov-16 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 23-Nov-16 | Liquid Culture | Positive | 23-Nov-16 | $350.00 | Solid Culture | Positive | 29-Nov-16 | Signs and Symptoms | Cough; Wheezing / Shortness of breath | Previous TB Exposure | Recent contact with person with TB. Previous TB diagnosis in Nov-2010. Previous treatment with HZRE from Nov-2010 to 10-May-2011. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35698-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 25 Y | M | Hispanic | <-70C | 23-Nov-16 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 23-Nov-16 | Liquid Culture | Positive | 23-Nov-16 | $350.00 | Solid Culture | Positive | 29-Nov-16 | Signs and Symptoms | Cough; Wheezing / Shortness of breath | Previous TB Exposure | Recent contact with person with TB. Previous TB diagnosis in Nov-2010. Previous treatment with HZRE from Nov-2010 to 10-May-2011. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35698-RAW | Tuberculosis (TB) | Mexico | Sputum | 1.00 | 2.00 | $350.00 | 25 Y | M | Hispanic | <-70C | 23-Nov-16 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 23-Nov-16 | Liquid Culture | Positive | 23-Nov-16 | $350.00 | Solid Culture | Positive | 29-Nov-16 | Signs and Symptoms | Cough; Wheezing / Shortness of breath | Previous TB Exposure | Recent contact with person with TB. Previous TB diagnosis in Nov-2010. Previous treatment with HZRE from Nov-2010 to 10-May-2011. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35700-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 38 Y | M | Hispanic | <-70C | 25-Apr-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 25-Apr-17 | Liquid Culture | Positive | 25-Apr-17 | $350.00 | Solid Culture | Contaminated | 30-Apr-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Lymphadenopathy | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35700-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.00 | 1.00 | $350.00 | 38 Y | M | Hispanic | <-70C | 25-Apr-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 25-Apr-17 | Liquid Culture | Positive | 25-Apr-17 | $350.00 | Solid Culture | Contaminated | 30-Apr-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Lymphadenopathy | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35700-RAW | Tuberculosis (TB) | Mexico | Sputum | 2.00 | 2.00 | $350.00 | 38 Y | M | Hispanic | <-70C | 25-Apr-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 25-Apr-17 | Liquid Culture | Positive | 25-Apr-17 | $350.00 | Solid Culture | Contaminated | 30-Apr-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Lymphadenopathy | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35701-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 58 Y | M | Hispanic | <-70C | 02-Dec-16 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 2-Dec-16 | Liquid Culture | Positive | 2-Dec-16 | $350.00 | Solid Culture | Positive | 8-Dec-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35701-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 58 Y | M | Hispanic | <-70C | 02-Dec-16 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 2-Dec-16 | Liquid Culture | Positive | 2-Dec-16 | $350.00 | Solid Culture | Positive | 8-Dec-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35701-RAW | Tuberculosis (TB) | Mexico | Sputum | 3.00 | 2.00 | $350.00 | 58 Y | M | Hispanic | <-70C | 02-Dec-16 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 2-Dec-16 | Liquid Culture | Positive | 2-Dec-16 | $350.00 | Solid Culture | Positive | 8-Dec-16 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35709-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 49 Y | M | Hispanic | <-70C | 01-Dec-16 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 1-Dec-16 | Liquid Culture | Positive | 1-Dec-16 | $350.00 | Solid Culture | Positive | 9-Dec-16 | Signs and Symptoms | Cough; Night sweats | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in Oct-2010. Previous treatment with H,R,AZT,Lfx from Aug-2011 to Mar-2012. Unknown if previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | HIV Seropositive | Unknown | Date of Last HIV Positive Test and Test Manufacturer | Subject has been seropositive for 14 years | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35709-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 49 Y | M | Hispanic | <-70C | 01-Dec-16 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 1-Dec-16 | Liquid Culture | Positive | 1-Dec-16 | $350.00 | Solid Culture | Positive | 9-Dec-16 | Signs and Symptoms | Cough; Night sweats | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in Oct-2010. Previous treatment with H,R,AZT,Lfx from Aug-2011 to Mar-2012. Unknown if previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | HIV Seropositive | Unknown | Date of Last HIV Positive Test and Test Manufacturer | Subject has been seropositive for 14 years | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35709-RAW | Tuberculosis (TB) | Mexico | Sputum | 1.00 | 2.00 | $350.00 | 49 Y | M | Hispanic | <-70C | 01-Dec-16 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 1-Dec-16 | Liquid Culture | Positive | 1-Dec-16 | $350.00 | Solid Culture | Positive | 9-Dec-16 | Signs and Symptoms | Cough; Night sweats | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in Oct-2010. Previous treatment with H,R,AZT,Lfx from Aug-2011 to Mar-2012. Unknown if previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | HIV Seropositive | Unknown | Date of Last HIV Positive Test and Test Manufacturer | Subject has been seropositive for 14 years | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35714-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.00 | 1.00 | $350.00 | 51 Y | F | Hispanic | <-70C | 07-Dec-16 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 7-Dec-16 | Liquid Culture | Positive | 7-Dec-16 | $350.00 | Solid Culture | Positive | 17-Dec-16 | Signs and Symptoms | Cough; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35714-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 51 Y | F | Hispanic | <-70C | 07-Dec-16 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 7-Dec-16 | Liquid Culture | Positive | 7-Dec-16 | $350.00 | Solid Culture | Positive | 17-Dec-16 | Signs and Symptoms | Cough; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35717-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 24 Y | M | Hispanic | <-70C | 22-Nov-16 | Clinical Diagnosis | Suspect TB | Smear | Negative | 22-Nov-16 | Liquid Culture | Negative | 22-Nov-16 | $350.00 | Solid Culture | Negative | N/A | Signs and Symptoms | Cough; Night sweats; Fatigue | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | No TB detected | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Negative | ||||||||||
| DLS16-35717-RAW | Tuberculosis (TB) | Mexico | Sputum | 2.00 | 2.00 | $350.00 | 24 Y | M | Hispanic | <-70C | 22-Nov-16 | Clinical Diagnosis | Suspect TB | Smear | Negative | 22-Nov-16 | Liquid Culture | Negative | 22-Nov-16 | $350.00 | Solid Culture | Negative | N/A | Signs and Symptoms | Cough; Night sweats; Fatigue | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | No TB detected | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Negative | ||||||||||
| DLS16-35718-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 79 Y | F | Hispanic | <-70C | 27-Sep-16 | Clinical Diagnosis | Suspect TB | Smear | Negative | 27-Sep-16 | Liquid Culture | Negative | 27-Sep-16 | $350.00 | Solid Culture | Negative | N/A | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | N/A | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Negative | ||||||||||
| DLS16-35718-RAW | Tuberculosis (TB) | Mexico | Sputum | 2.50 | 1.00 | $350.00 | 79 Y | F | Hispanic | <-70C | 27-Sep-16 | Clinical Diagnosis | Suspect TB | Smear | Negative | 27-Sep-16 | Liquid Culture | Negative | 27-Sep-16 | $350.00 | Solid Culture | Negative | N/A | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | N/A | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Negative | ||||||||||
| DLS16-35719-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 69 Y | F | Hispanic | <-70C | 13-Jun-17 | Clinical Diagnosis | Suspect TB | Smear | Negative | 13-Jun-17 | Liquid Culture | Negative | 13-Jun-17 | $350.00 | Solid Culture | Contaminated | N/A | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | No TB detected | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35719-RAW | Tuberculosis (TB) | Mexico | Sputum | 2.00 | 2.00 | $350.00 | 69 Y | F | Hispanic | <-70C | 13-Jun-17 | Clinical Diagnosis | Suspect TB | Smear | Negative | 13-Jun-17 | Liquid Culture | Negative | 13-Jun-17 | $350.00 | Solid Culture | Contaminated | N/A | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | No TB detected | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35721-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 39 Y | F | Hispanic | <-70C | 13-Jun-17 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 13-Jun-17 | Liquid Culture | Positive | 13-Jun-17 | $350.00 | Solid Culture | Positive | 19-Jun-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Recent contact with person with TB. Previous TB diagnosis in Sep-2015. Previous treatment with HZRE from Sep-2015 to Mar-2016. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35721-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.00 | 1.00 | $350.00 | 39 Y | F | Hispanic | <-70C | 13-Jun-17 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 13-Jun-17 | Liquid Culture | Positive | 13-Jun-17 | $350.00 | Solid Culture | Positive | 19-Jun-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Recent contact with person with TB. Previous TB diagnosis in Sep-2015. Previous treatment with HZRE from Sep-2015 to Mar-2016. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35725-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 34 Y | F | Hispanic | <-70C | 10-Jan-17 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 10-Jan-17 | Liquid Culture | Positive | 10-Jan-17 | $350.00 | Solid Culture | Positive | 22-Jan-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35725-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 34 Y | F | Hispanic | <-70C | 10-Jan-17 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 10-Jan-17 | Liquid Culture | Positive | 10-Jan-17 | $350.00 | Solid Culture | Positive | 22-Jan-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35725-RAW | Tuberculosis (TB) | Mexico | Sputum | 2.00 | 1.00 | $350.00 | 34 Y | F | Hispanic | <-70C | 10-Jan-17 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 10-Jan-17 | Liquid Culture | Positive | 10-Jan-17 | $350.00 | Solid Culture | Positive | 22-Jan-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35726-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 35 Y | M | Hispanic | <-70C | 18-Jan-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 18-Jan-17 | Liquid Culture | Positive | 18-Jan-17 | $350.00 | Solid Culture | Positive | 22-Jan-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Fatigue | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis on 18-Nov-2015. Previous treatment with HZRE from 18-Nov-2015 to 7-Feb-2016. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Poly-resistance | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35726-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 35 Y | M | Hispanic | <-70C | 18-Jan-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 18-Jan-17 | Liquid Culture | Positive | 18-Jan-17 | $350.00 | Solid Culture | Positive | 22-Jan-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Fatigue | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis on 18-Nov-2015. Previous treatment with HZRE from 18-Nov-2015 to 7-Feb-2016. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Poly-resistance | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35726-RAW | Tuberculosis (TB) | Mexico | Sputum | 0.10 | 2.00 | $350.00 | 35 Y | M | Hispanic | <-70C | 18-Jan-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 18-Jan-17 | Liquid Culture | Positive | 18-Jan-17 | $350.00 | Solid Culture | Positive | 22-Jan-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Fatigue | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis on 18-Nov-2015. Previous treatment with HZRE from 18-Nov-2015 to 7-Feb-2016. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Poly-resistance | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35729-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 49 Y | M | Hispanic | <-70C | 14-Sep-16 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 14-Sep-16 | Liquid Culture | Positive | 14-Sep-16 | $350.00 | Solid Culture | Positive | 20-Sep-16 | Signs and Symptoms | Cough; Fever; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35729-NALC | Tuberculosis (TB) | Mexico | Sputum | 0.50 | 1.00 | $350.00 | 49 Y | M | Hispanic | <-70C | 14-Sep-16 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 14-Sep-16 | Liquid Culture | Positive | 14-Sep-16 | $350.00 | Solid Culture | Positive | 20-Sep-16 | Signs and Symptoms | Cough; Fever; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35729-RAW | Tuberculosis (TB) | Mexico | Sputum | 1.00 | 2.00 | $350.00 | 49 Y | M | Hispanic | <-70C | 14-Sep-16 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 14-Sep-16 | Liquid Culture | Positive | 14-Sep-16 | $350.00 | Solid Culture | Positive | 20-Sep-16 | Signs and Symptoms | Cough; Fever; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35739-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 22 Y | F | Hispanic | <-70C | 21-Jun-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 21-Jun-17 | Liquid Culture | Positive | 21-Jun-17 | $350.00 | Solid Culture | Positive | 29-Jun-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats | Previous TB Exposure | Recent contact with person with TB. Previous TB diagnosis on 10-May-2012. Previous treatment with HZRE from 20-May-2012 to 20-Feb-2013. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | HIV Seropositive | Birth | Date of Last HIV Positive Test and Test Manufacturer | Last test date unknown. Subject has been seropositive for 22 years | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35739-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 22 Y | F | Hispanic | <-70C | 21-Jun-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 21-Jun-17 | Liquid Culture | Positive | 21-Jun-17 | $350.00 | Solid Culture | Positive | 29-Jun-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats | Previous TB Exposure | Recent contact with person with TB. Previous TB diagnosis on 10-May-2012. Previous treatment with HZRE from 20-May-2012 to 20-Feb-2013. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | HIV Seropositive | Birth | Date of Last HIV Positive Test and Test Manufacturer | Last test date unknown. Subject has been seropositive for 22 years | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35739-RAW | Tuberculosis (TB) | Mexico | Sputum | 1.00 | 2.00 | $350.00 | 22 Y | F | Hispanic | <-70C | 21-Jun-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 21-Jun-17 | Liquid Culture | Positive | 21-Jun-17 | $350.00 | Solid Culture | Positive | 29-Jun-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats | Previous TB Exposure | Recent contact with person with TB. Previous TB diagnosis on 10-May-2012. Previous treatment with HZRE from 20-May-2012 to 20-Feb-2013. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | HIV Seropositive | Birth | Date of Last HIV Positive Test and Test Manufacturer | Last test date unknown. Subject has been seropositive for 22 years | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35745-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 28 Y | M | Hispanic | <-70C | 07-Jun-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 7-Jun-17 | Liquid Culture | Positive | 7-Jun-17 | $350.00 | Solid Culture | Positive | 14-Jun-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35745-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 28 Y | M | Hispanic | <-70C | 07-Jun-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 7-Jun-17 | Liquid Culture | Positive | 7-Jun-17 | $350.00 | Solid Culture | Positive | 14-Jun-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35746-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 24 Y | M | Hispanic | <-70C | 07-Jun-17 | Clinical Diagnosis | Suspect TB | Smear | Negative | 7-Jun-17 | Liquid Culture | Negative | 7-Jun-17 | $350.00 | Solid Culture | Negative | N/A | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | No TB detected | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35746-RAW | Tuberculosis (TB) | Mexico | Sputum | 3.00 | 2.00 | $350.00 | 24 Y | M | Hispanic | <-70C | 07-Jun-17 | Clinical Diagnosis | Suspect TB | Smear | Negative | 7-Jun-17 | Liquid Culture | Negative | 7-Jun-17 | $350.00 | Solid Culture | Negative | N/A | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | No TB detected | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35748-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 70 Y | F | Hispanic | <-70C | 22-Sep-16 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 22-Sep-16 | Liquid Culture | Positive | 22-Sep-16 | $350.00 | Solid Culture | Positive | 29-Sep-16 | Signs and Symptoms | Cough | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in 1962. Previous treatment with HZRE from Mar-1962 to Mar-1963. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35748-NALC | Tuberculosis (TB) | Mexico | Sputum | 0.75 | 1.00 | $350.00 | 70 Y | F | Hispanic | <-70C | 22-Sep-16 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 22-Sep-16 | Liquid Culture | Positive | 22-Sep-16 | $350.00 | Solid Culture | Positive | 29-Sep-16 | Signs and Symptoms | Cough | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in 1962. Previous treatment with HZRE from Mar-1962 to Mar-1963. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35748-RAW | Tuberculosis (TB) | Mexico | Sputum | 2.00 | 2.00 | $350.00 | 70 Y | F | Hispanic | <-70C | 22-Sep-16 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 22-Sep-16 | Liquid Culture | Positive | 22-Sep-16 | $350.00 | Solid Culture | Positive | 29-Sep-16 | Signs and Symptoms | Cough | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in 1962. Previous treatment with HZRE from Mar-1962 to Mar-1963. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35750-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 43 Y | F | Hispanic | <-70C | 19-Sep-16 | Clinical Diagnosis | Suspect TB | Smear | Negative | 19-Sep-16 | Liquid Culture | Negative | 19-Sep-16 | $350.00 | Solid Culture | Negative | N/A | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Unknown if recent contact with person with TB. Previous TB diagnosis in Jan-2005. Previous treatment with DOTBAL from Jan-2005 to Jun-2005. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | N/A | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Negative | ||||||||||
| DLS16-35750-RAW | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 2.00 | $350.00 | 43 Y | F | Hispanic | <-70C | 19-Sep-16 | Clinical Diagnosis | Suspect TB | Smear | Negative | 19-Sep-16 | Liquid Culture | Negative | 19-Sep-16 | $350.00 | Solid Culture | Negative | N/A | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Unknown if recent contact with person with TB. Previous TB diagnosis in Jan-2005. Previous treatment with DOTBAL from Jan-2005 to Jun-2005. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | N/A | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Negative | ||||||||||
| DLS16-35752-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 18 Y | M | Hispanic | <-70C | 29-Nov-16 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 29-Nov-16 | Liquid Culture | Positive | 29-Nov-16 | $350.00 | Solid Culture | Positive | 8-Dec-16 | Signs and Symptoms | Cough; Fever; Wheezing / Shortness of breath; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35752-NALC | Tuberculosis (TB) | Mexico | Sputum | 0.50 | 1.00 | $350.00 | 18 Y | M | Hispanic | <-70C | 29-Nov-16 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 29-Nov-16 | Liquid Culture | Positive | 29-Nov-16 | $350.00 | Solid Culture | Positive | 8-Dec-16 | Signs and Symptoms | Cough; Fever; Wheezing / Shortness of breath; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35752-RAW | Tuberculosis (TB) | Mexico | Sputum | 0.50 | 2.00 | $350.00 | 18 Y | M | Hispanic | <-70C | 29-Nov-16 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 29-Nov-16 | Liquid Culture | Positive | 29-Nov-16 | $350.00 | Solid Culture | Positive | 8-Dec-16 | Signs and Symptoms | Cough; Fever; Wheezing / Shortness of breath; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | MGIT 960 SIRE : Positive | ||||||||||
| DLS16-35755-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 32 Y | M | Hispanic | <-70C | 24-Apr-17 | Clinical Diagnosis | Suspect TB | Smear | Negative | 24-Apr-17 | Liquid Culture | Negative | 24-Apr-17 | $350.00 | Solid Culture | Negative | N/A | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | No TB detected | Diagnostic Status | Mode of transmission | HIV Seropositive | Sexual transmission | Date of Last HIV Positive Test and Test Manufacturer | Last Positive Test on 21-Mar-2017. Seropositive for 13 years. | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35755-RAW | Tuberculosis (TB) | Mexico | Sputum | 2.00 | 2.00 | $350.00 | 32 Y | M | Hispanic | <-70C | 24-Apr-17 | Clinical Diagnosis | Suspect TB | Smear | Negative | 24-Apr-17 | Liquid Culture | Negative | 24-Apr-17 | $350.00 | Solid Culture | Negative | N/A | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | No TB detected | Diagnostic Status | Mode of transmission | HIV Seropositive | Sexual transmission | Date of Last HIV Positive Test and Test Manufacturer | Last Positive Test on 21-Mar-2017. Seropositive for 13 years. | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35659-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 54 Y | M | Hispanic | <-70C | 09-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 9-Aug-17 | Liquid Culture | Positive | 9-Aug-17 | $350.00 | Solid Culture | Positive | 30-Aug-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35659-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 54 Y | M | Hispanic | <-70C | 09-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 9-Aug-17 | Liquid Culture | Positive | 9-Aug-17 | $350.00 | Solid Culture | Positive | 30-Aug-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35669-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 40 Y | M | Hispanic | <-70C | 04-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 4-Aug-17 | Liquid Culture | Positive | 4-Aug-17 | $350.00 | Solid Culture | Positive | 23-Aug-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in May-2015. Previous treatment with HZRE from May-2015 to Nov-2015. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | HIV Seropositive | IV Drug Abuse | Date of Last HIV Positive Test and Test Manufacturer | Positive in 2013. Seropositive for 4 years. | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35669-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 40 Y | M | Hispanic | <-70C | 04-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 4-Aug-17 | Liquid Culture | Positive | 4-Aug-17 | $350.00 | Solid Culture | Positive | 23-Aug-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in May-2015. Previous treatment with HZRE from May-2015 to Nov-2015. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | HIV Seropositive | IV Drug Abuse | Date of Last HIV Positive Test and Test Manufacturer | Positive in 2013. Seropositive for 4 years. | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35671-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 56 Y | M | Hispanic | <-70C | 05-Jul-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 5-Jul-17 | Liquid Culture | Positive | 5-Jul-17 | $350.00 | Solid Culture | Positive | 7-Aug-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35671-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 56 Y | M | Hispanic | <-70C | 05-Jul-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 5-Jul-17 | Liquid Culture | Positive | 5-Jul-17 | $350.00 | Solid Culture | Positive | 7-Aug-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35673-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 19 Y | M | Hispanic | <-70C | 12-Jul-17 | Clinical Diagnosis | Suspect TB | Smear | Negative | 12-Jul-17 | Liquid Culture | Negative | 12-Jul-17 | $350.00 | Solid Culture | Negative | N/A | Signs and Symptoms | Cough; Night sweats | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in Feb-2016. Previous treatment with HZRE from Mar-2016 to Aug-2016. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | No TB detected | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35673-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 19 Y | M | Hispanic | <-70C | 12-Jul-17 | Clinical Diagnosis | Suspect TB | Smear | Negative | 12-Jul-17 | Liquid Culture | Negative | 12-Jul-17 | $350.00 | Solid Culture | Negative | N/A | Signs and Symptoms | Cough; Night sweats | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in Feb-2016. Previous treatment with HZRE from Mar-2016 to Aug-2016. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | No TB detected | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35673-RAW | Tuberculosis (TB) | Mexico | Sputum | 2.00 | 2.00 | $350.00 | 19 Y | M | Hispanic | <-70C | 12-Jul-17 | Clinical Diagnosis | Suspect TB | Smear | Negative | 12-Jul-17 | Liquid Culture | Negative | 12-Jul-17 | $350.00 | Solid Culture | Negative | N/A | Signs and Symptoms | Cough; Night sweats | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in Feb-2016. Previous treatment with HZRE from Mar-2016 to Aug-2016. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | No TB detected | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35674-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 33 Y | M | Hispanic | <-70C | 21-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 21-Aug-17 | Liquid Culture | Positive | 21-Aug-17 | $350.00 | Solid Culture | Positive | 14-Sep-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Lymphadenopathy | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | HIV Seropositive | Unknown | Date of Last HIV Positive Test and Test Manufacturer | Positive on 15-May-2017. Seropositive for 1 year. | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35674-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 33 Y | M | Hispanic | <-70C | 21-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 21-Aug-17 | Liquid Culture | Positive | 21-Aug-17 | $350.00 | Solid Culture | Positive | 14-Sep-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Lymphadenopathy | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | HIV Seropositive | Unknown | Date of Last HIV Positive Test and Test Manufacturer | Positive on 15-May-2017. Seropositive for 1 year. | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35683-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 21 Y | M | Hispanic | <-70C | 12-Sep-17 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 12-Sep-17 | Liquid Culture | Positive | 12-Sep-17 | $350.00 | Solid Culture | Positive | 10-Oct-17 | Signs and Symptoms | Cough; Fever; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35683-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 21 Y | M | Hispanic | <-70C | 12-Sep-17 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 12-Sep-17 | Liquid Culture | Positive | 12-Sep-17 | $350.00 | Solid Culture | Positive | 10-Oct-17 | Signs and Symptoms | Cough; Fever; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35683-RAW | Tuberculosis (TB) | Mexico | Sputum | 4.00 | 1.00 | $350.00 | 21 Y | M | Hispanic | <-70C | 12-Sep-17 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 12-Sep-17 | Liquid Culture | Positive | 12-Sep-17 | $350.00 | Solid Culture | Positive | 10-Oct-17 | Signs and Symptoms | Cough; Fever; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35693-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 39 Y | M | Hispanic | <-70C | 24-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 24-Aug-17 | Liquid Culture | Positive | 24-Aug-17 | $350.00 | Solid Culture | Positive | 6-Sep-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35693-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 39 Y | M | Hispanic | <-70C | 24-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 24-Aug-17 | Liquid Culture | Positive | 24-Aug-17 | $350.00 | Solid Culture | Positive | 6-Sep-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35694-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 19 Y | F | Hispanic | <-70C | 28-Sep-17 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 28-Sep-17 | Liquid Culture | Positive | 28-Sep-17 | $350.00 | Solid Culture | Positive | 10-Oct-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35694-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 19 Y | F | Hispanic | <-70C | 28-Sep-17 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 28-Sep-17 | Liquid Culture | Positive | 28-Sep-17 | $350.00 | Solid Culture | Positive | 10-Oct-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35710-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 19 Y | F | Hispanic | <-70C | 04-Sep-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 4-Sep-17 | Liquid Culture | Positive | 4-Sep-17 | $350.00 | Solid Culture | Positive | 18-Sep-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | N/A | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35710-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 19 Y | F | Hispanic | <-70C | 04-Sep-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 4-Sep-17 | Liquid Culture | Positive | 4-Sep-17 | $350.00 | Solid Culture | Positive | 18-Sep-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | N/A | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35710-RAW | Tuberculosis (TB) | Mexico | Sputum | 3.00 | 1.00 | $350.00 | 19 Y | F | Hispanic | <-70C | 04-Sep-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 4-Sep-17 | Liquid Culture | Positive | 4-Sep-17 | $350.00 | Solid Culture | Positive | 18-Sep-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | N/A | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35711-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 21 Y | F | Hispanic | <-70C | 27-Sep-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 27-Sep-17 | Liquid Culture | Positive | 27-Sep-17 | $350.00 | Solid Culture | Positive | 2-Oct-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | N/A | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35711-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 21 Y | F | Hispanic | <-70C | 27-Sep-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 27-Sep-17 | Liquid Culture | Positive | 27-Sep-17 | $350.00 | Solid Culture | Positive | 2-Oct-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | N/A | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35711-RAW | Tuberculosis (TB) | Mexico | Sputum | 3.00 | 2.00 | $350.00 | 21 Y | F | Hispanic | <-70C | 27-Sep-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 27-Sep-17 | Liquid Culture | Positive | 27-Sep-17 | $350.00 | Solid Culture | Positive | 2-Oct-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | N/A | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35712-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 21 Y | M | Hispanic | <-70C | 21-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 21-Aug-17 | Liquid Culture | Positive | 21-Aug-17 | $350.00 | Solid Culture | Positive | 15-Sep-17 | Signs and Symptoms | Cough; Weight loss / Anorexia | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35712-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 21 Y | M | Hispanic | <-70C | 21-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 21-Aug-17 | Liquid Culture | Positive | 21-Aug-17 | $350.00 | Solid Culture | Positive | 15-Sep-17 | Signs and Symptoms | Cough; Weight loss / Anorexia | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35712-RAW | Tuberculosis (TB) | Mexico | Sputum | 3.00 | 2.00 | $350.00 | 21 Y | M | Hispanic | <-70C | 21-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 21-Aug-17 | Liquid Culture | Positive | 21-Aug-17 | $350.00 | Solid Culture | Positive | 15-Sep-17 | Signs and Symptoms | Cough; Weight loss / Anorexia | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35722-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 29 Y | M | Hispanic | <-70C | 22-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 22-Aug-17 | Liquid Culture | Positive | 22-Aug-17 | $350.00 | Solid Culture | Positive | 13-Sep-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in Sep-2016. Previous treatment from Sep-2016 to Jan-2017. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | HIV Seropositive | Sexual transmission | Date of Last HIV Positive Test and Test Manufacturer | Last Positive test on Jun-2017. Seropositive for 5 years. | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35722-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 29 Y | M | Hispanic | <-70C | 22-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 22-Aug-17 | Liquid Culture | Positive | 22-Aug-17 | $350.00 | Solid Culture | Positive | 13-Sep-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in Sep-2016. Previous treatment from Sep-2016 to Jan-2017. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | HIV Seropositive | Sexual transmission | Date of Last HIV Positive Test and Test Manufacturer | Last Positive test on Jun-2017. Seropositive for 5 years. | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35722-RAW | Tuberculosis (TB) | Mexico | Sputum | 3.00 | 1.00 | $350.00 | 29 Y | M | Hispanic | <-70C | 22-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 22-Aug-17 | Liquid Culture | Positive | 22-Aug-17 | $350.00 | Solid Culture | Positive | 13-Sep-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in Sep-2016. Previous treatment from Sep-2016 to Jan-2017. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | HIV Seropositive | Sexual transmission | Date of Last HIV Positive Test and Test Manufacturer | Last Positive test on Jun-2017. Seropositive for 5 years. | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35723-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.25 | 1.00 | $350.00 | 53 Y | M | Hispanic | <-70C | 24-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 24-Aug-17 | Liquid Culture | Positive | 24-Aug-17 | $350.00 | Solid Culture | Positive | 10-Sep-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath | Previous TB Exposure | Unknown if recent contact with person with TB. Previous TB diagnosis in Dec-2015. Previous treatment with HRZE from Dec-2015 to May-2016. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35723-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 53 Y | M | Hispanic | <-70C | 24-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 24-Aug-17 | Liquid Culture | Positive | 24-Aug-17 | $350.00 | Solid Culture | Positive | 10-Sep-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath | Previous TB Exposure | Unknown if recent contact with person with TB. Previous TB diagnosis in Dec-2015. Previous treatment with HRZE from Dec-2015 to May-2016. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35724-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 70 Y | M | Hispanic | <-70C | 28-Jun-17 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 28-Jun-17 | Liquid Culture | Positive | 28-Jun-17 | $350.00 | Solid Culture | Positive | 10-Jul-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Mono-resistant TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35724-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.00 | 1.00 | $350.00 | 70 Y | M | Hispanic | <-70C | 28-Jun-17 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 28-Jun-17 | Liquid Culture | Positive | 28-Jun-17 | $350.00 | Solid Culture | Positive | 10-Jul-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Mono-resistant TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35731-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.25 | 1.00 | $350.00 | 18 Y | M | Hispanic | <-70C | 28-Sep-17 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 28-Sep-17 | Liquid Culture | Positive | 28-Sep-17 | $350.00 | Solid Culture | Positive | 12-Oct-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35731-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 18 Y | M | Hispanic | <-70C | 28-Sep-17 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 28-Sep-17 | Liquid Culture | Positive | 28-Sep-17 | $350.00 | Solid Culture | Positive | 12-Oct-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35731-RAW | Tuberculosis (TB) | Mexico | Sputum | 3.00 | 2.00 | $350.00 | 18 Y | M | Hispanic | <-70C | 28-Sep-17 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 28-Sep-17 | Liquid Culture | Positive | 28-Sep-17 | $350.00 | Solid Culture | Positive | 12-Oct-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35738-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 34 Y | F | Hispanic | <-70C | 21-Jul-17 | Clinical Diagnosis | Suspect TB | Smear | Negative | 21-Jul-17 | Liquid Culture | Positive | 21-Jul-17 | $350.00 | Solid Culture | Positive | 17-Aug-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in 2000. Previous treatment with HZRE in 2000. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | HIV Seropositive | Sexual transmission | Date of Last HIV Positive Test and Test Manufacturer | Last test date unknown. Subject has been seropositive for 17 years | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35738-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 34 Y | F | Hispanic | <-70C | 21-Jul-17 | Clinical Diagnosis | Suspect TB | Smear | Negative | 21-Jul-17 | Liquid Culture | Positive | 21-Jul-17 | $350.00 | Solid Culture | Positive | 17-Aug-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in 2000. Previous treatment with HZRE in 2000. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | HIV Seropositive | Sexual transmission | Date of Last HIV Positive Test and Test Manufacturer | Last test date unknown. Subject has been seropositive for 17 years | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35738-RAW | Tuberculosis (TB) | Mexico | Sputum | 4.00 | 2.00 | $350.00 | 34 Y | F | Hispanic | <-70C | 21-Jul-17 | Clinical Diagnosis | Suspect TB | Smear | Negative | 21-Jul-17 | Liquid Culture | Positive | 21-Jul-17 | $350.00 | Solid Culture | Positive | 17-Aug-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in 2000. Previous treatment with HZRE in 2000. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | HIV Seropositive | Sexual transmission | Date of Last HIV Positive Test and Test Manufacturer | Last test date unknown. Subject has been seropositive for 17 years | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35741-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 36 Y | M | Hispanic | <-70C | 04-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 4-Aug-17 | Liquid Culture | Positive | 4-Aug-17 | $350.00 | Solid Culture | Positive | 23-Aug-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Previous TB Exposure | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35741-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 36 Y | M | Hispanic | <-70C | 04-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 4-Aug-17 | Liquid Culture | Positive | 4-Aug-17 | $350.00 | Solid Culture | Positive | 23-Aug-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Previous TB Exposure | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35742-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 32 Y | M | Hispanic | <-70C | 02-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 2-Aug-17 | Liquid Culture | Positive | 2-Aug-17 | $350.00 | Solid Culture | Positive | 16-Aug-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Fatigue | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35742-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 32 Y | M | Hispanic | <-70C | 02-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 2-Aug-17 | Liquid Culture | Positive | 2-Aug-17 | $350.00 | Solid Culture | Positive | 16-Aug-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Fatigue | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35742-RAW | Tuberculosis (TB) | Mexico | Sputum | 3.00 | 2.00 | $350.00 | 32 Y | M | Hispanic | <-70C | 02-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 2-Aug-17 | Liquid Culture | Positive | 2-Aug-17 | $350.00 | Solid Culture | Positive | 16-Aug-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Fatigue | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35744-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 48 Y | M | Hispanic | <-70C | 12-Jul-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 12-Jul-17 | Liquid Culture | Positive | 12-Jul-17 | $350.00 | Solid Culture | Positive | 4-Aug-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pansusceptible Pulmonary Tuberculosis | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35744-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 48 Y | M | Hispanic | <-70C | 12-Jul-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 12-Jul-17 | Liquid Culture | Positive | 12-Jul-17 | $350.00 | Solid Culture | Positive | 4-Aug-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pansusceptible Pulmonary Tuberculosis | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35747-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 40 Y | M | Hispanic | <-70C | 20-Jul-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 20-Jul-17 | Liquid Culture | Positive | 20-Jul-17 | $350.00 | Solid Culture | Positive | 4-Aug-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Recent contact with person with TB. Previous TB diagnosis in Jan-2008. Previous treatment with HZRE from Jan-2008 until Aug-2008. Unknown if previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35747-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 40 Y | M | Hispanic | <-70C | 20-Jul-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 20-Jul-17 | Liquid Culture | Positive | 20-Jul-17 | $350.00 | Solid Culture | Positive | 4-Aug-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Recent contact with person with TB. Previous TB diagnosis in Jan-2008. Previous treatment with HZRE from Jan-2008 until Aug-2008. Unknown if previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35749-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 32 Y | M | Hispanic | <-70C | 23-Jun-17 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 23-Jun-17 | Liquid Culture | Positive | 23-Jun-17 | $350.00 | Solid Culture | Positive | 29-Jun-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure | Recent contact with person with TB. Previous TB diagnosis in 1998. Previous treatment (cannot remember which treatment). No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35749-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 32 Y | M | Hispanic | <-70C | 23-Jun-17 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 23-Jun-17 | Liquid Culture | Positive | 23-Jun-17 | $350.00 | Solid Culture | Positive | 29-Jun-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure | Recent contact with person with TB. Previous TB diagnosis in 1998. Previous treatment (cannot remember which treatment). No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35749-RAW | Tuberculosis (TB) | Mexico | Sputum | 2.00 | 2.00 | $350.00 | 32 Y | M | Hispanic | <-70C | 23-Jun-17 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 23-Jun-17 | Liquid Culture | Positive | 23-Jun-17 | $350.00 | Solid Culture | Positive | 29-Jun-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue; Lymphadenopathy | Previous TB Exposure | Recent contact with person with TB. Previous TB diagnosis in 1998. Previous treatment (cannot remember which treatment). No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | MTB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35751-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 29 Y | M | Hispanic | <-70C | 03-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 3-Aug-17 | Liquid Culture | Positive | 3-Aug-17 | $350.00 | Solid Culture | Positive | 16-Aug-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35751-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 29 Y | M | Hispanic | <-70C | 03-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 3-Aug-17 | Liquid Culture | Positive | 3-Aug-17 | $350.00 | Solid Culture | Positive | 16-Aug-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35753-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 38 Y | M | Hispanic | <-70C | 17-Jul-17 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 17-Jul-17 | Liquid Culture | Positive | 17-Jul-17 | $350.00 | Solid Culture | Positive | 9-Aug-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in 2010. Previous treatment with HZRE 2010. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35753-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 38 Y | M | Hispanic | <-70C | 17-Jul-17 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 17-Jul-17 | Liquid Culture | Positive | 17-Jul-17 | $350.00 | Solid Culture | Positive | 9-Aug-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in 2010. Previous treatment with HZRE 2010. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35753-RAW | Tuberculosis (TB) | Mexico | Sputum | 3.00 | 1.00 | $350.00 | 38 Y | M | Hispanic | <-70C | 17-Jul-17 | Clinical Diagnosis | Suspect TB | Smear | 1+ | 17-Jul-17 | Liquid Culture | Positive | 17-Jul-17 | $350.00 | Solid Culture | Positive | 9-Aug-17 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. Previous TB diagnosis in 2010. Previous treatment with HZRE 2010. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35754-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 49 Y | M | Hispanic | <-70C | 23-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 23-Aug-17 | Liquid Culture | Positive | 23-Aug-17 | $350.00 | Solid Culture | Positive | 6-Sep-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | N/A | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35754-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 49 Y | M | Hispanic | <-70C | 23-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 23-Aug-17 | Liquid Culture | Positive | 23-Aug-17 | $350.00 | Solid Culture | Positive | 6-Sep-17 | Signs and Symptoms | Cough; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | N/A | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35657-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 34 Y | M | Hispanic | <-70C | 25-Aug-17 | Clinical Diagnosis | Suspect TB | Smear | 3+ | 25-Aug-17 | Liquid Culture | Positive | 5-Nov-2017 | $350.00 | Solid Culture | Positive | 5-Sep-2017 | Signs and Symptoms | Cough; Weight loss / Anorexia; Night sweats; Fatigue | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | N/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35658-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 81 Y | F | Hispanic | <-70C | 02-Oct-17 | Clinical Diagnosis | Suspect TB | Smear | Negative | 2-Oct-17 | Liquid Culture | Negative | N/A | $350.00 | Solid Culture | Negative | N/A | Signs and Symptoms | Cough | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | No TB detected | Diagnostic Status | Mode of transmission | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35658-RAW | Tuberculosis (TB) | Mexico | Sputum | 3.00 | 1.00 | $350.00 | 81 Y | F | Hispanic | <-70C | 02-Oct-17 | Clinical Diagnosis | Suspect TB | Smear | Negative | 2-Oct-17 | Liquid Culture | Negative | N/A | $350.00 | Solid Culture | Negative | N/A | Signs and Symptoms | Cough | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | No TB detected | Diagnostic Status | Mode of transmission | N/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35756-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 29 Y | M | Hispanic | <-70C | 15-Sep-17 | Clinical Diagnosis | Suspect TB | Smear | Negative | 15-Sep-17 | Liquid Culture | Negative | N/A | $350.00 | Solid Culture | Negative | N/A | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | No TB detected | Diagnostic Status | Mode of transmission | HIV Seropositive | Sexual Transmission | Date of Last HIV Positive Test and Test Manufacturer | Positive | 13-Sep-17 | TB Molecular Test Type | N/A | |||||||||
| DLS16-35756-RAW | Tuberculosis (TB) | Mexico | Sputum | 5.00 | 2.00 | $350.00 | 29 Y | M | Hispanic | <-70C | 15-Sep-17 | Clinical Diagnosis | Suspect TB | Smear | Negative | 15-Sep-17 | Liquid Culture | Negative | N/A | $350.00 | Solid Culture | Negative | N/A | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | No TB detected | Diagnostic Status | Mode of transmission | HIV Seropositive | Sexual Transmission | Date of Last HIV Positive Test and Test Manufacturer | Positive | 13-Sep-17 | TB Molecular Test Type | N/A | |||||||||
| DLS16-35672-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 37 Y | F | Hispanic | <-70C | 04-Sep-17 | Clinical Diagnosis | Suspect TB | Smear | Negative | 4-Sep-17 | Liquid Culture | Negative | 4-Sep-2017 | $350.00 | Solid Culture | Negative | 4-Sep-2017 | Signs and Symptoms | Cough; Wheezing / Shortness of breath | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | No TB detected | Diagnostic Status | Mode of transmission | U/A | U/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35672-RAW | Tuberculosis (TB) | Mexico | Sputum | 4.00 | 1.00 | $350.00 | 37 Y | F | Hispanic | <-70C | 04-Sep-17 | Clinical Diagnosis | Suspect TB | Smear | Negative | 4-Sep-17 | Liquid Culture | Negative | 4-Sep-2017 | $350.00 | Solid Culture | Negative | 4-Sep-2017 | Signs and Symptoms | Cough; Wheezing / Shortness of breath | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | No TB detected | Diagnostic Status | Mode of transmission | U/A | U/A | Date of Last HIV Positive Test and Test Manufacturer | N/A | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35695-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.25 | 1.00 | $350.00 | 39 Y | M | Hispanic | <-70C | 20-Sep-17 | Clinical Diagnosis | Suspect TB | Smear | Negative | 20-Sep-17 | Liquid Culture | Negative | 20-Sep-2017 | $350.00 | Solid Culture | Negative | 20-Sep-2017 | Signs and Symptoms | Cough | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | No TB detected | Diagnostic Status | Mode of transmission | Negative | U/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35695-RAW | Tuberculosis (TB) | Mexico | Sputum | 4.00 | 1.00 | $350.00 | 39 Y | M | Hispanic | <-70C | 20-Sep-17 | Clinical Diagnosis | Suspect TB | Smear | Negative | 20-Sep-17 | Liquid Culture | Negative | 20-Sep-2017 | $350.00 | Solid Culture | Negative | 20-Sep-2017 | Signs and Symptoms | Cough | Previous TB Exposure | Recent contact with person with TB. No previous TB diagnosis or treatment. No previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | No TB detected | Diagnostic Status | Mode of transmission | Negative | U/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35699-NALC | Tuberculosis (TB) | Mexico | Sputum | 1.50 | 1.00 | $350.00 | 43 Y | M | Hispanic | <-70C | 26-Sep-17 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 20-Sep-17 | Liquid Culture | Positive | 20-Sep-2017 | $350.00 | Solid Culture | Positive | 26-Sep-2017 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | U/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS16-35699-ISOLATE | Tuberculosis (TB) | Mexico | Sputum | 1.25 | 1.00 | $350.00 | 43 Y | M | Hispanic | <-70C | 26-Sep-17 | Clinical Diagnosis | Suspect TB | Smear | 2+ | 20-Sep-17 | Liquid Culture | Positive | 20-Sep-2017 | $350.00 | Solid Culture | Positive | 26-Sep-2017 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats | Previous TB Exposure | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Clinical Diagnosis Following Clincial Assessment | Pulmonary TB | Diagnostic Status | Mode of transmission | Negative | U/A | Date of Last HIV Positive Test and Test Manufacturer | Negative | TB Molecular Test Type | N/A | ||||||||||
| DLS15-10635 | Tuberculosis (TB) | Uganda | Sputum | 3.00 | 1.00 | $350.00 | 20 Y | M | Black | <-70C | 04-Aug-15 | Smear 1 | 2+ | 4-Aug-15 | Solid Culture | Positive | 4-Aug-2015 | Smear 2 | 2+ | 3-Aug-15 | $350.00 | Signs and Symptoms | Cough; Fever | Date of Last Positive HIV Test | 4-Aug-15 | Mode of Transmission | Sexual transmission | Previous TB Exposure History | No recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Sample Acquisition Method | Expectorated | |||||||||||||||
| DLS15-10708 | Tuberculosis (TB) | Uganda | Sputum | 6.00 | 1.00 | $350.00 | 23 Y | M | Black | <-70C | 13-Aug-15 | Smear 1 | Negative | 13-Aug-15 | Solid Culture | Negative | 21-Aug-2015 | Smear 2 | Negative | 12-Aug-15 | $350.00 | Signs and Symptoms | Cough; Fever; Weight loss / Anorexia | Date of Last Positive HIV Test | 13-Aug-15 | Mode of Transmission | Sexual transmission | Previous TB Exposure History | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Sample Acquisition Method | Expectorated | |||||||||||||||
| DLS15-10754 | Tuberculosis (TB) | Uganda | Sputum | 4.50 | 1.00 | $350.00 | 27 Y | F | Black | <-70C | 18-Aug-15 | Smear 1 | Negative | 18-Aug-15 | Solid Culture | Negative | 21-Aug-2015 | Smear 2 | Negative | 17-Aug-15 | $350.00 | Signs and Symptoms | Cough; Fever; Fatigue | Date of Last Positive HIV Test | 18-Aug-15 | Mode of Transmission | Sexual transmission | Previous TB Exposure History | No recent contact with person with TB. No previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Sample Acquisition Method | Expectorated | |||||||||||||||
| DLS15-10767 | Tuberculosis (TB) | Uganda | Sputum | 1.75 | 1.00 | $350.00 | 20 Y | M | Black | <-70C | 12-Aug-15 | Smear 1 | Negative | 12-Aug-15 | Solid Culture | Negative | 28-Aug-16 | Smear 2 | Negative | 11-Aug-15 | $350.00 | Signs and Symptoms | Cough; Fever; Weight loss / anorexia | Date of Last Positive HIV Test | 12-Aug-15 | Mode of Transmission | Sexual transmission | Previous TB Exposure History | Unknown if recent contact with person with TB. No previous TB diagnosis or treatment. Has previous BCG vaccine. | Sample Acquisition Method | Expectorated | |||||||||||||||
| DLS15-10774 | Tuberculosis (TB) | Uganda | Sputum | 6.00 | 1.00 | $350.00 | 23 Y | F | Black | <-70C | 04-Aug-15 | Smear 1 | Negative | 4-Aug-15 | Solid Culture | Negative | 21-Aug-2015 | Smear 2 | Negative | 3-Aug-15 | $350.00 | Signs and Symptoms | Cough; Fever; Fatigue | Date of Last Positive HIV Test | 4-Aug-15 | Mode of Transmission | Sexual transmission | Previous TB Exposure History | No recent contact with person with TB. No previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Sample Acquisition Method | Expectorated | |||||||||||||||
| DLS15-10882 | Tuberculosis (TB) | Uganda | Sputum | 3.00 | 1.00 | $350.00 | 33 Y | M | Black | <-70C | 06-Aug-15 | Smear 1 | Negative | 6-Aug-15 | Solid Culture | Negative | 21-Aug-2015 | Smear 2 | Negative | 5-Aug-15 | $350.00 | Signs and Symptoms | Cough; Fever | Date of Last Positive HIV Test | 6-Aug-15 | Mode of Transmission | Sexual transmission | Previous TB Exposure History | No recent contact with person with TB. No previous TB diagnosis or treatment. Unknown if received BCG vaccine. | Sample Acquisition Method | Expectorated | |||||||||||||||
| DLS16-36102-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 18 Y | F | Black | <-70C | 16-Nov-16 | Smear | 1+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Wheezing / Shortness of breath; Night sweats | Alere Determine HIV 1/2 | Negative | 10-Jul-11 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36104-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 36 Y | F | Black | <-70C | 16-Nov-16 | Smear | 1+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Wheezing / Shortness of breath | Alere Determine HIV 1/2 | Negative | 9-Aug-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36114-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 49 Y | M | Black | <-70C | 16-Nov-16 | Smear | 1+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Negative | 10-Jul-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67663-RAW | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $450.00 | 42 Y | M | Black | <-70C | 03-Nov-16 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 23-Jun-17 | $450.00 | Symptoms | Cough; Fever; Wheezing / Shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 16-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36102-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 18 Y | F | Black | <-70C | 29-Aug-16 | Smear | 1+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Wheezing / Shortness of breath; Night sweats | Alere Determine HIV 1/2 | Negative | 10-Jul-11 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67674-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 24 Y | F | Black | <-70C | 18-Nov-16 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 18-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67684-RAW | Tuberculosis (TB) | Uganda | Sputum | 2.50 | 1.00 | $450.00 | 31 Y | F | Black | <-70C | 25-Nov-16 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Wheezing / shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 9-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36104-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 36 Y | F | Black | <-70C | 22-Aug-16 | Smear | 1+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Wheezing / Shortness of breath | Alere Determine HIV 1/2 | Negative | 9-Aug-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67700-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 37 Y | F | Black | <-70C | 25-Nov-16 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Night sweats; Fatigue; Lymphadenopathy | Alere Determine HIV 1/2 | Negative | 10-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67698-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 24 Y | M | Black | <-70C | 15-Nov-16 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Weight loss / anorexia; Wheezing / shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 15-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67704-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 30 Y | M | Black | <-70C | 24-Nov-16 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 6-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36114-RAW | Tuberculosis (TB) | Uganda | Sputum | 7.50 | 1.00 | $450.00 | 49 Y | M | Black | <-70C | 06-Sep-16 | Smear | 1+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Negative | 10-Jul-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36110-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 30 Y | M | Black | <-70C | 16-Nov-16 | Smear | 2+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Night sweats | Alere Determine HIV 1/2 | Negative | 30-Aug-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36106-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.25 | 1.00 | $450.00 | 30 Y | M | Black | <-70C | 25-Nov-16 | Smear | 2+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Negative | 1-Sep-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36078-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 36 Y | M | Black | <-70C | 25-Nov-16 | Smear | 2+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Fatigue | Alere Determine HIV 1/2 | Negative | 2-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67669-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 25 Y | F | Black | <-70C | 02-Nov-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Wheezing / Shortness of breath; Night sweats | Alere Determine HIV 1/2 | Negative | 11-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67681-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 29 Y | F | Black | <-70C | 23-Nov-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 18-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36110-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 30 Y | M | Black | <-70C | 03-Sep-16 | Smear | 2+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Night sweats | Alere Determine HIV 1/2 | Negative | 30-Aug-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36106-RAW | Tuberculosis (TB) | Uganda | Sputum | 6.00 | 1.00 | $450.00 | 30 Y | M | Black | <-70C | 28-Sep-16 | Smear | 2+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Negative | 1-Sep-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67705-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 30 Y | M | Black | <-70C | 14-Nov-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Wheezing / shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 10-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36078-RAW | Tuberculosis (TB) | Uganda | Sputum | 8.00 | 1.00 | $450.00 | 36 Y | M | Black | <-70C | 03-Oct-16 | Smear | 2+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Fatigue | Alere Determine HIV 1/2 | Negative | 2-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67707-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 39 Y | M | Black | <-70C | 11-Nov-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 23-Jun-17 | $450.00 | Symptoms | Cough; Fever; Wheezing / shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 11-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67670-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 41 Y | M | Black | <-70C | 17-Nov-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 23-Jun-17 | $450.00 | Symptoms | Cough; Fever; Wheezing / Shortness of breath; Night sweats; Lymphadenopathy | Alere Determine HIV 1/2 | Negative | 10-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67665-RAW | Tuberculosis (TB) | Uganda | Sputum | 0.75 | 1.00 | $450.00 | 26 Y | M | Black | <-70C | 22-Nov-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Wheezing / shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 22-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67666-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 22 Y | F | Black | <-70C | 08-Nov-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Weight loss / anorexia; Wheezing / shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 10-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67677-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 22 Y | F | Black | <-70C | 21-Nov-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 23-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Night sweats; Fatigue; Lymphadenopathy | Alere Determine HIV 1/2 | Negative | 10-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67701-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 25 Y | F | Black | <-70C | 16-Nov-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 23-Jun-17 | $450.00 | Symptoms | Cough; Fever; Wheezing / shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 14-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67682-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 30 Y | F | Black | <-70C | 03-Nov-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Wheezing / shortness of breath; Night sweats | Alere Determine HIV 1/2 | Negative | 3-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67709-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 27 Y | M | Black | <-70C | 09-Nov-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 23-Jun-17 | $450.00 | Symptoms | Cough; Weight loss / anorexia; Wheezing / shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 12-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67679-RAW | Tuberculosis (TB) | Uganda | Sputum | 3.00 | 1.00 | $450.00 | 28 Y | M | Black | <-70C | 03-Nov-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 23-Jun-17 | $450.00 | Symptoms | Cough; Weight loss / anorexia; Wheezing / shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 15-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67671-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.50 | 1.00 | $450.00 | 28 Y | M | Black | <-70C | 17-Nov-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Wheezing / shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 14-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67699-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 32 Y | F | Black | <-70C | 14-Nov-16 | Smear | 1+ | Culture | Negative | 8-Dec-2016 | N/A | $450.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Night sweats; Fatigue; Lymphadenopathy | Alere Determine HIV 1/2 | Negative | 14-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-67693-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 29 Y | M | Black | <-70C | 07-Nov-16 | Smear | 1+ | Culture | Negative | 8-Dec-2016 | N/A | $450.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Wheezing / shortness of breath; Night sweats | Alere Determine HIV 1/2 | Negative | 18-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-67678-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 25 Y | F | Black | <-70C | 21-Nov-16 | Smear | 2+ | Culture | Negative | 8-Dec-2016 | N/A | $450.00 | Symptoms | Cough; Fever; Wheezing / shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 10-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-67688-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 31 Y | F | Black | <-70C | 07-Nov-16 | Smear | 2+ | Culture | Negative | 8-Dec-2016 | N/A | $450.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Wheezing / shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 12-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-67691-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 33 Y | F | Black | <-70C | 10-Nov-16 | Smear | 2+ | Culture | Negative | 8-Dec-2016 | N/A | $450.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Negative | 10-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-36086-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 21 Y | F | Black | <-70C | 20-Jan-17 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Fatigue | Alere Determine HIV 1/2 | Positive | 20-Jul-13 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36148-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.25 | 1.00 | $450.00 | 23 Y | F | Black | <-70C | 25-Nov-16 | Smear | 1+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 20-May-15 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36084-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.25 | 1.00 | $450.00 | 31 Y | F | Black | <-70C | 16-Nov-16 | Smear | 1+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Night sweats | Alere Determine HIV 1/2 | Positive | 6-Feb-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36116-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 40 Y | F | Black | <-70C | 20-Dec-16 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 11-Mar-07 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36103-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 20 Y | M | Black | <-70C | 16-Nov-16 | Smear | 1+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 6-Jul-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36081-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 30 Y | M | Black | <-70C | 20-Jan-17 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 10-Apr-11 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36082-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.25 | 1.00 | $450.00 | 32 Y | M | Black | <-70C | 22-Nov-16 | Smear | 1+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Fatigue | Alere Determine HIV 1/2 | Positive | 2-Aug-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36136-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 35 Y | M | Black | <-70C | 16-Nov-16 | Smear | 1+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 3-Aug-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36155-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 37 Y | M | Black | <-70C | 20-Jan-17 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 10-Sep-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36086-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 21 Y | F | Black | <-70C | 08-Dec-16 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Fatigue | Alere Determine HIV 1/2 | Positive | 20-Jul-13 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36119-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 24 Y | F | Black | <-70C | 08-Dec-16 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 23-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 10-Oct-12 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36116-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 40 Y | F | Black | <-70C | 08-Dec-16 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 11-Mar-07 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36081-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 30 Y | M | Black | <-70C | 08-Dec-16 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 10-Apr-11 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36155-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 37 Y | M | Black | <-70C | 08-Dec-16 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 10-Sep-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36085-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 56 Y | M | Black | <-70C | 08-Dec-16 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 23-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 10-Sep-00 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67694-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 21 Y | F | Black | <-70C | 09-Nov-16 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Wheezing / shortness of breath; Night sweats; Fatigue; Lymphadenopathy | Alere Determine HIV 1/2 | Positive | 19-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36086-RAW | Tuberculosis (TB) | Uganda | Sputum | 7.50 | 1.00 | $450.00 | 21 Y | F | Black | <-70C | 18-Nov-16 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Fatigue | Alere Determine HIV 1/2 | Positive | 20-Jul-13 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36148-RAW | Tuberculosis (TB) | Uganda | Sputum | 7.50 | 1.00 | $450.00 | 23 Y | F | Black | <-70C | 04-Sep-16 | Smear | 1+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 20-May-15 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36119-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 24 Y | F | Black | <-70C | 18-Oct-16 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 23-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 10-Oct-12 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36084-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 31 Y | F | Black | <-70C | 29-Aug-16 | Smear | 1+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Night sweats | Alere Determine HIV 1/2 | Positive | 6-Feb-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36116-RAW | Tuberculosis (TB) | Uganda | Sputum | 7.00 | 1.00 | $450.00 | 40 Y | F | Black | <-70C | 07-Nov-16 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 11-Mar-07 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36103-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 20 Y | M | Black | <-70C | 29-Aug-16 | Smear | 1+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 6-Jul-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67661-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 22 Y | M | Black | <-70C | 18-Nov-16 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Night sweats; Fatigue; Lymphadenopathy | Alere Determine HIV 1/2 | Positive | 10-Sep-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36081-RAW | Tuberculosis (TB) | Uganda | Sputum | 12.50 | 1.00 | $450.00 | 30 Y | M | Black | <-70C | 14-Nov-16 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 10-Apr-11 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36082-RAW | Tuberculosis (TB) | Uganda | Sputum | 7.50 | 1.00 | $450.00 | 32 Y | M | Black | <-70C | 04-Oct-16 | Smear | 1+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Fatigue | Alere Determine HIV 1/2 | Positive | 2-Aug-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36136-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 35 Y | M | Black | <-70C | 29-Aug-16 | Smear | 1+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 3-Aug-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36155-RAW | Tuberculosis (TB) | Uganda | Sputum | 7.50 | 1.00 | $450.00 | 37 Y | M | Black | <-70C | 14-Oct-16 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 10-Sep-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36107-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 56 Y | M | Black | <-70C | 06-Oct-16 | Smear | 1+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 10-Jun-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36085-RAW | Tuberculosis (TB) | Uganda | Sputum | 10.00 | 1.00 | $450.00 | 56 Y | M | Black | <-70C | 21-Nov-16 | Smear | 1+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 23-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 10-Sep-00 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36139-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 20 Y | F | Black | <-70C | 20-Jan-17 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 12-Mar-09 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36101-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.25 | 1.00 | $450.00 | 19 Y | M | Black | <-70C | 20-Jan-17 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 12-Jun-14 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36108-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 35 Y | M | Black | <-70C | 06-Dec-16 | Smear | 2+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 9-Apr-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36149-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 40 Y | M | Black | <-70C | 20-Jan-17 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 5-Feb-07 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36139-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 20 Y | F | Black | <-70C | 08-Dec-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 12-Mar-09 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36147-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 29 Y | F | Black | <-70C | 08-Dec-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 11-Aug-08 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36101-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 19 Y | M | Black | <-70C | 08-Dec-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 12-Jun-14 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36149-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 40 Y | M | Black | <-70C | 08-Dec-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 5-Feb-07 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36147-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 0.75 | 1.00 | $450.00 | 29 Y | F | Black | <-70C | 24-Oct-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 11-Aug-08 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36139-RAW | Tuberculosis (TB) | Uganda | Sputum | 7.50 | 1.00 | $450.00 | 20 Y | F | Black | <-70C | 11-Nov-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 12-Mar-09 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36147-RAW | Tuberculosis (TB) | Uganda | Sputum | 6.00 | 1.00 | $450.00 | 29 Y | F | Black | <-70C | 24-Oct-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 11-Aug-08 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67692-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 30 Y | F | Black | <-70C | 17-Nov-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Wheezing / shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 17-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67703-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 31 Y | F | Black | <-70C | 21-Nov-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Wheezing / shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 14-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36101-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 19 Y | M | Black | <-70C | 09-Nov-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 12-Jun-14 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67710-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 28 Y | M | Black | <-70C | 25-Nov-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Wheezing / shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 11-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36108-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 35 Y | M | Black | <-70C | 06-Oct-16 | Smear | 2+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 9-Apr-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67690-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 37 Y | M | Black | <-70C | 16-Nov-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Wheezing / shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 16-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36149-RAW | Tuberculosis (TB) | Uganda | Sputum | 7.50 | 1.00 | $450.00 | 40 Y | M | Black | <-70C | 15-Nov-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 5-Feb-07 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36117-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 28 Y | F | Black | <-70C | 25-Nov-16 | Smear | 3+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 11-Jun-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36083-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.25 | 1.00 | $450.00 | 45 Y | M | Black | <-70C | 20-Dec-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 10-Sep-09 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36137-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 38 Y | F | Black | <-70C | 08-Dec-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 26-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36154-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 20 Y | M | Black | <-70C | 08-Dec-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 23-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 10-Sep-14 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36083-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 45 Y | M | Black | <-70C | 08-Dec-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 10-Sep-09 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36137-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 38 Y | F | Black | <-70C | 26-Oct-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 26-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36117-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.50 | 1.00 | $450.00 | 28 Y | F | Black | <-70C | 05-Oct-16 | Smear | 3+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 11-Jun-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36137-RAW | Tuberculosis (TB) | Uganda | Sputum | 7.50 | 1.00 | $450.00 | 38 Y | F | Black | <-70C | 26-Oct-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 26-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36154-RAW | Tuberculosis (TB) | Uganda | Sputum | 7.50 | 1.00 | $450.00 | 20 Y | M | Black | <-70C | 19-Oct-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 23-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 10-Sep-14 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-67683-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 41 Y | M | Black | <-70C | 02-Nov-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Weight loss / anorexia; Wheezing / shortness of breath; Fatigue; Lymphadenopathy | Alere Determine HIV 1/2 | Positive | 15-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36083-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.50 | 1.00 | $450.00 | 45 Y | M | Black | <-70C | 20-Oct-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 10-Sep-09 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36120-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 37 Y | M | Black | <-70C | 08-Dec-16 | Smear | 1+ | Culture | Negative | 8-Dec-2016 | N/A | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 28-Mar-13 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-36113-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 24 Y | F | Black | <-70C | 22-Sep-16 | Smear | 1+ | Culture | Negative | 31-Oct-2016 | N/A | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 2-Sep-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-67695-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 27 Y | F | Black | <-70C | 22-Dec-16 | Smear | 1+ | Culture | Negative | 13-Apr-2017 | N/A | $450.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 10-Sep-12 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-67696-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 33 Y | F | Black | <-70C | 09-Nov-16 | Smear | 1+ | Culture | Negative | 8-Dec-2016 | N/A | $450.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Night sweats; Fatigue; Lymphadenopathy | Alere Determine HIV 1/2 | Positive | 11-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-67706-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 26 Y | M | Black | <-70C | 15-Nov-16 | Smear | 1+ | Culture | Negative | 8-Dec-2016 | N/A | $450.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Wheezing / shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 12-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-36120-RAW | Tuberculosis (TB) | Uganda | Sputum | 7.50 | 1.00 | $450.00 | 37 Y | M | Black | <-70C | 11-Nov-16 | Smear | 1+ | Culture | Negative | 8-Dec-2016 | N/A | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 28-Mar-13 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-36135-RAW | Tuberculosis (TB) | Uganda | Sputum | 7.50 | 1.00 | $450.00 | 43 Y | M | Black | <-70C | 13-Sep-16 | Smear | 1+ | Culture | Negative | 31-Oct-2016 | N/A | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 9-Feb-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-36150-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 25 Y | F | Black | <-70C | 08-Dec-16 | Smear | 2+ | Culture | Negative | 8-Dec-2016 | N/A | $450.00 | Symptoms | Cough; Fever; Wheezing / Shortness of breath; Night sweats; Fatigue; Lymphadenopathy | Alere Determine HIV 1/2 | Positive | 26-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-36150-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 25 Y | F | Black | <-70C | 26-Nov-16 | Smear | 2+ | Culture | Negative | 8-Dec-2016 | N/A | $450.00 | Symptoms | Cough; Fever; Wheezing / Shortness of breath; Night sweats; Fatigue; Lymphadenopathy | Alere Determine HIV 1/2 | Positive | 26-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-67697-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 42 Y | M | Black | <-70C | 09-Nov-16 | Smear | 2+ | Culture | Negative | 8-Dec-2016 | N/A | $450.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Wheezing / shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 10-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-67668-RAW | Tuberculosis (TB) | Uganda | Sputum | 1.50 | 1.00 | $450.00 | 42 Y | M | Black | <-70C | 22-Nov-16 | Smear | 3+ | Culture | Negative | 8-Dec-2016 | N/A | $450.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Night sweats; Fatigue; Lymphadenopathy | Alere Determine HIV 1/2 | Positive | 22-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-36072-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 30 Y | F | Black | <-70C | 14-Sep-16 | Smear | 3+ | Culture | Negative | 31-Oct-2016 | N/A | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 2-Jul-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-67667-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 35 Y | F | Black | <-70C | 08-Nov-16 | Smear | 3+ | Culture | Negative | 8-Dec-2016 | N/A | $450.00 | Symptoms | Cough; Fever; Wheezing / Shortness of breath; Night sweats; Lymphadenopathy | Alere Determine HIV 1/2 | Positive | 10-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-67689-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 35 Y | F | Black | <-70C | 23-Nov-16 | Smear | 3+ | Culture | Negative | 8-Dec-2016 | N/A | $450.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Wheezing / shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 23-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-67664-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 36 Y | F | Black | <-70C | 24-Nov-16 | Smear | 3+ | Culture | Negative | 8-Dec-2016 | N/A | $450.00 | Symptoms | Cough; Fever; Weight loss / anorexia; Night sweats; Fatigue; Lymphadenopathy | Alere Determine HIV 1/2 | Positive | 14-Oct-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-67676-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 33 Y | M | Black | <-70C | 07-Nov-16 | Smear | 3+ | Culture | Negative | 8-Dec-2016 | N/A | $450.00 | Symptoms | Cough; Weight loss / anorexia; Wheezing / shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 3-Nov-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-36138-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 45 Y | F | Black | <-70C | 08-Dec-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 8-Sep-08 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36138-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 0.75 | 1.00 | $450.00 | 45 Y | F | Black | <-70C | 04-Nov-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 8-Sep-08 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36138-RAW | Tuberculosis (TB) | Uganda | Sputum | 7.50 | 1.00 | $450.00 | 45 Y | F | Black | <-70C | 04-Nov-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 8-Sep-08 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36156-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.25 | 1.00 | $450.00 | 56 Y | F | Black | <-70C | 20-Dec-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 11-Nov-03 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36153-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 40 Y | M | Black | <-70C | 20-Dec-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 11-Oct-12 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36156-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 56 Y | F | Black | <-70C | 08-Dec-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 11-Nov-03 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36153-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 40 Y | M | Black | <-70C | 08-Dec-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 11-Oct-12 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36156-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 56 Y | F | Black | <-70C | 20-Oct-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 11-Nov-03 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36153-RAW | Tuberculosis (TB) | Uganda | Sputum | 7.50 | 1.00 | $450.00 | 40 Y | M | Black | <-70C | 07-Nov-16 | Smear | 3+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 11-Oct-12 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36091-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 32 Y | M | Black | <-70C | 08-Dec-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 23-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 15-Jun-01 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36091-RAW | Tuberculosis (TB) | Uganda | Sputum | 6.00 | 1.00 | $450.00 | 32 Y | M | Black | <-70C | 11-Nov-16 | Smear | 2+ | Culture | Positive | 8-Dec-2016 | HAIN Genotype MTBDRplus | Positive | 23-Jun-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 15-Jun-01 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36152-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 64 Y | M | Black | <-70C | 27-Sep-16 | Smear | 2+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Night sweats | Alere Determine HIV 1/2 | Negative | 2-Sep-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36025-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 52 Y | M | Black | <-70C | 30-Aug-16 | Smear | 3+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Night sweats | Alere Determine HIV 1/2 | Negative | 1-Sep-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36145-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 47 Y | M | Black | <-70C | 16-Nov-16 | Smear | 3+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Night sweats | Alere Determine HIV 1/2 | Negative | 10-Sep-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36145-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 47 Y | M | Black | <-70C | 21-Sep-16 | Smear | 3+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Night sweats | Alere Determine HIV 1/2 | Negative | 10-Sep-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36025-RAW | Tuberculosis (TB) | Uganda | Sputum | 7.00 | 1.00 | $450.00 | 52 Y | M | Black | <-70C | 30-Aug-16 | Smear | 3+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Night sweats | Alere Determine HIV 1/2 | Negative | 1-Sep-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36151-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 32 Y | M | Black | <-70C | 25-Nov-16 | Smear | 1+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 10-Jun-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36151-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 32 Y | M | Black | <-70C | 28-Sep-16 | Smear | 1+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 10-Jun-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36133-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.50 | 1.00 | $450.00 | 35 Y | M | Black | <-70C | 28-Sep-16 | Smear | 1+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 30-Aug-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36118-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 36 Y | M | Black | <-70C | 18-Nov-16 | Smear | 2+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 12-May-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36140-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 42 Y | M | Black | <-70C | 16-Nov-16 | Smear | 2+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 9-Apr-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36118-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 36 Y | M | Black | <-70C | 06-Oct-16 | Smear | 2+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 12-May-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36140-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 42 Y | M | Black | <-70C | 30-Aug-16 | Smear | 2+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Alere Determine HIV 1/2 | Positive | 9-Apr-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36109-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.25 | 1.00 | $450.00 | 23 Y | F | Black | <-70C | 25-Nov-16 | Smear | 3+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 16-Jun-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36080-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.25 | 1.00 | $450.00 | 76 Y | F | Black | <-70C | 16-Nov-16 | Smear | 3+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 10-Aug-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36105-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.50 | 1.00 | $450.00 | 35 Y | M | Black | <-70C | 25-Nov-16 | Smear | 3+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Night sweats | Alere Determine HIV 1/2 | Positive | 9-Apr-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36109-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 23 Y | F | Black | <-70C | 05-Oct-16 | Smear | 3+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 16-Jun-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36080-RAW | Tuberculosis (TB) | Uganda | Sputum | 7.50 | 1.00 | $450.00 | 76 Y | F | Black | <-70C | 29-Sep-16 | Smear | 3+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 10-Aug-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36105-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 35 Y | M | Black | <-70C | 15-Sep-16 | Smear | 3+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Night sweats | Alere Determine HIV 1/2 | Positive | 9-Apr-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | ||||||||||||||
| DLS16-36144-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 49 Y | F | Black | <-70C | 09-Sep-16 | Smear | 1+ | Culture | Negative | 30-Oct-2016 | N/A | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 22-Jul-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-36071-RAW | Tuberculosis (TB) | Uganda | Sputum | 7.50 | 1.00 | $450.00 | 50 Y | M | Black | <-70C | 28-Sep-16 | Smear | 1+ | Culture | Negative | 8-Dec-2016 | N/A | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing / Shortness of breath; Night sweats; Fatigue | Alere Determine HIV 1/2 | Positive | 10-Jun-16 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | ||||||||||||||||
| DLS16-36134-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 53 Y | M | Black | <-70C | 16-Nov-16 | Smear | 1+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Fatigue | Alere Determine HIV 1/2 | U/A | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | |||||||||||||||
| DLS16-36134-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 53 Y | M | Black | <-70C | 17-Aug-16 | Smear | 1+ | Culture | Positive | 31-Oct-2016 | HAIN Genotype MTBDRplus | Positive | 27-Mar-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia; Fatigue | Alere Determine HIV 1/2 | U/A | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF, INH | |||||||||||||||
| DLS17-048369-RAW | Tuberculosis (TB) | South Africa | Sputum | 2.50 | 1.00 | $350.00 | 42 Y | M | Black | <-70C | 27-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 30-May-16 | $350.00 | Culture | Negative | 6-Jul-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats; Chest pain | Recent HIV Test | Positive | UNK-97 | Unknown test | Previous TB Exposure History | No recent contact with someone with TB. Previous TB diagnosis on UNK-2013, received 1st line treatment from Mar-2013 to Sep-2013. Previous BCG vaccine. | Last known CD4 Result | 400 | 4-Sep-13 | Current Medications | None | Acquisition Method | Expectorated | |||||||||
| DLS17-048363-RAW | Tuberculosis (TB) | South Africa | Sputum | 3.50 | 1.00 | $350.00 | 48 Y | M | Black | <-70C | 04-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 4-May-16 | $350.00 | Culture | Negative | 15-Jun-16 | Symptoms | Cough; Weight loss / Anorexia; Night sweats | Recent HIV Test | Positive | Mar-10 | Test Type N/A | Previous TB Exposure History | No recent contact with person with TB. Was diagnosed with TB previously and received treatment of Rifafour and Pyradoxine from 26-Sep-2011 until 30-Apr-2012. Unknown if previous BCG vaccine. | Last known CD4 Result | 387 | 11-Oct-13 | Current Medications | None | Acquisition Method | Induced | |||||||||
| DLS17-048403-RAW | Tuberculosis (TB) | South Africa | Sputum | 5.00 | 1.00 | $350.00 | 48 Y | M | Black | <-70C | 15-Jul-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 18-Jul-16 | $350.00 | Culture | Negative | 26-Aug-16 | Symptoms | Cough; Fever; Night sweats; Fatigue | Recent HIV Test | Positive | 2011 | Advanced Quality | Previous TB Exposure History | Recent contact with someone with TB. Previous TB diagnosis in 2012, received 2nd line treatment and Streptomycin from Feb-2012 to Oct-2012. Unknown if previous BCG vaccine. | Last known CD4 Result | 229 | 3-Dec-14 | Current Medications | None | Acquisition Method | Expectorated | |||||||||
| DLS17-048343-RAW | Tuberculosis (TB) | South Africa | Sputum | 5.00 | 1.00 | $350.00 | 33 Y | F | Black | <-70C | 29-Apr-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 3-May-16 | $350.00 | Culture | Negative | 10-Jun-16 | Symptoms | Cough; Weight loss / Anorexia; Night Sweats; Chest Pain | Recent HIV Test | Positive | 2001 | Test Type N/A | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | Last known CD4 Result | 563 | 20-Feb-15 | Current Medications | None | Acquisition Method | Expectorated | |||||||||
| DLS17-048356-RAW | Tuberculosis (TB) | South Africa | Sputum | 7.00 | 1.00 | $350.00 | 30 Y | M | Black | <-70C | 18-Jul-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 21-Jul-16 | $350.00 | Culture | Negative | 29-Aug-16 | Symptoms | Cough; Weight loss / Anorexia; Fatigue | Recent HIV Test | Positive | 16-Apr-15 | Advanced Quality | Previous TB Exposure History | Recent contact with someone with TB. Previous TB diagnosis on 26-May-2015, received Rifampin, PZA and Ethambutol from 27-May-2015 to 11-Nov-2015. Previous BCG vaccine. | Last known CD4 Result | 548 | 17-Apr-15 | Current Medications | Odimune | Acquisition Method | Expectorated | |||||||||
| DLS17-048395-RAW | Tuberculosis (TB) | South Africa | Sputum | 3.50 | 1.00 | $350.00 | 58 Y | F | Black | <-70C | 14-Jun-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 15-Jun-16 | $350.00 | Culture | Negative | 26-Jul-16 | Symptoms | Cough; Fever; Weight loss / anorexia; Wheezing / shortness of breath; Night sweats | Recent HIV Test | Positive | UNK-97 | Unknown test | Previous TB Exposure History | Recent contact with someone with TB. Previous TB diagnosis on UNK-1997, received 1st line treatment in 1997. Previous BCG vaccine. | Last known CD4 Result | 926 | 21-Aug-15 | Current Medications | None | Acquisition Method | Expectorated | |||||||||
| DLS17-048385-RAW | Tuberculosis (TB) | South Africa | Sputum | 2.50 | 1.00 | $350.00 | 53 Y | M | Black | <-70C | 20-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 23-May-16 | $350.00 | Culture | Negative | 1-Jul-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats | Recent HIV Test | Positive | 7-Sep-15 | Test type unknown | Previous TB Exposure History | No recent contact with someone with TB, previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Last known CD4 Result | 45 | 21-Sep-15 | Current Medications | None | Acquisition Method | Expectorated | |||||||||
| DLS17-048389-RAW | Tuberculosis (TB) | South Africa | Sputum | 4.00 | 1.00 | $350.00 | 29 Y | F | Black | <-70C | 07-Jun-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 8-Jun-16 | $350.00 | Culture | Negative | 19-Jul-16 | Symptoms | Cough; Night sweats | Recent HIV Test | Positive | UNK-08 | Unknown test | Previous TB Exposure History | No recent contact with someone with TB, previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Last known CD4 Result | 448 | 20-Nov-15 | Current Medications | None | Acquisition Method | Expectorated | |||||||||
| DLS17-048340-RAW | Tuberculosis (TB) | South Africa | Sputum | 3.00 | 1.00 | $350.00 | 32 Y | M | Black | <-70C | 18-Jul-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 19-Jul-16 | $350.00 | Culture | Negative | 30-Aug-16 | Symptoms | Cough; Weight loss / Anorexia; Night sweats | Recent HIV Test | Positive | UNK-13 | Unknown test | Previous TB Exposure History | Recent contact with someone with TB. Previous TB diagnosis on UNK-2013, received 1st line treatment in 2013. Previous BCG vaccine. | Last known CD4 Result | 246 | 2-Dec-15 | Current Medications | Odimune Nocte | Acquisition Method | Expectorated | |||||||||
| DLS17-048364-RAW | Tuberculosis (TB) | South Africa | Sputum | 3.00 | 1.00 | $350.00 | 48 Y | F | Black | <-70C | 24-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 25-May-16 | $350.00 | Culture | Negative | 5-Jul-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats; Chest pain | Recent HIV Test | Positive | 24-May-16 | Advanced Quality | Previous TB Exposure History | No recent contact with someone with TB, previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Last known CD4 Result | 742 | 16-Mar-16 | Current Medications | Epilim Tablets | Acquisition Method | Expectorated | |||||||||
| DLS17-048409-RAW | Tuberculosis (TB) | South Africa | Sputum | 1.50 | 1.00 | $350.00 | 58 Y | M | Black | <-70C | 24-Jun-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 27-Jun-16 | $350.00 | Culture | Negative | 8-Aug-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats; Chest pain | Recent HIV Test | Positive | 28-Mar-12 | Unknown Test | Previous TB Exposure History | No recent contact with person with TB. Previous TB diagnosis in Dec-2012, received 1st Line treatment from Dec-2012 until May-2013. Unknown if previous BCG vaccine. | Last known CD4 Result | 485 | 6-Apr-16 | Current Medications | HCTZ; Amlodipine | Acquisition Method | Expectorated | |||||||||
| DLS17-048398-RAW | Tuberculosis (TB) | South Africa | Sputum | 2.50 | 1.00 | $350.00 | 28 Y | M | Black | <-70C | 24-Jun-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 27-Jun-16 | $350.00 | Culture | Negative | 8-Aug-16 | Symptoms | Cough; Weight loss / anorexia; Wheezing / shortness of breath; Fatigue; Chest pain | Recent HIV Test | Positive | Dec-13 | Advanced Quality | Previous TB Exposure History | Recent contact with someone with TB. Previous TB diagnosis on Jan-2014, received 1st Line treatment Jan-2014 until Aug-2014. Previous BCG vaccine. | Last known CD4 Result | 971 | 10-Jun-16 | Current Medications | None | Acquisition Method | Expectorated | |||||||||
| DLS17-048396-RAW | Tuberculosis (TB) | South Africa | Sputum | 5.00 | 1.00 | $350.00 | 34 Y | F | Black | <-70C | 24-Jun-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 27-Jun-16 | $350.00 | Culture | Negative | 8-Aug-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats; Chest pain | Recent HIV Test | Positive | 22-Jun-16 | Advanced Quality | Previous TB Exposure History | Recent contact with someone with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Last known CD4 Result | 667 | 22-Jun-16 | Current Medications | None | Acquisition Method | Expectorated | |||||||||
| DLS17-048407-RAW | Tuberculosis (TB) | South Africa | Sputum | 1.50 | 1.00 | $350.00 | 27 Y | F | Black | <-70C | 28-Jun-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 29-Jun-16 | $350.00 | Culture | Negative | 10-Aug-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats | Recent HIV Test | Positive | 24-Jun-16 | Advanced Quality | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Last known CD4 Result | 101 | 28-Jun-16 | Current Medications | None | Acquisition Method | Induced | |||||||||
| DLS17-048388-RAW | Tuberculosis (TB) | South Africa | Sputum | 4.50 | 1.00 | $350.00 | 40 Y | F | Black | <-70C | 07-Jun-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 8-Jun-16 | $350.00 | Culture | Contaminated | 14-Jun-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats; Fatigue | Recent HIV Test | Positive | UNK-11 | Unknown test | Previous TB Exposure History | No recent contact with someone with TB, previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Last known CD4 Result | 194 | 12-Jul-16 | Current Medications | Defaulted Treatment | Acquisition Method | Expectorated | |||||||||
| DLS17-048348-RAW | Tuberculosis (TB) | South Africa | Sputum | 6.00 | 1.00 | $350.00 | 52 Y | M | Black | <-70C | 15-Aug-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 16-Aug-16 | $350.00 | Culture | Negative | 27-Aug-16 | Symptoms | Cough; Weight loss / Anorexia; Night sweats; Loss of appetite; Chest pain | Recent HIV Test | Positive | UNK-09 | Unknown test | Previous TB Exposure History | No recent contact with someone with TB. Previous TB diagnosis on UNK-2009, received 1st line treatment in 2009 and 2010. No previous BCG vaccine. | Last known CD4 Result | 272 | 7-Aug-16 | Current Medications | ARVs | Acquisition Method | Expectorated | |||||||||
| DLS17-048377-RAW | Tuberculosis (TB) | South Africa | Sputum | 4.00 | 1.00 | $350.00 | 42 Y | M | Black | <-70C | 16-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 17-May-16 | $350.00 | Culture | Negative | 28-Jun-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats | Recent HIV Test | Positive | 12-May-16 | Advanced Quality | Previous TB Exposure History | No recent contact with someone with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | Last known CD4 Result | 371 | 8-Aug-16 | Current Medications | Venteze | Acquisition Method | Expectorated | |||||||||
| DLS17-048382-RAW | Tuberculosis (TB) | South Africa | Sputum | 3.50 | 1.00 | $350.00 | 35 Y | F | Black | <-70C | 16-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 17-May-16 | $350.00 | Culture | Negative | 27-Jun-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats; Chest pain | Recent HIV Test | Positive | UNK-2004 | Test type unknown | Previous TB Exposure History | No recent contact with someone with TB. Previous TB diagnosis in 2014, received treatment from Jul-2014 until 2015. Previous BCG vaccine. | Last known CD4 Result | 227 | Date U/A | Current Medications | None | Acquisition Method | Expectorated | |||||||||
| DLS17-048355-RAW | Tuberculosis (TB) | South Africa | Sputum | 2.50 | 1.00 | $350.00 | 32 Y | M | Black | <-70C | 21-Jul-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 22-Jul-16 | $350.00 | Culture | Negative | 1-Sep-16 | Symptoms | Cough; Fever; Night sweats | Recent HIV Test | Negative | 21-Jul-16 | Advanced Quality | Previous TB Exposure History | No recent contact with someone with TB, previous TB diagnosis or treatment. No previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048404-RAW | Tuberculosis (TB) | South Africa | Sputum | 2.00 | 1.00 | $350.00 | 32 Y | M | Black | <-70C | 14-Jul-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 15-Jul-16 | $350.00 | Culture | Negative | 26-Aug-16 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night sweats | Recent HIV Test | Negative | 14-Jul-16 | Advanced Quality | Previous TB Exposure History | Recent contact with someone with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | Odimune Nocte | Acquisition Method | Expectorated | ||||||||||
| DLS17-048342-RAW | Tuberculosis (TB) | South Africa | Sputum | 2.50 | 1.00 | $350.00 | 34 Y | M | Black | <-70C | 21-Apr-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 22-Apr-16 | $350.00 | Culture | Negative | 2-Jun-16 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night Sweats; Chest pain | Recent HIV Test | Negative | 19-Apr-16 | One Step | Previous TB Exposure History | No recent contact with someone with TB, previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048399-RAW | Tuberculosis (TB) | South Africa | Sputum | 2.00 | 1.00 | $350.00 | 41 Y | M | Black | <-70C | 24-Jun-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 27-Jun-16 | $350.00 | Culture | Negative | 8-Aug-16 | Symptoms | Cough; Fever; Weight loss / Anorexia; Night Sweats; Chest pain | Recent HIV Test | Negative | 24-Jun-16 | Advanced Quality | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048400-RAW | Tuberculosis (TB) | South Africa | Sputum | 5.50 | 1.00 | $350.00 | 48 Y | M | Black | <-70C | 24-Jun-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 27-Jun-16 | $350.00 | Culture | Negative | 8-Aug-16 | Symptoms | Cough; Fever; Weight loss / anorexia; Wheezing / Shortness of breath; Night sweats; Chest pain | Recent HIV Test | Negative | 24-Jun-16 | Advanced Quality | Previous TB Exposure History | Recent contact with person with TB. No previous TB diagnosis or treatment. Previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048351-RAW | Tuberculosis (TB) | South Africa | Sputum | 5.00 | 1.00 | $350.00 | 32 Y | M | Black | <-70C | 04-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 4-May-16 | $350.00 | Culture | Contaminated | 10-May-16 | Symptoms | Cough; Fever; Weight loss / Anorexia; Wheezing/ shortness of breath; Night sweats; Fatigue | Recent HIV Test | Negative | 4-May-16 | One Step | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048408-RAW | Tuberculosis (TB) | South Africa | Sputum | 6.00 | 1.00 | $350.00 | 60 Y | F | Black | <-70C | 24-Jun-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 27-Jun-16 | $350.00 | Culture | Negative | 8-Aug-16 | Symptoms | Cough; Night sweats; Chest pain | Recent HIV Test | Negative | 24-Jun-16 | Advanced Quality | Previous TB Exposure History | Recent contact with person with TB. Previous TB diagnosis in 2011, received 1st Line treatment in 2011 until 2012. Previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | Ridaq | Acquisition Method | Expectorated | ||||||||||
| DLS17-048397-RAW | Tuberculosis (TB) | South Africa | Sputum | 2.50 | 1.00 | $350.00 | 51 Y | M | Black | <-70C | 14-Jul-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 15-Jul-16 | $350.00 | Culture | Negative | 25-Aug-16 | Symptoms | Cough; Night sweats; Chest pain | Recent HIV Test | Negative | 5-Feb-16 | Advanced Quality | Previous TB Exposure History | No recent contact with someone with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | Odimune Nocte | Acquisition Method | Expectorated | ||||||||||
| DLS17-048392-RAW | Tuberculosis (TB) | South Africa | Sputum | 3.00 | 1.00 | $350.00 | 48 Y | M | Black | <-70C | 13-Jun-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 14-Jun-16 | $350.00 | Culture | Negative | 21-Jul-2016 Contaminated | Symptoms | Cough; Night Sweats; Chest Pain | Recent HIV Test | Negative | 13-Jun-16 | Advanced Quality | Previous TB Exposure History | Recent contact with someone with TB. Previous TB diagnosis on Oct-2014, received 1st line treatment from 22-Oct-2014 until 2-Apr-2015. Previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048387-RAW | Tuberculosis (TB) | South Africa | Sputum | 2.50 | 1.00 | $350.00 | 28 Y | M | Black | <-70C | 06-Jun-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 7-Jun-16 | $350.00 | Culture | Negative | 18-Jul-16 | Symptoms | Cough; Weight loss / Anorexia; Chest Pain | Recent HIV Test | Negative | 6-Jun-16 | Advanced Quality | Previous TB Exposure History | No recent contact with someone with TB. Previous TB diagnosis in 2007, received 1st line treatment from Mar-2007 until Nov-2007. Unknown if previous BCG vaccine | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048384-RAW | Tuberculosis (TB) | South Africa | Sputum | 4.50 | 1.00 | $350.00 | 55 Y | F | Black | <-70C | 16-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 17-May-16 | $350.00 | Culture | Negative | 27-Jun-16 | Symptoms | Cough; Weight loss / Anorexia; Fatigue | Recent HIV Test | Negative | 16-May-16 | Advanced Quality | Previous TB Exposure History | No recent contact with someone with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048402-RAW | Tuberculosis (TB) | South Africa | Sputum | 2.50 | 1.00 | $350.00 | 18 Y | M | Black | <-70C | 15-Jul-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 18-Jul-16 | $350.00 | Culture | Negative | 26-Aug-16 | Symptoms | Cough; Weight loss / Anorexia; Fatigue; No appetite | Recent HIV Test | Negative | 15-Jul-16 | Advanced Quality | Previous TB Exposure History | No recent contact with someone with TB, previous TB diagnosis or treatment. No previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | Odimune Nocte | Acquisition Method | Expectorated | ||||||||||
| DLS17-048346-RAW | Tuberculosis (TB) | South Africa | Sputum | 3.00 | 1.00 | $350.00 | 28 Y | M | Black | <-70C | 21-Apr-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 22-Apr-16 | $350.00 | Culture | Negative | 2-Jun-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats | Recent HIV Test | Negative | 19-Apr-16 | One Step | Previous TB Exposure History | No recent contact with someone with TB, previous TB diagnosis or treatment. No previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048358-RAW | Tuberculosis (TB) | South Africa | Sputum | 4.00 | 1.00 | $350.00 | 34 Y | M | Black | <-70C | 21-Apr-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 22-Apr-16 | $350.00 | Culture | Negative | 2-Jun-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats | Recent HIV Test | Negative | 19-Apr-16 | One Step | Previous TB Exposure History | No recent contact with someone with TB, previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048345-RAW | Tuberculosis (TB) | South Africa | Sputum | 2.50 | 1.00 | $350.00 | 49 Y | F | Black | <-70C | 29-Apr-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 3-May-16 | $350.00 | Culture | Negative | 11-Jun-16 | Symptoms | Cough; Weight loss / Anorexia; Night sweats | Recent HIV Test | Negative | 26-Apr-16 | One Step | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048349-RAW | Tuberculosis (TB) | South Africa | Sputum | 3.00 | 1.00 | $350.00 | 38 Y | M | Black | <-70C | 10-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 11-May-16 | $350.00 | Culture | Negative | 21-Jun-16 | Symptoms | Cough; Weight loss / Anorexia; Night sweats | Recent HIV Test | Negative | 6-May-16 | One Step | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048380-RAW | Tuberculosis (TB) | South Africa | Sputum | 1.00 | 1.00 | $350.00 | 20 Y | M | Black | <-70C | 12-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 13-May-16 | $350.00 | Culture | Negative | 24-Jun-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats | Recent HIV Test | Negative | 10-May-16 | One Step | Previous TB Exposure History | No recent contact with someone with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048381-RAW | Tuberculosis (TB) | South Africa | Sputum | 4.50 | 1.00 | $350.00 | 49 Y | M | Black | <-70C | 13-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 16-May-16 | $350.00 | Culture | Negative | 24-Jun-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats | Recent HIV Test | Negative | 11-May-16 | One Step | Previous TB Exposure History | No recent contact with someone with TB, previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048401-RAW | Tuberculosis (TB) | South Africa | Sputum | 5.00 | 1.00 | $350.00 | 66 Y | M | Black | <-70C | 17-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 18-May-16 | $350.00 | Culture | Negative | 28-Jun-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats | Recent HIV Test | Negative | 17-May-16 | Advanced Quality | Previous TB Exposure History | No recent contact with someone with TB. Previous TB diagnosis on UNK-2011, received treatment in 2011. Unknown if previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048376-RAW | Tuberculosis (TB) | South Africa | Sputum | 2.50 | 1.00 | $350.00 | 35 Y | F | Black | <-70C | 19-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 20-May-16 | $350.00 | Culture | Negative | 30-Jun-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats | Recent HIV Test | Negative | Unknown date | Unknown test | Previous TB Exposure History | No recent contact with someone with TB. Previous TB diagnosis on UNK-2011, received 1st line treatment from May-2011 until Oct-2011. Unknown if previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048367-RAW | Tuberculosis (TB) | South Africa | Sputum | 5.00 | 1.00 | $350.00 | 37 Y | M | Black | <-70C | 19-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 20-May-16 | $350.00 | Culture | Negative | 30-Jun-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats | Recent HIV Test | Negative | 19-May-16 | One Step | Previous TB Exposure History | No recent contact with someone with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048368-RAW | Tuberculosis (TB) | South Africa | Sputum | 4.75 | 1.00 | $350.00 | 41 Y | M | Black | <-70C | 19-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 20-May-16 | $350.00 | Culture | Negative | 1-Jul-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats | Recent HIV Test | Negative | 17-May-16 | Advanced Quality | Previous TB Exposure History | No recent contact with someone with TB. Previous TB diagnosis in 2003. Received 2nd line treatment from A-2003 until Dec-2003. Previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048371-RAW | Tuberculosis (TB) | South Africa | Sputum | 1.00 | 1.00 | $350.00 | 53 Y | M | Black | <-70C | 20-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 23-May-16 | $350.00 | Culture | Negative | 1-Jul-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats | Recent HIV Test | Negative | 18-May-16 | Advanced Quality | Previous TB Exposure History | No recent contact with someone with TB, previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048365-RAW | Tuberculosis (TB) | South Africa | Sputum | 1.50 | 1.00 | $350.00 | 31 Y | M | Black | <-70C | 24-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 25-May-16 | $350.00 | Culture | Negative | 5-Jul-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats | Recent HIV Test | Negative | 24-May-16 | ABON Quality | Previous TB Exposure History | No recent contact with someone with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048383-RAW | Tuberculosis (TB) | South Africa | Sputum | 5.00 | 1.00 | $350.00 | 58 Y | M | Black | <-70C | 27-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 30-May-16 | $350.00 | Culture | Negative | 8-Jul-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats | Recent HIV Test | Positive | UNK-03 | Unknown test | Previous TB Exposure History | No recent contact with someone with TB. Previous TB diagnosis on UNK-2003, received 1st line treatment in 2003. Previous BCG vaccine | Last known CD4 Result | U/A | Current Medications | Asthma pumps | Acquisition Method | Expectorated | ||||||||||
| DLS17-048374-RAW | Tuberculosis (TB) | South Africa | Sputum | 3.50 | 1.00 | $350.00 | 23 Y | F | Black | <-70C | 25-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 26-May-16 | $350.00 | Culture | Negative | 9-Jul-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats | Recent HIV Test | Negative | 23-May-16 | ABON Quality | Previous TB Exposure History | No recent contact with someone with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048394-RAW | Tuberculosis (TB) | South Africa | Sputum | 5.00 | 1.00 | $350.00 | 39 Y | M | Black | <-70C | 15-Jun-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 17-Jun-16 | $350.00 | Culture | Negative | 27-Jul-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats | Recent HIV Test | Negative | 15-Jun-16 | Advanced Quality | Previous TB Exposure History | No recent contact with someone with TB, previous TB diagnosis or treatment. Unknown previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048405-RAW | Tuberculosis (TB) | South Africa | Sputum | 2.50 | 1.00 | $350.00 | 46 Y | M | Black | <-70C | 14-Jul-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 15-Jul-16 | $350.00 | Culture | Negative | 25-Aug-16 | Symptoms | Cough; Weight loss / Anorexia; Night sweats | Recent HIV Test | Negative | 14-Jun-16 | Advanced Quality | Previous TB Exposure History | No recent contact with someone with TB. Previous TB diagnosis in 2000, received 1st line treatment for 6 months in 2000. Unknown if previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048350-RAW | Tuberculosis (TB) | South Africa | Sputum | 2.50 | 1.00 | $350.00 | 53 Y | M | Black | <-70C | 06-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 9-May-16 | $350.00 | Culture | Negative | 17-Jun-16 | Symptoms | Cough; Weight loss / Anorexia; Night Sweats; Chest Pain | Recent HIV Test | Negative | 29-Apr-16 | One Step | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048372-RAW | Tuberculosis (TB) | South Africa | Sputum | 2.50 | 1.00 | $350.00 | 56 Y | M | Black | <-70C | 12-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 13-May-16 | $350.00 | Culture | Negative | 23-Jun-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats; Chest pain | Recent HIV Test | Negative | 29-Apr-16 | One Step | Previous TB Exposure History | No recent contact with someone with TB. Previously diagnosed with TB in 2012 and received treatment in 2012. Unknown if BCG vaccine | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048375-RAW | Tuberculosis (TB) | South Africa | Sputum | 4.00 | 1.00 | $350.00 | 57 Y | M | Black | <-70C | 26-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 27-May-16 | $350.00 | Culture | Negative | 7-Jul-16 | Symptoms | Cough; Weight loss / Anorexia; Night Sweats; Chest Pain | Recent HIV Test | Negative | 20-May-16 | ABON | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. No previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048386-RAW | Tuberculosis (TB) | South Africa | Sputum | 4.75 | 1.00 | $350.00 | 45 Y | F | Black | <-70C | 27-May-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 30-May-16 | $350.00 | Culture | Negative | 10-Jul-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats; Chest pain | Recent HIV Test | Negative | 23-May-15 | ABON Quality | Previous TB Exposure History | No recent contact with someone with TB. Previous TB diagnosis on UNK-2014, received 1st line treatment in 2014. Unknown if previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048393-RAW | Tuberculosis (TB) | South Africa | Sputum | 2.00 | 1.00 | $350.00 | 44 Y | F | Black | <-70C | 13-Jun-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 14-Jun-16 | $350.00 | Culture | Negative | 25-Jul-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats; Chest pain | Recent HIV Test | Negative | 13-Jun-16 | Advanced Quality | Previous TB Exposure History | No recent contact with someone with TB, previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048362-RAW | Tuberculosis (TB) | South Africa | Sputum | 5.00 | 1.00 | $350.00 | 57 Y | M | Black | <-70C | 31-Mar-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 1-Apr-16 | $350.00 | Culture | Negative | 17-Jun-16 | Symptoms | Cough; Weight loss / Anorexia; Night Sweats; Chest pain | Recent HIV Test | Negative | 31-Mar-16 | Advanced Quality | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048360-RAW | Tuberculosis (TB) | South Africa | Sputum | 2.00 | 1.00 | $350.00 | 49 Y | F | Black | <-70C | 07-Oct-15 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 9-Oct-15 | $350.00 | Culture | Negative | 30-Nov-15 | Symptoms | Cough; Weight loss / Anorexia; Night Sweats; Fatigue | Recent HIV Test | Negative | 5-Oct-15 | Advanced Quality | Previous TB Exposure History | No recent contact with person with TB, previous TB diagnosis or treatment. No previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048390-RAW | Tuberculosis (TB) | South Africa | Sputum | 4.00 | 1.00 | $350.00 | 25 Y | M | Black | <-70C | 07-Jun-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 8-Jun-16 | $350.00 | Culture | Negative | 19-Jul-16 | Symptoms | Cough; Weight loss / anorexia; Night sweats; Fatigue | Recent HIV Test | Negative | 3-Jun-16 | Advanced Quality | Previous TB Exposure History | No recent contact with someone with TB, previous TB diagnosis or treatment. Unknown if previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS17-048391-RAW | Tuberculosis (TB) | South Africa | Sputum | 3.00 | 1.00 | $350.00 | 54 Y | M | Black | <-70C | 08-Jun-16 | Clinical Diagnosis | Suspect TB | Cepheid GeneXpert MTB/RIF | Not Detected | Smear | Negative | 9-Jun-16 | $350.00 | Culture | Negative | 20-Jul-16 | Symptoms | Cough; Weight loss / anorexia; Wheezing / shortness of breath; Night sweats; Fatigue; Chest pain | Recent HIV Test | Negative | 6-Jun-16 | Advanced Quality | Previous TB Exposure History | No recent contact with someone with TB, previous TB diagnosis or treatment. Previous BCG vaccine. | Last known CD4 Result | U/A | Current Medications | None | Acquisition Method | Expectorated | ||||||||||
| DLS16-36008-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.50 | 1.00 | $450.00 | 27 Y | M | Black | <-70C | 26-May-17 | Smear | 2+ | 10-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Weight loss | Alere Determine HIV 1/2 | Positive | 10-Apr-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36008-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 27 Y | M | Black | <-70C | 25-Apr-17 | Smear | 2+ | 10-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Weight loss | Alere Determine HIV 1/2 | Positive | 10-Apr-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36008-RAW | Tuberculosis (TB) | Uganda | Sputum | 7.50 | 1.00 | $450.00 | 27 Y | M | Black | <-70C | 10-Apr-17 | Smear | 2+ | 10-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Weight loss | Alere Determine HIV 1/2 | Positive | 10-Apr-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36009-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 69 Y | M | Black | <-70C | 25-Apr-17 | Smear | 1+ | 3-Apr-2017 | Culture | Negative (26-Jun-17) | 25-Apr-2017 | N/A | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Negative | 3-Apr-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | Final Drug Susceptibility Results | N/A | Acquisition Method | Expectorated | |||||||||||
| DLS16-36009-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 69 Y | M | Black | <-70C | 03-Apr-17 | Smear | 1+ | 3-Apr-2017 | Culture | Negative (26-Jun-17) | 25-Apr-2017 | N/A | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Negative | 3-Apr-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | Final Drug Susceptibility Results | N/A | Acquisition Method | Expectorated | |||||||||||
| DLS16-36010-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 36 Y | F | Black | <-70C | 16-Mar-17 | Smear | 1+ | 16-Mar-2017 | Culture | Negative (26-Jun-17) | 25-Apr-2017 | N/A | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 16-Mar-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | Final Drug Susceptibility Results | N/A | Acquisition Method | Expectorated | |||||||||||
| DLS16-36011-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.50 | 1.00 | $450.00 | 37 Y | F | Black | <-70C | 26-May-17 | Smear | 1+ | 13-Mar-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 13-Mar-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36011-NALC | Tuberculosis (TB) | Uganda | NALC | 1.00 | 1.00 | $450.00 | 37 Y | F | Black | <-70C | 25-Apr-17 | Smear | 1+ | 13-Mar-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 13-Mar-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36012-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 48 Y | M | Black | <-70C | 25-Apr-17 | Smear | 1+ | 12-Apr-2017 | Culture | Negative (26-Jun-17) | 25-Apr-2017 | N/A | $450.00 | Symptoms | Cough; Fever; Night sweats | Alere Determine HIV 1/2 | Negative | 12-Apr-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | Final Drug Susceptibility Results | N/A | Acquisition Method | Expectorated | |||||||||||
| DLS16-36012-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 48 Y | M | Black | <-70C | 12-Apr-17 | Smear | 1+ | 12-Apr-2017 | Culture | Negative (26-Jun-17) | 25-Apr-2017 | N/A | $450.00 | Symptoms | Cough; Fever; Night sweats | Alere Determine HIV 1/2 | Negative | 12-Apr-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | Final Drug Susceptibility Results | N/A | Acquisition Method | Expectorated | |||||||||||
| DLS16-36013-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 40 Y | F | Black | <-70C | 25-Apr-17 | Smear | 2+ | 20-Apr-2017 | Culture | Negative (26-Jun-17) | 25-Apr-2017 | N/A | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 20-Apr-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | Final Drug Susceptibility Results | N/A | Acquisition Method | Expectorated | |||||||||||
| DLS16-36014-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.50 | 1.00 | $450.00 | 30 Y | M | Black | <-70C | 26-May-17 | Smear | 1+ | 4-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Wheezing / Shortness of breath; Fatigue | Alere Determine HIV 1/2 | Negative | 4-Apr-17 | Previous Exposure History | Unknown if has had recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36014-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 30 Y | M | Black | <-70C | 25-Apr-17 | Smear | 1+ | 4-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Wheezing / Shortness of breath; Fatigue | Alere Determine HIV 1/2 | Negative | 4-Apr-17 | Previous Exposure History | Unknown if has had recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36014-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 30 Y | M | Black | <-70C | 04-Apr-17 | Smear | 1+ | 4-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Wheezing / Shortness of breath; Fatigue | Alere Determine HIV 1/2 | Negative | 4-Apr-17 | Previous Exposure History | Unknown if has had recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36016-NALC | Tuberculosis (TB) | Uganda | NALC | 1.00 | 1.00 | $450.00 | 29 Y | M | Black | <-70C | 25-Apr-17 | Smear | 2+ | 30-Mar-2017 | Culture | Negative (26-Jun-17) | 25-Apr-2017 | N/A | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Negative | 30-Mar-17 | Previous Exposure History | Unknown if has had recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | Final Drug Susceptibility Results | N/A | Acquisition Method | Expectorated | |||||||||||
| DLS16-36016-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 29 Y | M | Black | <-70C | 30-Mar-17 | Smear | 2+ | 30-Mar-2017 | Culture | Negative (26-Jun-17) | 25-Apr-2017 | N/A | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Negative | 30-Mar-17 | Previous Exposure History | Unknown if has had recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | Final Drug Susceptibility Results | N/A | Acquisition Method | Expectorated | |||||||||||
| DLS16-36019-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.50 | 1.00 | $450.00 | 45 Y | M | Black | <-70C | 26-May-17 | Smear | 3+ | 25-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia | Alere Determine HIV 1/2 | Negative | 25-Apr-17 | Previous Exposure History | Unknown if has had recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36019-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 45 Y | M | Black | <-70C | 25-Apr-17 | Smear | 3+ | 25-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia | Alere Determine HIV 1/2 | Negative | 25-Apr-17 | Previous Exposure History | Unknown if has had recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36019-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 45 Y | M | Black | <-70C | 25-Apr-17 | Smear | 3+ | 25-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia | Alere Determine HIV 1/2 | Negative | 25-Apr-17 | Previous Exposure History | Unknown if has had recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36020-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.25 | 1.00 | $450.00 | 23 Y | M | Black | <-70C | 14-Apr-17 | Smear | 2+ | 21-Mar-2017 | Culture | Positive (14-Apr-17) | 21-Mar-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Negative | 21-Mar-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36020-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 23 Y | M | Black | <-70C | 21-Mar-17 | Smear | 2+ | 21-Mar-2017 | Culture | Positive (14-Apr-17) | 21-Mar-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Negative | 21-Mar-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36021-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.50 | 1.00 | $450.00 | 52 Y | M | Black | <-70C | 26-May-17 | Smear | 2+ | 28-Mar-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Wheezing / Shortness of breath | Alere Determine HIV 1/2 | Negative | 28-Mar-17 | Previous Exposure History | Unknown if has had recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36021-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 52 Y | M | Black | <-70C | 25-Apr-17 | Smear | 2+ | 28-Mar-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Wheezing / Shortness of breath | Alere Determine HIV 1/2 | Negative | 28-Mar-17 | Previous Exposure History | Unknown if has had recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36023-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.50 | 1.00 | $450.00 | 25 Y | M | Black | <-70C | 26-May-17 | Smear | 1+ | 10-Mar-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Wheezing / Shortness of breath | Alere Determine HIV 1/2 | Positive | 10-Mar-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36023-NALC | Tuberculosis (TB) | Uganda | NALC | 1.25 | 1.00 | $450.00 | 25 Y | M | Black | <-70C | 25-Apr-17 | Smear | 1+ | 10-Mar-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Wheezing / Shortness of breath | Alere Determine HIV 1/2 | Positive | 10-Mar-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36023-RAW | Tuberculosis (TB) | Uganda | Sputum | 7.50 | 1.00 | $450.00 | 25 Y | M | Black | <-70C | 10-Mar-17 | Smear | 1+ | 10-Mar-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Wheezing / Shortness of breath | Alere Determine HIV 1/2 | Positive | 10-Mar-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36024-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.50 | 1.00 | $450.00 | 39 Y | F | Black | <-70C | 26-May-17 | Smear | 3+ | 16-Mar-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 16-Mar-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36024-NALC | Tuberculosis (TB) | Uganda | NALC | 1.25 | 1.00 | $450.00 | 39 Y | F | Black | <-70C | 25-Apr-17 | Smear | 3+ | 16-Mar-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 16-Mar-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36024-RAW | Tuberculosis (TB) | Uganda | Sputum | 7.50 | 1.00 | $450.00 | 39 Y | F | Black | <-70C | 16-Mar-17 | Smear | 3+ | 16-Mar-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 16-Mar-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36027-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.50 | 1.00 | $450.00 | 32 Y | F | Black | <-70C | 21-Mar-17 | Smear | 3+ | 16-Mar-2017 | Culture | Positive (17-Apr-17) | 21-Mar-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 16-Mar-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36027-NALC | Tuberculosis (TB) | Uganda | NALC | 1.25 | 1.00 | $450.00 | 32 Y | F | Black | <-70C | 25-Apr-17 | Smear | 3+ | 16-Mar-2017 | Culture | Positive (17-Apr-17) | 21-Mar-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 16-Mar-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36027-RAW | Tuberculosis (TB) | Uganda | Sputum | 4.00 | 1.00 | $450.00 | 32 Y | F | Black | <-70C | 16-Mar-17 | Smear | 3+ | 16-Mar-2017 | Culture | Positive (17-Apr-17) | 21-Mar-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 16-Mar-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36030-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.50 | 1.00 | $450.00 | 30 Y | M | Black | <-70C | 26-May-17 | Smear | 1+ | 20-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Negative | 20-Apr-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36030-NALC | Tuberculosis (TB) | Uganda | NALC | 1.25 | 1.00 | $450.00 | 30 Y | M | Black | <-70C | 25-Apr-17 | Smear | 1+ | 20-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Negative | 20-Apr-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36030-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 30 Y | M | Black | <-70C | 21-Apr-17 | Smear | 1+ | 20-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Negative | 20-Apr-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36031-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.50 | 1.00 | $450.00 | 60 Y | M | Black | <-70C | 26-May-17 | Smear | 3+ | 12-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 12-Apr-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. No previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36031-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 60 Y | M | Black | <-70C | 25-Apr-17 | Smear | 3+ | 12-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 12-Apr-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. No previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36031-RAW | Tuberculosis (TB) | Uganda | Sputum | 10.00 | 1.00 | $450.00 | 60 Y | M | Black | <-70C | 12-Apr-17 | Smear | 3+ | 12-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 12-Apr-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. No previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36032-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.50 | 1.00 | $450.00 | 30 Y | M | Black | <-70C | 26-May-17 | Smear | 1+ | 25-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Negative | 25-Apr-17 | Previous Exposure History | Unknown if has had recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36032-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 30 Y | M | Black | <-70C | 25-Apr-17 | Smear | 1+ | 25-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Negative | 25-Apr-17 | Previous Exposure History | Unknown if has had recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36032-RAW | Tuberculosis (TB) | Uganda | Sputum | 10.00 | 1.00 | $450.00 | 30 Y | M | Black | <-70C | 25-Apr-17 | Smear | 1+ | 25-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Negative | 25-Apr-17 | Previous Exposure History | Unknown if has had recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36033-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.50 | 1.00 | $450.00 | 38 Y | F | Black | <-70C | 26-May-17 | Smear | 3+ | 24-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Fatigue | Alere Determine HIV 1/2 | Negative | 24-Apr-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36033-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 38 Y | F | Black | <-70C | 25-Apr-17 | Smear | 3+ | 24-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Fatigue | Alere Determine HIV 1/2 | Negative | 24-Apr-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36033-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 38 Y | F | Black | <-70C | 24-Apr-17 | Smear | 3+ | 24-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Fatigue | Alere Determine HIV 1/2 | Negative | 24-Apr-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36034-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 25 Y | M | Black | <-70C | 25-Apr-17 | Smear | 2+ | 10-Apr-2017 | Culture | Negative (26-Jun-17) | 25-Apr-2017 | N/A | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Negative | 10-Apr-17 | Previous Exposure History | Unknown if has had recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | Final Drug Susceptibility Results | N/A | Acquisition Method | Expectorated | |||||||||||
| DLS16-36034-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 25 Y | M | Black | <-70C | 10-Apr-17 | Smear | 2+ | 10-Apr-2017 | Culture | Negative (26-Jun-17) | 25-Apr-2017 | N/A | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Negative | 10-Apr-17 | Previous Exposure History | Unknown if has had recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | N/A | Final Drug Susceptibility Results | N/A | Acquisition Method | Expectorated | |||||||||||
| DLS16-36040-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.50 | 1.00 | $450.00 | 35 Y | M | Black | <-70C | 26-May-17 | Smear | 1+ | 14-Mar-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 14-Mar-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36040-NALC | Tuberculosis (TB) | Uganda | NALC | 1.25 | 1.00 | $450.00 | 35 Y | M | Black | <-70C | 25-Apr-17 | Smear | 1+ | 14-Mar-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 14-Mar-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36040-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.50 | 1.00 | $450.00 | 35 Y | M | Black | <-70C | 14-Mar-17 | Smear | 1+ | 14-Mar-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 14-Mar-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36053-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.50 | 1.00 | $450.00 | 42 Y | M | Black | <-70C | 14-Aug-17 | Smear | 2+ | 10-Mar-2017 | Culture | Positive (14-Aug-17) | 14-Jul-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Night sweats | Alere Determine HIV 1/2 | Negative | 10-Mar-17 | Previous Exposure History | Unknown if has had recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36053-NALC | Tuberculosis (TB) | Uganda | NALC | 1.25 | 1.00 | $450.00 | 42 Y | M | Black | <-70C | 14-Jul-17 | Smear | 2+ | 10-Mar-2017 | Culture | Positive (14-Aug-17) | 14-Jul-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Night sweats | Alere Determine HIV 1/2 | Negative | 10-Mar-17 | Previous Exposure History | Unknown if has had recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36054-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.50 | 1.00 | $450.00 | 18 Y | M | Black | <-70C | 17-Apr-17 | Smear | 3+ | 21-Jan-2017 | Culture | Positive (17-Apr-17) | 21-Mar-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 21-Jan-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36054-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 18 Y | M | Black | <-70C | 21-Mar-17 | Smear | 3+ | 21-Jan-2017 | Culture | Positive (17-Apr-17) | 21-Mar-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 21-Jan-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36054-RAW | Tuberculosis (TB) | Uganda | Sputum | 10.00 | 1.00 | $450.00 | 18 Y | M | Black | <-70C | 21-Jan-17 | Smear | 3+ | 21-Jan-2017 | Culture | Positive (17-Apr-17) | 21-Mar-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 21-Jan-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36055-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.00 | 1.00 | $450.00 | 60 Y | F | Black | <-70C | 26-May-17 | Smear | 2+ | 12-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 12-Apr-17 | Previous Exposure History | Unknown if has had recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36055-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 60 Y | F | Black | <-70C | 25-Apr-17 | Smear | 2+ | 12-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 12-Apr-17 | Previous Exposure History | Unknown if has had recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36067-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.50 | 1.00 | $450.00 | 25 Y | F | Black | <-70C | 26-May-17 | Smear | 1+ | 27-Mar-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia | Alere Determine HIV 1/2 | Negative | 27-Mar-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36067-NALC | Tuberculosis (TB) | Uganda | NALC | 0.50 | 1.00 | $450.00 | 25 Y | F | Black | <-70C | 25-Apr-17 | Smear | 1+ | 27-Mar-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia | Alere Determine HIV 1/2 | Negative | 27-Mar-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36067-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 25 Y | F | Black | <-70C | 27-Mar-17 | Smear | 1+ | 27-Mar-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever; Weight loss / Anorexia | Alere Determine HIV 1/2 | Negative | 27-Mar-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36068-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.50 | 1.00 | $450.00 | 43 Y | F | Black | <-70C | 26-May-17 | Smear | 1+ | 16-Mar-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 16-Mar-17 | Previous Exposure History | Unknown if has had recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36068-NALC | Tuberculosis (TB) | Uganda | NALC | 0.50 | 1.00 | $450.00 | 43 Y | F | Black | <-70C | 25-Apr-17 | Smear | 1+ | 16-Mar-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 16-Mar-17 | Previous Exposure History | Unknown if has had recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36068-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 43 Y | F | Black | <-70C | 16-Mar-17 | Smear | 1+ | 16-Mar-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 16-Mar-17 | Previous Exposure History | Unknown if has had recent contact with person with TB. Has not been diagnosed with TB previously or been treated for TB previously. Has had previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36070-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.50 | 1.00 | $450.00 | 32 Y | F | Black | <-70C | 26-May-17 | Smear | 2+ | 21-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 21-Apr-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36070-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 32 Y | F | Black | <-70C | 25-Apr-17 | Smear | 2+ | 21-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 21-Apr-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36070-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 32 Y | F | Black | <-70C | 21-Apr-17 | Smear | 2+ | 21-Apr-2017 | Culture | Positive (26-May-17) | 25-Apr-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Positive | 21-Apr-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36076-ISOLATE | Tuberculosis (TB) | Uganda | Isolate | 1.50 | 1.00 | $450.00 | 40 Y | M | Black | <-70C | 14-Aug-17 | Smear | 1+ | 10-Mar-2017 | Culture | Positive (14-Aug-17) | 14-Jul-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Negative | 10-Mar-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36076-NALC | Tuberculosis (TB) | Uganda | NALC | 1.50 | 1.00 | $450.00 | 40 Y | M | Black | <-70C | 14-Jul-17 | Smear | 1+ | 10-Mar-2017 | Culture | Positive (14-Aug-17) | 14-Jul-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Negative | 10-Mar-17 | Previous Exposure History | Has not had recent contact with person with TB, been diagnosed with TB previously or been treated for TB previously. Unknown if previous BCG vaccination. | Clinical Diagnosis Following Test Results | MTB | Sensitive for | RIF; INH | Final Drug Susceptibility Results | TB Drug Sensitive (no drug resistance) | Acquisition Method | Expectorated | |||||||||
| DLS16-36076-RAW | Tuberculosis (TB) | Uganda | Sputum | 5.00 | 1.00 | $450.00 | 40 Y | M | Black | <-70C | 10-Mar-17 | Smear | 1+ | 10-Mar-2017 | Culture | Positive (14-Aug-17) | 14-Jul-2017 | HAIN Genotype MTBDRplus | Positive | 13-Sep-17 | $450.00 | Symptoms | Cough; Fever | Alere Determine HIV 1/2 | Negative |